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ABSTRACT
Components of the fibrinolytic system are reviewed,
with particular reference to urokinase type (uPA), tissue
type (tPA) plasminogen activators and plasminogen in tissues
both iri vivo and in vitro. Methods which may be used to
demonstrate the presence of plasminogen activators in tissues
are described. Both uPA and tPA were identified in
histological sections of normal and malignant epithelial
cells by fibrinolytic autography and immunocytochemica1
staining.
A method for culturing oral keratinocytes from normal
gingival mucosa and from oral squamous cell carcinomas was
developed. Morphological and biochemical markers of cultured
cells were consistent with their tissue of origin. Cultured
cells synthesized and secreted plasminogen activators
predominantly of the uPA type. Plasminogen activator
activity was significantly higher in gingival epithelial
cultures than in tumour cultures when assayed by the fibrin
plate method. However, analysis of culture supernatants
after separation of plasminogen activators, from inhibitors
by polyacrylamide gel electrophoresis indicated that tumour
cultures contained high levels of plasminogen activator which
were masked by the presence of inhibitors in the
supernatants. These findings are consistent with previous
observations that plasminogen activator activity is
increased in malignant cells when compared with normal cells
from similar tissue.
xxvii
Immunocytochemical examination of normal and malignant
oral epithelium demonstrated the presence of plasminogen in
epithelial cells. Binding of plasminogen activators to
plasminogen is known to protect plasminogen activators from
the action of inhibitors and its presence in tumours may
enhance local generation of plasmin by tumour plasminogen
activators.
In this study, plasminogen activators have been located
in normal and malignant oral epithelium. The development of
an in vitro model, in which plasminogen activators have been
identified and characterised, provides a useful tool with
which to investigate the role of plasminogen activators in





1.1.1 The Discovery Of Plasminogen Activator
In the eighteenth century it was first observed that the
blood of sudden death victims did not clot or if it did, then
the clots dissolved spontaneously within a short period of
time (Morgagni, 1769). However, it was not until very much
later that the lytic activity of cadaver blood was ascribed
to the presence of activators of the serum protein
plasminogen.
Towards the end of the nineteenth century Denys and
Marbaix (1889) made the observation that canine fibrin
dissolved rapidly in serum which had been treated with
chloroform indicating the presence of a lytic substance in
serum. Soon after, Dastre (1893) showed that fibrin would
gradually dissolve in its own serum even in the absence of an
organic solvent and thus concluded that the lytic substance
found was normally present in serum. He named the process
fibrinolysis.
Hedin (1904) reported that the fibrinolytic activity of
blood resided in the euglobulin fraction of serum and several
years later Opie and Baker (1907) repeated this work and
showed that the fibrinolytic activity of chloroform treated
blood also resided in the euglobulin fraction of plasma.
1
Nolf (1904, 1905) reported that irritation of the
vascular wall increased fibrinolytic activity and postulated
the release of a substance from the vascular wall into the
blood which enhanced fibrinolysis. Thus by the early
twentieth century fibrinolytic activity was ascribed to the
euglobulin fraction of serum and it was observed that this
activity could be greatly enhanced after irritation of the
vascular wall.
Studies of fibrinolysis, however, remained at best
fragmentary until Tillet and Garner (1933) discovered that
filtrates of beta haemolytic streptococci caused rapid
liquefaction of human blood clots, and studies of the
properties of these filtrates finally led to the
identification of plasmin as the proteolytic enzyme
possessing fibrinolytic activity in blood. Shortly after its
discovery it was realized that the streptococcal fibrinolysin
was not a true enzyme as it was unusually stable at
denaturation temperatures and it did not itself digest casein
or gelatin (Garner and Tillet, 1934). Later Milstone (1941)
partly resolved this discrepancy when he realised that this
streptococcal fibrinolysin did not lyse highly purified
fibrin but required the addition of the euglobulin fraction
of serum before lysis would occur and that the same
euglobulin fraction would allow clots from other species to
lyse. He called this accessory component "lytic factor".
Christensen and Macleod (1945) further clarified matters by
demonstrating that the lytic factor activated by
2
streptococcal fibrinolysin (latei termed streptokinase) was
identical to the serum protein activated by prolonged
exposure to chloroform which they named plasminogen. It then
became apparent that Milstone's lytic factor was in fact
plasminogen, which is largely removed from highly purified
fibrin.
Streptokinase was thus able to activate the precursor
protein plasminogen to the active proteolytic enzyme which
Christensen and Macleod named plasmin.
A paradox, however, existed in that the conversion of
plasminogen to plasmin required the enzymatic cleavage of
peptide bonds and yet streptokinase (SK) did not have the
capacity to hydrolyse proteins. Considerable efforts were
subsequently expended in resolving this issue and contributed
greatly to our present understanding of the fibrinolytic
system.
1.1.2 Activation Of Plasminogen - The Pro-activator Theory
Human plasminogen preparations upon treatment with
streptokinase were found to give rise to two types of
enzymatic activity - the ability to activate plasminogen from
other species (activator activity) and plasmin activity.
This observation led Mullertz and Lassen (1953) to postulate
that streptokinase activation required the presence of a
hypothetical proactivator which was present in human but not
bovine plasminogen, which, once transformed by streptokinase,
would catalytica1ly activate plasminogen. The existence of a
further lytic component was questionable since attempts to
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physically separate proactivator and plasminogen consistently
failed and a number of workers proposed that either
plasminogen (or plasmin) and proactivator were one and the
same substance (Ablondi and Hagan, 1956; Kline and Fishman,
1961; DeRenzo et aJL 1967).
1.1.2.1 Streptokinase-plasmin Complex
A complex between SK and plasmin, rather than
plasminogen initially seemed more plausible as the
proactivator since plasmin already contained an active site.
Furthermore less purified preparations of plasminogen at that
time always contained some preformed plasmin. By the early
1970's unequivocal physical evidence for the existence of a
complex between SK-plasmin was provided by ultracentrifuga1
analyses (Davies, 1 9 6 6 ; Baumgarten, 1 9 6 7), column
chromatography (De Renzo et al. 1967) and by discontinuous
polyacrylamide gel electrophoresis (Tomar and Taylor, 1971).
Kline and Fishman (1969) further elucidated the process when
they found a method of differentiating between activator
activity and plasmin activity in activated mixtures of SK and
plasminogen, by their reaction towards pancreatic trypsin
inhibitor (PTI). PTI completely inhibited the methyl lysine
esterase activity of plasmin while the esterase activity of
activator was unaffected. This enabled them to investigate,
on a quantitative basis, the formation of plasmin or
activators in reaction mixtures of SK and plasminogen. They
found with the addition of large amounts of SK to
plasminogen, that activator activity predominated at the
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expense of plasmin. Markus and Werheiser (1964) established
quantitatively the relationship between activator activity
and caseinolytic activity in plasminogen preparations
activated with increasing amounts of SK. They also found that
because of the stochiometric interaction between plasminogen
and SK, that plasmin, obtained by activation with catalytic
amounts of SK, had little activator activity and high
caseinolytic activity. The stochiometric complex, however,
possessed full activator activity but little caseinolytic
activity. Pro-activator activity was therefore identified as
plasmin and activator as the SK-plasmin complex.
Detailed studies, however, on the role of spontaneously
formed plasmin in the activation of plasminogen by SK showed
that the activation of plasminogen did not necessarily
depend on the presence of preformed plasmin. It was then
suggested that another activator may exist. Independently
Summaria et a_l (1969) and Kline and Tsao (1971) demonstrated
using either diisopropyl fluorophosphate (DFP) or PTI, at
levels necessary to completely inhibit preformed plasmin,
that activation of plasminogen by the addition of SK still
occurred. In control experiments it was shown that SK was
not displacing trypsin inhibitor from the plasmin inhLbLtor
complex, thus the observed activation could not be due to the
participation of plasmin.
1.1.2.2 Streptokinase-plasminogen Complex
The hypothesis that the interation of human plasminogen
with SK results in the formation of a SK-plasminogen complex,
with enzyme activity, was attractive. However, to establish
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this, it had to be demonstrated that a complex between SK and
plasminogen existed and that such a complex had the enzymatic
properties of an activator.
Reddy and Markus (1972) re-examined the role of
spontaneous plasmin in reaction mixtures using the burst
reagent p-nitro guanidine benzoate, NPGB, (Chase and Shaw,
1970) which reacts as an active centre site specific compound
yielding nitrophenol and the inactive acylated enzyme. If SK
is mixed with plasminogen in the presence of excess NPGB
activation of the sample still occurs. They also showed a
linear correlation existed between the amount of plasminogen
remaining for activation and the amount of SK added; ie. if
SK and plasminogen were added in an equimolar ratio no
activatable plasminogen remained after removal of NPGB.
Further evidence for the enzymatic properties of the SK-
plasminogen complex were provided by Reddy and Markus (1974)
and later by Wohl et a_l (1977) who reported that the complex
could hydrolyse appropriate synthetic substrates.
Based on their studies, Markus and Reddy described the
mechanism of activation of plasminogen (Fig. 1) as follows:
(i) SK reacts with plasminogen to form an
equimolar complex which acquires the
properties of an enzyme by exposing an
active centre in the plasminogen moiety
without cleavage of peptide bonds.
(ii) The enzymatic SK-plasminogen complex then
generated catalyses the conversion of
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FIG. 1
Effect of NPGB - inhibition of the spontaneous plasma content
of plasminogen on activation rates by streptokinase.
(a) Spontaneous plasmin inhibited : activation with low
levels of streptokinase.
(b) Spontaneous plasmin not inhibited : activation with low
levels of streptokinase.
(c) Spontaneous plasmin inhibited : activation with high
levels of streptokinase.
From Reddy and Markus, 1972
 
plasminogen to plasmin by splitting the
arginy 1-valy 1 bond in the plasminogen
molecule.
(iii) Cleavage of this same bond in the SK-
plasminogen complex converts it to SK-
plasmin.
Thus if catalytic amounts of SK are used to activate
plasminogen the products will be plasmin and an amount
of SK-plasmin equivalent to the amount of SK used for the
activation. If, however, an equimolar amount of SK is added
to plasminogen then only modified SK-plasmin will be formed.
To date no other activators isolated from vertebrates
function in this manner. Thus, whilst the discovery and use
of streptokinase was historically very important in expanding
the field of fibrinolysis it also probably served to confuse
the issue of plasminogen activation in higher animals by
vertebrate activators.
1.2 THE BIOCHEMISTRY OF PLASMINOGEN
Central to the understanding of plasminogen activation
has been the determination of the amino acid sequences of the
region of the plasminogen molecule in which proteolytic
cleavage generates plasmin. The inactive zymogen,
plasminogen, is present in blood plasma at a concentration
of approximately 3uM (Robbins and Summaria, 1970; Collen et
al 1972; Linjen and Collen, 1982) and is maintained at a
relatively constant level with a half life of approximately
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2.2 days. The isolation of native plasminogen from plasma
has long been complicated by its marked tendency to stick to
other proteins (Remmert and Cohen, 1949; Kline, 1953) and by
its sensitivity for partial proteolytic degradation by traces
of plasmin generated during purification (Wallen, 1962). An
important step in the elucidation of the biochemistry of
plasminogen was the development of an effective purification
procedure, using affinity chromatography, in which lysine
coupled to Sepharose was used as an adsorbent of plasminogen
(Deutsch and Mertz, 1970). Several modifications of this
technigue have subsequently been used and current methods of
working at near neutral pH in the presence of the low
molecular weight inhibitor aprotinin have yielded essentially
pure preparations of highly stable plasminogen (Wallen and
Wiman, 1970, 1972). In the last ten years the complete amino
acid sequence of the plasminogen molecule has been determined
(Wallen, 1977; Wiman and Wallen, 1975; Sottrup-Jensen et al_
1978a, b). Native plasminogen consists of a polypeptide
chain composed of 790 amino acid residues, Mr 92000, and has
glutamic acid as a single NH2 terminal amino acid and
asparagine as the COOH terminal residue, the whole molecule
being stabilised by 24 disulphide bridges (Fig.2).
Plasminogen also contains approximately 2-3% carbohydrate
which is located in the A chain of the molecule and this may
contribute to the microheterogeneity found in even highly
purified preparations of plasminogen.
Plasminogen, containing glutamic acid as the N ferminal
acid, was found to be e 1 ectrophoretica11y identical to
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FIG. 2
The primary structure of glu-plasminogen.
Red = A (heavy) chain.
Yellow = B (light) chain.




plasminogen from fresh plasma and has been termed native or
Glu-plasminogen (Summaria, 1976). Glu-plasminogen is readily
converted to another form by partial digestion with plasmin
(Claeys et ad 1973) which is the result of cleavage of one of
three bonds in the N terminal region - Met 68, Lys 77 or Arg
78 - leading to the appearance of a new N terminal acid
(Fig.2). These forms, which are collectively termed Lys-
plasminogen, have an Mr of about 8000 daltons lower than
native plasminogen and differ markedly in their functional
properties. Proteolytic release of N terminal peptides
causes gross conformational changes in the Lys-plasminogen
molecule with activation of Lys-p1 asminogen occurring at a
considerably faster rate than Glu-plasminogen (Christensen
and Mullertz, 1977). Activation of plasminogen to the active
protease plasmin occurs as the result of cleavage of a single
peptide bond Ar<?560 ~ Val561 the plasminogen molecule.
The conformational change brought about in the Lys-
plasminogen molecule appears to make this bond more easily
accessible. I_n vivo activation of plasminogen can be brought
about by a number of activators and although the mechanism of
action may be different,the resulting structural changes in
the plasminogen molecule are very similar (Summaria, 1967).
Two questions arise concerning the enzymes involved and the
sequence of events. Firstly, whether enzymatic release of N
terminal peptides and cleavage of the Arg^gQ ~ Va^561 bond
are the result of activator activity or whether the cleavage
of the NH2 terminal region of the molecule is effected
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autocatalytical ly by plasmin. Secondly, whether Glu-
plasminogen is converted to Lys-plasminogen first or whether
the two cleavages occur at random. Analysis of the
plasminogen derivatives occuring on activation of plasminogen
have shown that in addition to Glu-plasminogen, Lys-
plasminogen and Lys-plasmin were also present (Wiman and
Wallen, 1973). In experimental conditions designed to
minimise autocatalytic digestion by plasmin, no Glu-plasmin
was found in the reaction products and based on these
experiments Wiman and Wallen (1973) suggested that activation
of plasminogen occurs in two consecutive steps:
1. 2.
Glu-plasminogen > Lys-plasminogen > Lys-plasmin.
Later, however, Sodetz et al (1974) found that by
activating plasminogen in the presence of the plasmin
inhibitor aprotinin, no peptides were released from the N-
terminal end of the molecule and therefore the activator did
not seem to cleave bonds in the heavy chain of the Glu-
plasminogen molecule. The two pathways of activation were
subsequently suggested by Violand and Castellino (19 7 6) and
both proceed in two steps as outlined in Fig. 3.
Glu and Lys-plasm inogen are converted to Glu or Lys
plasmin respectively by cleavage of the single Ar(?560 ~
Valsei bond by plasminogen activator. Small amounts of
plasmin, which are present during the initial stages of
activation (in the absence of inhibitors), then catalyse the
conversion of Glu-plasminogen to Lys-plasminogen and of Glu-
10
FIG. 3
Pathways of activation of glu-plasminogen.






plasmin to Lys-plasmin. As previously noted, the activation
of Ly s-p 1 a s in inogen occurs at a much faster rate, the
formation of Lys-plasminogen acting as a feedback mechanism
that amplifies plasminogen activation. In experimental
systems cleavage of N terminal peptides from Glu-plasminogen
precedes activator catalysed conversion of Lys-plasminogen to
Lys-plasmin but it is not clear yet whether Glu-plasmin or
Lys-plasmin is the physiological thrombolytic enzyme.
1.3 PLASMIN
The active protease plasmin consists of two polypeptide
chains held together by disulphide bonds (Fig. 4). The light
chain with an Mr of approximately 25,000 contains the active
site and has amino acid sequence homologies with other serine
proteases such as trypsin and elastase. Plasmin has broad
specificity hydrolysing proteins and peptides at lysyl and
arginyl bonds (Castel lino and Powell, 1981; Robbins et a_l
1981). Plasmin formation is essentially an irreversible
process because in common with other hydrolytic reactions
proteolysis is an exergonic reaction and under normal
physiological conditions there are no simple mechanisms to
repair a broken bond. This type of enzyme formation is also
more rapid than that regulated by selective transcription of
the genome and is triggered by signals operating entirely at
a post translationa1 level. Formation of the highly
aggressive plasmin enzyme must therefore be controlled at all
stages (Fig.5). Control of formation of plasmin can occur
11
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either in the cascade reaction before the formation of
plasmin, or by inhibitors of plasmin, once it has been formed
(Collen et ad 1983).
There are five well defined plasma proteins which
operate as plasmin inhibitors; alpha-2-antiplasmin, alpha-2-
macroglobulin, alpha-l-anti-trypsin, anti-thrombin III and
CI esterase. The two quantitatively most important inhibitors
are alpha-2-antiplasmin and alpha-2-macroglobulin. Alpha-
2-antiplasmin is an extremely fast acting inhibitor of
plasmin and a 1pha-2-macroglobulin is thought to be of
importance only when local depletion of alpha-2-antiplasmin
occurs (Travis and Salvesen, 1983). In the presence of normal
concentrations of these two inhibitors, the other plasma
protease inhibitors do not play a role in the inactivation
of plasmin (Mullertz, 1974), however, they are known to
participate in the inhibition of plasminogen activators.
Recently a cellular inhibitor of plasmin, protease nexin I
(PN I), secreted by a number of cell types has been detected
(Knauer and Cunningham, 1984; Farrell and Cunningham, 1986).
These inhibitors appear to act at the pericellular level but
are functionally related to circulating anti-thrombin III
(Scott and Baker, 1983). Because plasmin is so rapidly
inactivated it has been proposed that for fibrin degradation
to occur that plasminogen must be bound to fibrin (Aoki et a 1
1983). Plasminogen activation would therefore only occur on
the fibrin surface where the plasmin would be protected from
inactivation by plasma inhibitors. Several studies have
confirmed that plasminogen does indeed bind to fibrin and a
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number of investigators have established that interaction
with fibrin occurs at the lysine binding sites in the
plasminogen molecule (Thorsen et a_l 1981; Lucas et ad 1983).
Furthermore, plasminogen activators have also been found to
adsorb to clotted blood which would further localise the
generation of plasmin and confine its activity. Indeed,
plasminogen activators have been found not only to bind to
the fibrin surface but to markedly enhance the incorporation
of plasminogen, particularly Lys-plasminogen, into the fibrin
clot (Linjen et a_l 1981; Harpel et aj[_ 1985).
1.4 METABOLISM OF PLASMINOGEN
A decisive factor in the local formation of plasmin is
the presence of the inactive zymogen, plasminogen.
Approximately 40% of total plasminogen in mammals is located
extravascularly and has been demonstrated in a number of
locations including eosinophils (Barnhart and Riddle, 1963),
granulocytes (Prokopowicz and Niewiarowski, 19 68), bovine
follicular fluid (Beers et a_l 1975), ascites fluid in mice
(LeBlanc and Black, 1975), human and porcine uterine fluid
(Casslen and Ohlsson, 1981), human saliva (Moody, 1982) and
epidermis (Isserof and Rifkin, 1983; Nakagawa et a_l 19 8 4).
However, details of the sites of synthesis and storage of
plasminogen are still unclear.
Isotopic labelling and organ perfusion techniques have
shown that the liver is the primary site of synthesis of the
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majority of plasma proteins and perturbation of levels of
plasminogen in patients with liver disease indicated a
function for the liver in the synthesis of plasminogen
(Fletcher et a_l 1964; Davis and Picoff, 1969). The early
work of Barnhart and Riddle (1963) showed that eosinophils
from bone marrow contain plasminogen and subsequently
Prokopowicz and Niewiarowski (1968) found that it was
contained in all granulocytes, where it has similar
properties to plasma plasminogen. Data presented later by
Prokopowicz and Stormorken (1968) indicated that biosynthesis
of plasminogen occurred within the granulocytes although
their ability to release stored plasminogen was not
confirmed. However, the observation that plasminogen levels
in guinea pig granulocytes decreased rapidly after treatment
with protease inhibitors suggests that this may be likely.
Highsmith and Kline (1971) reported that the kidney is a
major site of synthesis of plasminogen in plasminogen
depleted cats. After a 10 hour delay, presumably for the
synthesis of plasminogen, normal levels were restored within
18 hours from depletion. These authors also found a large
negative arterial-venous difference in plasminogen
concentration across the kidney during the restoration phase
following acute depletion, which further supports the
contention that the kidney has a major role in plasminogen
biosynthesis. Furthermore, bilateral nephrectomy of their
animals blocked the return to normal plasminogen levels which
consistently occurred after depletion of intact animals. The
authors considered it unlikely that the release of
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plasminogen from granulocytes could account for this large
increase in circulating plasminogen but they suggested a
regulatory function for granulocytes in normal turnover.
Although bilateral nephrectomy prevented the return of normal
plasminogen levels in depleted cats, Siefring and Castellino
(1975) reported that synthesis of plasminogen occurred in
the absence of kidneys in the rat and further showed, by
incorporation of labelled proteins, that synthesis was de
novo. In another study using a rat liver perfusion system
Saito et al_ (1980) demonstrated the cumulative appearance of
plasminogen in the perfusate. Evidence for de novo synthesis
in the liver was provided by incorporation of labelled
leucine into specific immunoprecipitates of plasminogen and
by inhibition of this by eyeloheximide.
Evidence indicating that the liver was also the primary
site of synthesis of circulating plasminogen in man was
provided by Raum et a_l (1980). They determined genetic types
of plasminogen in a liver donor and recipient before hepatic
homotransplantation. In plasma samples obtained from the
recipient after transplantation it was shown by isoelectric
focusing in polyacrylamide gels that the plasminogen type had
been changed to that of the donor.
Whilst the liver may therefore be the primary site of
circulating plasminogen in man, granulocytes have also been
shown to contain, if not synthesize, plasminogen (Prokopowicz
and Stormorken 1968). More recently plasminogen has been
located in epidermis (Isseroff and Rifkin 1983; Nakagawa et
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al 1984) and in testes (Saksela, 1986). A function for
plasminogen at these sites remains to be elucidated.
1.5 PLASMINOGEN ACTIVATORS
Plasminogen activators are widely distributed in nature
occurring in microorganisms (most notably streptococci and
staphylococci species) and throughout the vertebrates,
although their distribution appears to exhibit some species
specificity.
The two activators of major importance found in humans
are tissue type plasminogen activator (tPA) and urokinase
type plasminogen activator (uPA).
1.5.1 The Biochemistry Of Plasminogen Activators
1.5.1.1 Urokinase Type Plasminogen Activator
The discovery of large amounts of uPA in urine made it
an attractive source for purification. Simple affinity
procedures coupled with the use of monoclonal antibodies to
uPA have led to the purification of this enzyme to apparent
homogeneity (Kaltoft et a_l 1982; Vetterlein and Calton,
1983) .
Human uPA occurs in a one chain and two chain form, the
latter being the active form of the enzyme. Active uPA has
an Mr of approximately 50,000 and is composed of two
subunits, Mr 20,000 and Mr 30,000, linked by one disulphide
bond (Sumi and Robbins, 1983). Studies of the amino acid
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sequence have shown that the active site is located in the
Mr 30,000 peptide. High and low molecular weight forms of the
active enzyme exist both of which are identical with respect
to the heavy B chain. The difference in molecular weight
appears to be due to limited proteolytic cleavage occuring
in the Mr 20,000 chain (Gunzler et a_l 1982a) although the
functional significance of this is not known.
1.5.1.2 Tissue Type Plasminogen Activator
As tissue PA constitutes such a small proportion of
total protein, multi-step purification procedures have led to
very low yields and only partially purified preparations (Kok
and Astrup, 1969; Rickli and Zaugg, 1970; Aoki, 1974). In
this respect, cultured cell lines, particularly melanomas,
have been a valuable source of tPA and it would appear that
Bowes melanoma activator is identical with that found in
human uterine tissue (Rijken and Collen, 1982; Wallen et al_
1983). Native tPA is a single polypeptide with an Mr of
approximately 70,000 (Nielsen et a_l 1983; Pennica et £1^ 1983)
and unlike uPA sometimes occurs in an active form. Digestion
with plasmin yields a two chain form with disulphide bonding
in the A and B chains. The B chain contains the active site
which is homologous with the active chains of other serine
proteases. Human tPA occurs in two variants of slightly
different relative mass (Wallen et a_l 1983 ; Andersean et a 1
1984) due to differences in g lycosy lation of the A chain of
the molecule.
1.5.1.3 Genes Coding For uPA And tPA
The complete amino acid sequence of uPA has been
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determined by Gunzler et a_l (1982b), and its comparison with
the amino acid sequence of tPA led them to conclude that the
two activators were products of different genes. This has
since been confirmed by the work of Rajput et a_l (1985) who,
using cDNA probes, were able to map human tissue PA to
chromosome 8 and uPA to chromosome 10. This, however,
disagrees with the earlier work of Kucherlapati et a_l (1978)
who located tPA to chromosome 6. Kucherplati and his
colleagues relied on the expression of the PA gene as a
means of determining its presence, while Rajput et a_l used
hybridisation of structural gene sequences to specific cDNA
probes, thus avoiding the uncertainty that a regulatory gene
was being identified in hybrids. The different distribution
of these two enzymes in tissues further supports the
contention that these enzymes have different functions.
1.5.2 Tissue Distribution Of Plasminogen Activators
Tissue PA is mainly located in tissues and has been
detected in endothelial cells, gastric mucosa, lung,
pituitary (Kristensen et a_l 1984 , 1985) thyroid, kidney,
uterus, prostate (Rijken et a_l 1981) and brain (Soreq and
Miskin, 1981; 1983). Tissue PA secreted from endothelial
cells into the blood is the major thrombolytic enzyme
(Wun and Capuano, 1985). Consistent with its role in
the removal of fibrin from arteries and veins, tPA has also
been located in fluids in other channels eg. uterine fluid
(Granel 1 i-Piperno and Reich, 1978), tears (Thong, 19 83),
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seminal plasma (Rijken et al_ 1981), human milk (Okamoto et a_l
1981) and bile (Oshiba and Ariga, 1983). Urokinase type PA,
detected first in urine because of its relatively high
concentration in this fluid, has since been found, albeit in
lower concentrations, in blood plasma (Shakespeare and Wolf,
1979), semen (Rijken et al_ 1981), uterine fluid (Casselsen et
al 1981) and bile (Oshiba and Ariga, 1983).
Immunocytochemical studies have shown the tissue distribution
of uPA to differ from tPA, being widely distributed in
connective tissue and in epithelial cells lining organs and
ducts; particularly kidney, bladder, prostate and involuting
mammary glands (Larsson et al^ 1984; Camioli et al_ 1984;
Nakamura et al 1984).
Generally serine proteases are released as inactive pro¬
enzymes (Neurath and Walsh, 1976) but it was not until
Skriver et al^ (1982) obtained a preparation of one chain uPA
from conditioned medium of 3T3 cells that latent uPA was
definitively demonstrated. Pro-uPA was unable to activate
plasminogen or to incorporate DFP. Since then other
laboratories have detected pro-uPA (Nielsen et aj_ 1 9 8 2 ;
Eaton et a_l 1984) and recently it was reported that freshly
removed urine contained 50% of its uPA in the inactive form
(Kielberg et a^ 1985).
The finding that uPA can be released in an inactive form
demonstrates the existence of another step in the cascade
reaction leading to the formation of active
plasmin, although the regulatory mechanisms which act at this
stage are unknown (Fig.5).
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1.5.3 Plasminogen Activators In Fibrinolysis
Some studies have suggested the existence of cellular
non-plasminogen substrates for uPA. Quigley ( 19 7 9 ) has
demonstrated alterations in cellular behaviour which occur as
a result of plasminogen activators but independently of
plasmin, although the site of action of plasminogen activator
is unkown. Keski-Oja and Vaheri (1982) have isolated from
cells a protein (Mr 66,000), which acts as a substrate for
plasminogen activator although its cellular location remains
unkown. Apart from these two studies, the only well
documented protein substrate for both uPA and tPA is
plasminogen although the enzymes do differ in their affinity
for fibrin. Plasminogen and thrombin both bind to fibrin
with binding sites located in characteristic triple
disulphide loops or kringle structures (Patthy et a_l 1984).
The A chain of tPA contains two kringle structures which
partly accounts for the fibrin binding properties of tPA
(Pennica et a_l 1983). In addition the 43 amino acid residue
located in the terminal portion of the A chain has regions
homologous with the finger domains responsible for the fibrin
binding properties of fibronectin (Banyai et al_ 1 9 8 3).
Although uPA has no similar finger domain counterpart in its
molecule (Gunzler et a_l 1982b) it does contain one kringle
structure in the N terminal part of the single chain form.
Pro-uPA was found to have a much greater binding affinity
than uPA and was efficient at clot lysis at concentrations
that did not result in removal of systemic fibrinogen (Kasai
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et a_l 1985). Pro-uPA is thus a more specific and better
thrombolytic enzyme than uPA, but its contribution in vivo is
not clear. The greater fibrin binding affinity of tPA makes
this the likely thrombolytic enzyme in vivo and the fact that
tPA, secreted by the endothelial cells lining the blood
vessels, is increased after venous occlusion (Nilsson and
Robertson, 1968), exercise or systemic administration of
agents such as adrenalin (Cash, 1975; 1978), further
supports this hypothesis. The rapidity with which the
increase in plasminogen activator is observed, approximately
10 minutes, suggests a release of tPA rather than an increase
in the synthesis of tPA. It is possible, however, that
there is activation of a pro-enzyme form. Indeed
abnormalities in tPA levels in the blood have been implicated
in a number of vascular disorders (Stead et a_l 19 83 ; Booth
et a 1 1983; Booth and Bennett, 1984; Nilsson et aj_ 19 8 5).
Tissue PA is also the better thrombolytic enzyme in
experimental systems, and clinical trials using tPA have
shown this therapy to be valuable in patients with coronary
thrombosis without concomitant alterations in systemic
fibrinogen or alpha-2 anti-plasmin. The dangerous bleeding
tendency caused by the systemic lytic effects with other
thrombolytic agents such as streptokinase can therefore be
avoided (Matsuo et aj^ 1981; Korninger et a_l 1982 ; Van der
Werf et a_l 1984). As a result tPA is now being produced in
several laboratories using recombinant DNA technology
(Pennica et al 1983; Edlund et al 1983; Brown et al 1985).
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Tissue PA mediated activation of plasminogen is known as
the extrinsic or cellular pathway, however, blood also
contains an intrinsic or humoral plasminogen activation
pathway to generate plasmin. Evidence has recently been
reported for pathways activated independently by Factor XII,
complement, kininogen and platelets (Kaplan and Yecies, 1980;
Kline and Reddy, 1980), all of which may subsequently enhance
plasminogen generation by the extrinsic pathway. These
activators of plasminogen appear in plasma when clotting
Factor XII (Hageman Factor) is activated (Ratnoff and
Rosenblum, 1958). Activation of Hageman Factor involves
proteolytic cleavage of the native molecule into one or more
fragments which activates pre-kallikrein to kallikrein, which
in turn activates plasminogen to plasmin. Kallikrein also
releases vasoactive peptides from kininogen which participate
by enhancing the rate of activation of Hageman Factor.
Although plasmin and kallikrein activate Hageman Factor, it
is not known how this occurs because they exist as
precursors until Hageman Factor itself is activated. The
existence of pathways other than Hageman Factor dependent
pathways have been suggested by a number of studies. Plasma
deficient in kallikrein activates plasminogen, although at a
slower rate, and Goldsmith et a_l (1977) have suggested that
Hageman Factor itself can activate plasminogen directly.
Astrup and Rosa (1974) also found that plasma, deficient in
Hageman Factor, exhibited normal levels of fibrinolytic
activity when dextran sulphate was added to plasma. Schreiber
and Austin (1974) have also observed that C3 deficient plasma
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did not sustain clot lysis. Plasma deficient in C2 allowed
normal clotting indictating that the reaction is not
dependent on classical C3 convertase, as did plasma deficient
in C6 indicating that the terminal C5-C9 complex was not
required. Their results suggested that C3 was a factor in
the lysis of clots but the mechanism was unknown. Earlier
Taylor (1973) observed that thrombin and Factor Xa
modify the platelet membrane at the time of polymerisation of
fibrinogen. Recruitment of the complement component C3 onto
the membrane is followed by platelet fusion and clot
retraction, indicating one possible role for complement in
thrombolysis. It would appear that multiple pathways exist
for the generation of plasmin in blood so that the absence of
a factor need not have serious consequences for normal
clotting.
1.5.4 Other Functions Of Plasminogen Activators
The very wide distribution of plasminogen activators in
tissues suggests that there may be biological processes in
which activators participate other than fibrinolysis and a
number of studies have provided evidence for their
involvement in processes requiring extracellular proteolysis.
A prerequisite for this function is their ability to
degrade components of the extracellular matrix. In addition
to proteoglycans, the extracellualr matrix contains several
well defined proteins; laminin, fibronectin, elastin and
several types of collagen. Plasmin is able to degrade
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fibronectin and laminin. Collagenous components within the
matrix, themselves resistant to plasmin digestion, may be
hydrolysed by latent collagenases which can be activated by
plasmin (Paranjpe et a_l 1980; O'Grady et a_l 1981). It has
also been reported that in vitro degradation of elastin and
collagen in the extracellular matrix by elastase and
collagenase is facilitated by plasmin mediated removal of
other glycoproteins (Jones and DeClerk, 1980; Chapman et al_
1984).
The presence of a large and widely distributed
extracellular reservoir of plasminogen makes the hypothesis
that plasminogen activators are involved in tissue
degradation feasible. Correlation with respect to time and
hormonal regulation between plasminogen activator production
and normal physiological events requiring limited proteolysis
corroborate this hypothesis. Interactions between cells and
components of the extracellular matrix are essential for
tissue differentiation and regulation during embryogenesis,
for maintenance of normal tissue differentiation and in
tissue remodelling (Beers et a_l 1975 ; Vassalli et a_l 1976;
Strickland et a_l 1976 ; Ossowski et a_l 1979; Valinsky et a_l
1981) .
At the time of ovulation, a close relationship has been
observed between the disruption of the follicle wall,
releasing the ovum, and plasminogen activator activity
(Beers, 1975; Strickland et a_l 1976; Shimada et a^ 1 9 83).
Secretion of plasminogen activators by granulosa cells occurs
only hours before ovulation. Tissue PA, but not uPA, is
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stimulated by the gonadotrophins, follicle stimulating
hormone (FSH) and luteinising hormone (LH), which are also
elevated in the blood prior to ovulation. Ny et al_ (1985)
have found that an inhibitor of plasminogen activator is also
produced by granulosa cells. However, the same
gonadotrophins which stimulate tPA also suppress this anti-
activator activity. Gonadotroph in induction of tPA and
suppression of anti-activator may therefore be sufficient for
the formation of plasmin, and hence activation of
collagenases (Reich et a_l 1985), leading to the disruption of
the follicle wall. The testicular counterpart of granulosa
cells, the Sertoli cells, are also believed to secrete
plasminogen activators under hormonal control. These are
involved in the release of primary spermatocytes from the
basal lamina, and the liberation of mature spermatids into
the adluminal compartment (Lacroix et a_l 1979).
Rapid degeneration of several tissue components also
occurs during mammary gland involution after lactation. In
murine species this involution correlates with the production
of activators by mammary epithelial cells (Ossowski et a_l
1979). Recently, direct evidence for uPA in mammary
epithelial cells has been demonstrated immunocytochemica1ly
by Larsson et a_l ( 19 8 4). Furthermore, hormones which
counter post-lactational involution, also inhibit uPA
production. Controlled tissue degradation occurs during
attachment of the embryo to the uterine wall. In mouse,
trophoblasts secrete plasminogen activators during the
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invasive growth phase (Strickland et a_l 1976). During the
early embryonic phase tPA is secreted by the parietal
endoderm and uPA by the visceral endoderm and mesoderm
(Marotti et al^ 1982). In the later stages tPA is synthesized
by endodermal cells but does not appear to have any obvious
function in tissue degradation (Strickland and Madhavi,
1978). For clarification of the roles of tPA and uPA in any
of these processes _in vivo, selective inhibition of tPA or
uPA enzyme activity would contribute greatly to our
understanding of their function.
Secretion of activators has also been implicated in the
migration of cells during embryogenesis, particularly
haemopoetic cells into the Bursa of Fabricus (Valinsky et a 1
1981) and endothelial cells in response to angiogenic factors
(Gross et al^ 1983^. More recently Moonen et a_l (1982; 1 98 5)
observed increased plasminogen activator activity in the
developing nervous system and this activity is thought to be
involved in neuronal migration. Both uPA and tPA are
produced in the developing cerebellum although uPA alone is
able to induce astrocyte proliferation in cultured explants
of nervous tissue. Production of both plasminogen activators
was decreased in adult material and the authors suggested a
developmental regulation in the expression of genes for
plasminogen activators. Cyclical fluctuations in plasminogen
activator activity also occur during the differentiation of
normal kerat inocy tes in culture (Isseroff et aj_ 1 9 8 3),
however, their role in maturation and shedding of
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keratinocytes has not been established with certainty.
1.6 PLASMINOGEN ACTIVATORS IN NON-NEOPLASTIC CONDITIONS
The abnormal formation of plasmin has been implicated in
a number of diseases, particularly vascular disorders,
dermatological conditions and diseases involving inflammatory
processes where mechanisms regulating activators produced
by these tissues are not controlled.
1.6.1 Vascular Disorders
An important factor in the pathogenesis of venous
thrombosis is a defective fibrinolytic system (Sundqvist et
al 1981) due to a decrease in vessel wall activator or
defective release of the activator. A recent study of
patients with recurrent idiopathic deep vein thrombosis found
that the predisposition to thrombosis was, in some patients,
the result not only of reduced tPA levels but also because of
a concomitant increase in inhibitor to PA ratio (Nilsson et
al 1985). At the other extreme, the only well characterized
bleeding disorder is due to a deficiency of the principal
plasmin inhibitor, a 1pha-2-anti-plasmin (Aoki et a_l_ 1979 ;
Kluft et al_ 1979). However, Booth et a_l (1983) have described
a new haemorrhagic disorder due to excessive production of
tPA, where no abnormality of platelet function or coagulation
was demonstrable. It would appear then that faults in the
regulation of plasminogen activators alone can result in
vascular disease. Abnormal plasminogen activator activity
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has long been associated with some of the secondary effects
of diabetes mellitus such as arteriosclerosis and
retinopathy. In the literature conflicting evidence is cited
of increased (Lassman et al_ 1974), normal (Cash and McGill,
1969) and decreased (Aimer and Pandolfi, 1976) fibrinolytic
activity in diabetics. Ishibashi et a_l (1985) suggest that
studies of localized fibrinolytic activity may be more
important than generalized fibrinolysis in the development of
diabetic retinopathy. They reported that decreased
plasminogen activator activity in the retinae of diabetic
rats leads to a reduction in the ability to control
microthrombus formation, resulting in occlusion of the
retinal vascular bed.
1.6.2 Permatological Conditions
Farb et al_ (1978) presented evidence of an enzymatic
mechanism which was active in the induction of acantholysis
in cultured keratinocytes by pemphigus IgG. They found that
cell detachment induced by pemphigus IgG could be blocked by
protease inhibitors (SBTI and alpha-2-macroglobulin) as did
Singer et a_l (1980) and they suggested that the loss of cell
adhesion was due to proteolytic activity. Schlitz et al_
(1978) has previously demonstrated that this enzyme activity
was not of lysosomal origin. Later Hashimoto et al_ (1982,
1983) found elevated plasminogen activator activity in
keratinocytes incubated with both pemphigus vulgaris and
pemphigus foliaceous IgG. Furthermore they demonstrated,
using Todd's technique of fibrinolytic autography, that
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cutaneous fibrinolytic activity could be inhibited by e-amino
caproic acid (eACA), which further implicated plasminogen
activator. Later Morioka et al^ ( 1 9 8 7) found that
acantholysis induced in skin explants by their incubation
with pemphigus vulgaris and pemphigus foliaceous IgG, could
be blocked by the addition of anti-urokinase antibody. The
molecular mechanisms leading to the release of plasminogen
activator are unknown.
Increased proteolytic activity in epithelial cells has
also been reported in rapidly proliferating psoriatic
epidermis (Fraki et a^l 1982) and most probably results from
an increase in tPA which has been found in abundance in shed
psoriatic scales (Grondhal-Hansen et a_l 1985). Although the
mechanism resulting in activation of plasminogen is unkown,
psoriatic epidermis maintains its increase in specific
activity of plasminogen activators even after grafting
epidermis onto nude mice (Fraki et al^ 1982).
Corneal ulceration after alkali burns to the eye is the
result of a fault in regulation of plasmin produced at the
corneal surface to effect resorption of fibrin after injury
(Wang et a_l 198 2). Increased levels of plasminogen
activators cause a persistent epithelial defect to develop
leading eventually to ulceration. The activators are produced
by epithelial cells but also by polymorphs which infiltrate
the cornea after injury and amplify the plasminogen activator
dependent destruction of tissue. The role of plasminogen





Vassali and his colleagues (1976; 1979) first discovered
that cultured stimulated macrophages or peritoneal
macrophages harvested from sterile inflammatory exudates
produce and release uPA. This process can be inhibited by
glucocorticoids and other anti-inflammatory steroids. There
is some evidence to suggest that PA facilitates migration of
inflammatory cells, including polymorphs, which also secrete
uPA, to the site of inflammation (Reich, 1978). This
function of macrophages in other inflammatory conditions has
since been noted.
Patients with chronic inflammatory bowel disease (IBD)
ie. Crohn's disease and ulcerative colitis, have lesions
characterized by an infiltrate in which macrophages are
prominent. The secretion of plasminogen activators by
cultured macrophages from patients with active IBD is
significantly greater than in age matched subjects without
the disease. This activity is also significantly greater
in untreated patients compared to treated patients (Doe and
Dorsman, 1982). In protein losing enteropathy, in which the
the intestinal mucosa is also ulcerated, increased tPA
secretion in the gastric mucosa appeared to enhance mucosal
permeability. It was found that drugs inhibiting plasmin,
such as amino-methyl cyclohexane carboxylic acid (AMCHA),
were effective at blocking the membrane disorder although the
mechanism of increased production of tPA was not clarified
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(Kondo et a _1 19 7 6).
Toki et a_l (1982) reported increased fibrinolytic
activity as a result of uPA synthesis in the skin lesion of
allergic vasculitis and suggested that uPA might originate
from the polymorphs which infiltrated the lesion and perhaps
from blood released into the tissue space after
disintegration of the vascular wall.
Excessive production of plasminogen activator by
mononuclear cells and polymorphs has been found in the rare
condition Chediak-Higashi syndrome, leading to profound
coagulation abnormalities. This appears to be the result of
increased numbers of cells producing activators rather than
an increase in synthesis and secretion of activators (deSaint
Basile et a_l 19 85).
Although evidence is circumstantial in many
instances, loss of control of plasmin production has been
implicated in a number of diseases in which inflammatory
processes occur.
Of the inflammatory diseases, rheumatoid arthritis (RA)
is a condition which afflicts a large percentage of the
population. Plasminogen activator has been detected in human
synovial fluids and membranes, and in cultures of enzyme
dissociated rheumatoid tissues (Werb et a_l 1977). Berger in
1977 postulated that a defect in the secretion of plasminogen
activator from RA synovial tissue was the cause of
perpetuation of the inflammatory process. Hamilton (1982)
found, however, that early passage synovial fibroblast
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cultures from RA and non-RA patients both had low levels of
plasminogen activator activity. It was suggested that even
if basal secretions between the two populations had differed,
that the observation may not be relevant in vivo.
Extracellular plasmin from synovial cells would be quickly
complexed and might be unavailable for activity. Such
plasmin-alpha-2-antiplasmin complexes have already been
detected in the joint spaces of RA patients (Clemmenson et
al 1977). They suggest that a significant degree of
plasminogen activator activity may result from a modulation
of synovial cell activity iji vivo. Indeed, in both RA and
non-RA fibroblast cell lines, plasminogen activator activity
can be stimulated by conditioned medium from peripheral blood
mononuclear cells (Hamilton and Slywka, 1981; Hamilton,
1982). This may be one example of an _in vivo regulator of
plasminogen activator activity.
The rheumatoid synovial pannus is not only inflammatory
but is hyperplastic and invasive (Zvaifler, 1977). The fact
that the pannus erodes and replaces cartilage in much the
same fashion as tumour destroys normal tissue has meant that
"aggressive" and "tumour-like" properties have been
ascribed to it (Linder, 1975). Macrophage mediated elevation
of synoviocyte PA levels, in the RA pannus, possibly by
interleukin 1 (Mochan et a_l 1986), may contribute to the
tissue remodelling and cell migration. Hamilton (1983)
further proposed that the active moiety from stimulated
macrophages may mimic to some extent the effects of tumour
promoters on cell function. Indeed, elevation of PA is often
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an early event associated with cellular transformation.
1.7 PLASMINOGEN ACTIVATORS IN NEOPLASIA
Proteolytic degradation of the extracellular matrix and
the basal lamina by neoplastic cells has been considered for
a number of years to be involved in the destruction of
surrounding tissues and the invasiveness of tumours.
Accumulating evidence would suggest that in general
proteolytic activity in tumour tissue is higher than in its
normal counterpart, but, reports to this effect are by no
means unequivocal (Dano®/ta|1985).
1.7.1 Plasminogen Activator In Neoplastic Tissue
The fibrinolytic activity of tumour tissue was
documented during the early twentieth century (Carrel and
Burrows, 1911). Fischer (1925) later correlated the rapidity
of clot lysis with the neoplastic state of tumour tissue but
failed to demonstrate the enzymatic nature of the phenomenon.
The use of the fibrin overlay technique (Todd, 1959)
confirmed Fischer's observations, plasminogen activator
activity being detected in a number of malignant tissues;
invasive squamous cell carcinoma (Weiss and Beller, 1969),
ovarian tumours (Svanberg et al^ 1975), human colon tumours
(Newstead et aj^ 1976) and even in dysplastic cervical cells
(Jensen et al_ 1979). No distinction was made between uPA and
tPA at this time, and since fibrin stimulates tPA activity,
it is possible that mainly tPA activity was being detected
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using this technique. Enzymatic analysis of tumour extracts
have also indicated the presence of plasminogen activator of
an undetermined type in human kidney and bladder carcinomas
(Ladehoff, 1962) bronchial carcinomas, prostatic, cervical
and ovarian tumours (Nagy et al_ 1977; Chylak and Brdar,
1983) and breast cancers (Peterson et a^ 1973) but since tPA
is found in endothelial cells lining vessels, it is likely
to be found in most tissues and the significance of these
findings should not be over-estimated. More specifically,
tPA has been found in murine tumours (Mira-y-Lopez et a_l
1983) and in extracts of human colon tissues (Tissot
et a I , 1983) although the same reservations apply.
Urokinase-type plasminogen activator has been detected
in lung, colon and breast carcinomas, in tumour aspirates and
in viral ly induced tumours (Corasanti et al^ 1980; Markus et
al 1980; Niklasson et a_l 1981; Evers et a_l 1982; Mira-y-
Lopez et al_ 19 83).
1.7.2 Plasminogen Activator In Neoplastic Cell Cultures
Much of the interest in the role of plasminogen
activators in tumour invasion and metastases resulted from
the finding that large numbers of cultures of neoplastic
origin have been reported to release elevated levels of
plasminogen activator (Danor*~i9 85), with far fewer reports of
cultures of neoplastic origin containing amounts of
plasminogen activator similar to those found in normal
tissues or lacking any detectable activator (Wilson and
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Dowdle, 1978 ;Recklies'etal 1980;Gronow and Blenheim, 1983).
More recently reports have established that some cell lines
produce uPA (Dano et a_l 19 8 0 ; Wilson et al^ 19 80 , 19 8 3 ;
Strickland et a_l 1983) and other lines tPA (Rifkin et al^
1974; Rifken and Collen, 1981; Ornstein et al^ 1983;
Strickland et al_ 1983). Infrequently neoplastic cultures
have been reported to produce both types of activator
although it is unclear whether both activators are produced
in the same cells or whether each activator is synthesized by
a different cell population (Wilson et a_l 1980, 1983;
Strickland et a_l 1983; Schleuning and Reich, 1983).
Furthermore the neoplastic transformation of many
cultured cells coincides with a marked increase in
extracellular proteolytic activity due mainly to the release
of plasminogen activators although other serine proteases and
collagenases have also been detected (Chen and Buchanan,
19 75; Dano et a_l 19 80).
1.7.3 Transformation Of Cell Cultures
Malignant transformation (Schaeffer, 1979) describes the
transition in vitro of non neoplastic cells into neoplastic
cells capable of forming tumours. Such transformation can be
induced either by viruses or chemical carcinogens (Heidelberg-
er, 1973; Graham et a_l, 1974; Barret et a^ 1978) or in
some species it may occur as a result of spontaneous events
(Sandford and Hoemann, 1967). The relationship between
transformation _in vitro and malignancy iji vivo is not clear.
Normal cells, which can be transformed in vitro, sometimes
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fail to produce tumours when inoculated back into the host.
Similarly, cultured cells derived from malignant tissues can
themselves undergo transformation resulting in further
alterations in growth characteristics. Since malignancy
itself cannot be demonstrated in vitro, we are obliged to use
the properties expressed by cultured cells derived from
tumours, or cells made tumorigenic, as indicators of
malignancy. Transformation results in a series of biochemical
alterations, which can include increased proteolytic activity
(Danoeta.1198 5) enhanced agglutination (Burger, 1969; Inbar and
Sachs, 1969) increased sugar uptake (Hatanaka and Hanafusa,
1970), a reduction in serum concentration required for growth
(Holley and Kiernan, 1968; Lindgren, 1975) and a decrease in
cyclic nucleotides (Goldberg et al_ 1975 ; DeLarco and
Todaro, 1978). Changes in the underlying biochemistry of the
transformed cell result in a morphological phenotype which is
associated with transformation (Pastan and Willingham, 1978)
and is characterized by cells rounded in shape, an increase
in cell surface irregularities and disordered alignment of
cells. Most of these phenomena are correlatedly expressed and
are unlikely to be under phenotypic control. These changes
are largely due to diminished cell adhesion. The loss of
cell to substrate adhesion is reflected in the ability of
many malignant or transformed cells to grow in suspension or
semi solid media. Furthermore, loss of adhesion leads to
reduced cell-cell recognition resulting ultimately in loss of
density limitation (contact inhibition) and a disordered
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growth pattern (Otten et al 1971; Anderson et a_l 1973;
Carchman et ajL 1974). Two molecules which may be important in
controlling the transformed phenotype are cyclic AMP (cAMP)
and cell surface protein (CSP) (Hynes, 1976; Keski-Oja et a_l
1977). Many normal lines show an increase in cAMP at
confluency which transformed lines often fail to do when
crowding occurs. Treatment of many transformed cell lines
with cAMP results in cell flattening and elongation,
decreased agglutination and decreased surface irregularities
(Willingham et a_l 1973). Cyclic AMP is thought to act by
phosphorylation of key proteins. Two phosphoproteins, filamin
and microtubule asssociated protein (MAP), are responsible
for maintaining cell shape and are located at the plasma
membrane (Willingham and Pastan, 1974; Davies et aj^ 1977).
These proteins may therefore be susceptible to the action of
cAMP. The assembly of microfilaments is increased by cAMP and
by CSP, both of which enhance adhesion, and it seems likely
that disruption of these structures in transformed cells is
the result of decreased adhesion rather than a defect in
microfilament assembly. The secretion of large amounts of
cell surface protein by normal cells is often reduced in
their transformed counterparts and although CSP increases
cell adhesion (01den&Yamadg,1977; Adams et al^ 1977) it has no
metabolic effects on growth, hexose transport or saturation
density (Yamada et a_l 1976; Yamada and Pastan, 1976). The
increase in proteolytic activity which often accompanies
transformation may assist in removing CSP from the surface of
cells.
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The role of proteases in transformation is generally
less clear. Enzymes and substrates located at the surface of
the cell on the plasma membrane mediate a variety of cellular
interactions including cell adhesion, cell recognition and
cell-cell communication and factors affecting growth control.
Trypsin, exogenously added to cultures can stimulate density
limited fibroblasts to undergo another round of cell division
(Vaheri et al^ 1974; Blumberg and Robbins, 1975). This surface
protease effect on cellular mitosis has been demonstrated in
normal and neoplastic tissues (Bosmann, 1972) and several
laboratories have indicated that the addition of proteases to
cultures can cause the cells to mimic some of the properties
of transformed cells. Further evidence that proteases might
be responsible for some of the characteristics of transformed
cells results from experiments in which the addition of
protease inhibitors to the growth medium of cultures of
transformed cells helped to restore properties associated
with normal cells (Borek et a_l 1979; DiP&olo et a_l_ 1980 ;
Markus, 1984).
In genetic studies using Rous sarcoma virus (RSV), rapid
morphological and metabolic changes occur in cell behaviour
when the transforming gene src is expressed (Bader, 1972;
Anderson et a_l 1973; Yoshida et a_l 1977). This gene has the
capacity to code for a protein 40-60,000 daltons but it seems
unlikely that the one gene product could be responsible for
all the properties of transformed cells and an alteration of
some basic control mechanism has been suggested. At an early
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stage in transformation the src gene product affects the
integrity of the cell surface, possibly mediated by
proteolysis of membrane proteins or by cAMP. Recent evidence
has suggested that the src gene product may be a polypeptide
hormone (Brugge and Erikson, 1977; Jay et al^ 1978) which
initiates changes resembling those which occur in cultures on
addition of growth factors appropriate to that cell type
(glucose transport is also increased). Addition of
polypeptide hormones to cell cultures has been known for some
time to stimulate synthesis of plasminogen activators (Lee
and Weinstein, 1978) thereby producing a factor which has
already been noted under certain circumstances to disturb
normal metabolism.
Much work is required to elucidate the nature of the
changes occurring on transformation of cells. Evidence would
seem to indicate, that the increase in proteolytic activity
associated with transformed cells, not only has the
potential to enhance tumour invasion, but can induce
alterations in growth control and cell metabolism.
1.7.4 Plasminogen Activator Production In Transformed
Cultures
The relationship between transformation by oncogenic
viruses and plasminogen activator synthesis has been
thoroughly studied by infection with Rous sarcoma virus
(RSV). Unkeless et a^ (1973) showed that chick embryo
fibroblasts consistently developed extracellular proteolytic
activity after transformation by RSV. Proteolytic activity
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was not present in normal cells or in cells after infection
with non transforming strains of the virus. In cells infected
with temperature sensitive mutants proteolytic activity only
appeared after the cultures were incubated at permissive
temperatures. The proteolytic activity was later shown to be
caused by induction of plasminogen activator which activated
plasminogen in the medium (Quigley et al^ 1974; Unkeless et al^
1974; Rifkin et a^L 1975). This activator was evaluated by
its Mr to be uPA (Granelli-Piperno and Reich, 1978).
Viral transformation may alter the host cell regulation
of plasminogen activator synthesis. Ossowski et a_l (1973)
using a strain of RSV that transformed both chick and rat
embryonic fibroblasts found an increase in uPA in both cell
types but each type of uPA showed species specificity for
plasminogen. Urokinase-type plasminogen activator must
therefore be determined by the host cell.
Balduzzi and Murphy (1975) found, using wild type,
mutant and non transforming RSV, that only viruses capable
of causing morphological transformation induced plasminogen
activator synthesis. Wolf and Goldberg (1976), however,
found no difference in the degree of morphological changes in
clones producing low, intermediate or high levels of
plasminogen activator although no evidence was produced in
these studies to indicate the presence of pro-enzymes or
inhibitors. Since 0'Donne 1-Tormey and Quigley (1981) found a
protease inhibitor in RSV transformed fibroblasts, which
would inhibit release of plasminogen activator from cells it
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is not surprising that conflicting results are sometimes
reported.
In general transformation by DNA oncogenic viruses,
causing extracellular proteolysis, is less consistent than
St e\ I
that obtained by RNA viruses particularly RSV (Dano7/~19 85).
Selection procedures for these transformed clones are very
elaborate and cultivation periods are often extensive.
Because of selection which occurs during culture procedures
particularly from tumours which have such a heterogenous
population of cells and because repeated cloning also
accentuates phenotypic and genotypic differences, studies
based on the use of cell cultures must always be interpreted
with caution.
1.7.5 The Role Of Plasminogen Activators In Neoplastic
Tissues
Transformed cell cultures and those derived from
malignant tissues generally secrete higher levels of
plasminogen activator than normal cells. Tumour tissue in
vivo also exhibits high extracellular proteolytic activity
(Dano et a_l 1985). This property of tumour cells may promote
tumour invasion and metastases. To firmly establish a causal
role for plasminogen activator in tissue degradation by
tumours, plasminogen activator activity of tumour tissue
need not necessarily be higher than in normal tissues but
should ideally be found where invasion into surrounding
tissue is taking place. Secondly protease inhibitors should
also inhibit metastases and reduce tumorigenicity of
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malignant cells. Studies using inhibitors specific to each
type of activator should help to clarify the role, if any, of
each type of activator in tumour biology.
1.7.6 Location Of Plasminogen Activators In Tumour Tissues
The recent development of specific antibodies to tPA and
uPA has allowed localization of activators in tissues and
should give a clearer indication of the role of these enzymes
in tumour invasion. In the limited number of studies so far
performed using these antibodies, uPA immunoreactivity has
been demonstrated in colon tumours and melanomas (Khoga et al_
1985; Burtin et al 1985; Markus et al^ 1983, 1984),
prostatic cancer (Camiolo et al^ 1984) and murine lung tumours
(Skriver et a_l 1984). In the latter study and that of Khoga
et al_ (1985) the number of cells containing uPA were greatest
in areas where tissue degradation was occurring and is
therefore consistent with its putative role in tumour
invasion. Extractable uPA from colon (Markus et al 198 3) and
murine tissues (Skriver et a_l 1984) was not significantly
higher than in normal tissues. However, in normal colon
fewer cells stained positively with uPA antibodies than in
tumour tissue. Such discrepancies may be resolved by better
control of possible cross reactivity with other antigens in
tissue sections and by better quantitation of the pro-enzyme
or inhibitor levels. Many more studies such as these are
required before a direct relationship between plasminogen
activator and extracellular proteolysis in tumours can be
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established.
1.7.7 Inhibition Of Tumour Metastases
In several experimental systems leupeptin and antipain,
both plasminogen activator inhibitors, reduce carcinogen and
radiation induced transformation of cells (Borek et a_l 1979;
DiPaolo et al^ 1980; Kennedy and Little, 1980; Kinsella and
Radman, 1980). Leupeptin has also been found to reduce lung
metastases in the rat after injection of hepatoma cells (Meyn
et al 1977). It should also, however, be noted that some
studies have failed to show this inhibition. The role of
inhibitors has been extensively reviewed by Markus (1984).
Specific inhibition in relation to metastases has been
attempted in only one study. Ossowski and Reich (1983) found
that antibodies which specifically inhibited the enzyme
activity of human uPA but not chicken uPA decreased
metastases of human tumour (Hep-3) to chicken lung after
transplantation onto the chorioallantoic membrane of chick
embryos. Since growth at the site of inoculation of the
tumour was not inhibited, then uPA potentially plays an
important role at an early stage in the metastatic process.
Another approach to the role of plasminogen activators in the
development of tumours is to compare the production of
plasminogen activators by cell lines for their metastasizing
capacity and their tumorlgenicity. Wang et a_l (1980) found
that subline F10 of the B16 melanoma line which secretes more
plasminogen activator than subline F1 had greater frequency
of lung metastases after subcutaneous inoculation although
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other laboratories have been unable to detect differences in
metastatic capacity using the same cell lines (Nicholson et
al 1978). Similarly a study of the metastatic capacity of
clones of Lewis lung tumours was found in one case to be
positively correlated with high levels of plasminogen
activator (Eisenbach et al_ 1985) while in another study no
correlation was found (Whur et a_l 1980). Similar conflicting
evidence surrounds the tumorigenicity of certain transformed
cell lines (Jones et al 1975a, b; Gallimore et ajL 1977) when
injected back into either nude mice or immunoincompetent
animals. Several laboratories have found good correlation
between the secretion of plasminogen activator and the
ability to form tumours (Pollack et al^ 1974, 1975; Laug
et a 1 1975; Ossowski and Reich, 1980; Adelman et a_l
1981; Bruggen et a_l 1981) while other studies have indicated
the correlation to be less pronounced or absent (Jones et a_l
1975a; Becker et a_l 1977; Gallimore et a_l 1977; Wolf and
Goldberg, 1978; Tenchini et al 1983). Conflicting results in
these kinds of studies are not surprising since no account
can be taken of local environmental factors especially
inhibitors and hormones, which can regulate cellular
synthesis of plasminogen activator. The hormonal milieu of
the tumour may be especially important since many tumours are
capable of synthesizing their own hormones (Todaro and
DeLarco, 1976), hence their reduced serum requirement in
vitro.
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1.8 REGULATION OP PLASMINOGEN ACTIVATOR ACTIVITY
Plasminogen activator activity is regulated by the rate
of biosynthesis of the pro-enzyme, the release of pro-enzyme
from the producer cells and the conversion of the pro-enzyme
to plasminogen activator. At each of these stages the
presence of stimulatory or inhibitory activity will affect
the final level of plasminogen activator activity detected in
a given tissue.
1.8.1 Conversion Of Pro-enzyme
Mechanisms which regulate the activation of pro-enzymes
have previously been considered unimportant because of the
presence of trace amounts of plasmin in extracellular spaces
likely to be responsible for the conversion of released pro¬
enzyme. However, Skriver et a_l (1984) found, in Lewis lung
tumour, that all of the extracellular uPA was in the one
©t cl]
chain form. In addition Kielbergy(1985) later demonstrated
that at least 50% of the uPA in the urine drawn from the
murine bladder was present in the inactive form. Mechanisms
as yet unknown must therefore exist which control the
conversion of the pro-enzyme to the active form.
1.8.2 Synthesis Of Plasminogen Activator
Glucocorticoids suppress uPA and tPA activity in many
tissues although suppression of tPA tends to be much more
variable. The possible role of inhibitors in steroid induced
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changes in uPA may be investigated by separation of these
components using gel electrophoresis. Involvement of
inhibitors, which either bind covalently or migrate at the
same position on the gels cannot be ruled out but results
obtained suggest that changes in the concentration of
inhibitors are not the only reason for steroid effects.
Steroids appear to regulate plasminogen activator levels by
regulating the rate of gene transcription. RNA synthesis
inhibitors block induction of plasminogen activator hence
there is a requirement for de novo synthesis of mRNA. RNA
synthesis inhibitors also inhibit glucocorticoid suppression
of intracellular levels of uPA and tPA probably by inducing
an intracellular regulatory molecule which in turn inhibits
plasminogen activator gene transcription or mRNA translation
(Rifkin and Crowe, 1980).
In many cell types, plasminogen activator activity is
regulated by polypeptide hormones, epidermal growth factor
(Lee and Weinstein, 1978; Eaton and Baker, 1983), luteinising
hormone, follicle stimulating hormone and human chorionic
gonadotrophin (Strickland and Beers, 1976), prolactin (Mira-
y-Lopez et al_ 1983) and calcitonin (Sims et a_l 1981; Sudol,
1985). Given that cAMP is the likely intracellular second
messenger for these hormones, other compounds known to
increase cAMP for example cholera toxin (Rheinwald and Green,
1977) are found to enhance or mimic the effects of these
hormones. These compounds also effect the synthesis of
plasminogen activator in a number of cell cultures many of
which show parallel changes in plasminogen activator levels
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with cAMP and hormones (Dayer et a_l 1981; Soreq et a_l 1983).
In a similar manner to steroid hormones, eyeloheximide and
actinomycin D block cAMP and growth factor induction of
plaminogen activator by a mechanism dependent on m RN A
synthesis.
1.8.3 Inhibition Of Plasminogen Activator Activity
Both uPA and tPA are inhibited by the circulating plasma
protease inhibitors (Fig. 5), however, the significance of
these inhibitors in neutralization of activators in the blood
is unknown because reaction rates between inhibitors and
activators are much lower than the clearance rates in vivo
would suggest (Waller et al^ 1983).
Until recently the presence of specific inhibitors of
plasminogen activators have never been convincingly
demonstrated because of the lack of appropriate kinetic data.
However, the existence of plasminogen activator inhibitors
has now been accepted (Sprengers et a_l 1986) and these have
been characterised into three immunologically distinct
groups; PAI-1 (endothelial cell type inhibitor), PAI-2
(placental inhibitor) and protease nexins. PAI-1 has been
demonstrated in plasma (Kruithof et a_l 1983) and in culture
fluids of normal and transformed cells lines (Van Mourik et
al 1984; Sprengers et a_l 1 985; Kruithof et a_l 1984; Schleef
et al 1985), although its precise function in the regulation
of fibrinolytic activity is still only partly understood. The
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inhibitors in some cases have been tested only with uPA or
tPA but some reports indicate the inhibition of both
activators (Erikson et a_l 1984; Lecander et al^ 1984; Van
Mourik et al 1984). Korninger and Collen (1981) have reported
second order rate constants for the reaction between
activator and these inhibitors in plasma. These are several
orders of magnitude higher than the rates of reaction between
plasminogen activator and the abundant plasma protease
inhibitors (Ranby et a_l 1982) and high enough to allow the
reaction rate within the plasma to be higher than the
observed clearance rates in vivo. The tissue distribution of
these inhibitors is unknown.
Recently it has been demonstrated that co-cultivation of
cell types can result in the reduction or disappearance of
plasminogen activator from culture media. Co-cultivation of
mouse melanoma cells secreting tPA with a non secreting sub
clone of the same cell type leads to the disappearance of tPA
from the culture medium (Kyner et al_ 1978). Similarly co-
cultivation of a rat neuroblastoma stem cell line with its
tumorigenic plasminogen activator secreting descendent also
results in the reduction in the synthesis of plasminogen
activator (Liu et a_l 1984). In both cases no inhibitor was
involved in this process. Hoal et a_l (1983) found that the
disappearance of tPA from melanoma cell lines co-cultivated
with normal fibroblasts was the result of attachment of the
tPA to a surface component of fibroblasts. Knauer and
Cunningham (1984) have reported at least three molecules
termed protease nexins (PN I, PN II, PN III) which are
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secreted by fibroblasts into culture medium where they form
covalent linkages with proteases. PN I is known to complex
with uPA (Baker et aj. 1980) and with plasmin (Eaton and
Baker, 1983). Protease nexins synthesized iri vivo would
therefore be able to remove certain proteases from their
extracellular environment and PN I in particular may function
to regulate endogenous uPA or plasmin. These complexes
readily bind to the cells which secrete them and are rapidly
internalised and degraded (Knauer and Cunningham, 1984). More
recently Saksela et a_l (1985) reported similar cell derived
factors produced by a fibrosarcoma cell line. They found not
only the secretion of a heparin binding protease similar to
protease nexin but also another unidentified inhibitor of
uPA.
Such interactions between various cell types which
produce a change in metabolism of plasminogen activator are
of obvious importance in connection with their function in
neoplasia. Enhancement or inhibition of local proteolytic
activity by contact between various cell types may be
involved in determining whether a tumour may metastasize and
in which place secondary tumours are likely to arise. Such
mechanisms also suggest a possible alternative to plasminogen
activator production by malignant cells themselves.
1.9 SUMMARY
Evidence is accumulating that plasminogen activators and
particularly uPA may be involved in pericellular proteolysis
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during tumour invasion and metastasis. Elevated levels of
plasminogen activator are associated with tumour tissue in
vivo, and increased plasminogen activator activity is
displayed by many cultures derived from malignant tissues or
by normal cultures after transformation. Control of
protease production in the cascade reaction is complex. The
rate of synthesis of activators can be controlled at the
transcriptional or translational level. After pro-activators
are secreted from cells, activation to the two chain form is
influenced by regulatory mechanisms, as yet unknown, or by
inhibitors of plasminogen activators. The production of the
protease plasmin is similarly under inhibitor control.
Plasminogen activator synthesis is extremely sensitive to
physiological concentrations of hormones and growth factors.
Events which increase the rate of synthesis of plasminogen
activators or shift the inhibitor balance in tumour areas are
largely still unknown. These events presumably depend to
some extent on tumour type. In the last few years attempts
have been made to identify uPA or tPA in certain tissues and
tumours and the recent development of monoclonal antibodies
to uPA and tPA should allow laboratories to separately locate
these molecules in tissues.
Furthermore, recognition of the importance of
attempting to measure pro-enzyme and inhibitor levels in
tissue should help elucidate events which result in the final




In this study the role of plasminogen activators and
plasminogen in oral squamous cell carcinoma was investigated.
The objectives were as follows:
1. To develop appropriate techniques for the culture of
gingival epithelium and epithelium from the squamous cell
carcinomas.
2. To study the presence of plasminogen activators and their
inhibitors in oral tissues in vivo and in vitro.
3. To determine levels of plasminogen activators in cultures
of normal and malignant oral epithelium.
4. To study the presence of plasminogen in oral epithelium





Tissue culture evolved as a natural progression from
early embryological work. Traditional culture procedures in
use today were established in the first two decades by
workers such as Carrel and Burrows (1911) and subsequently a
great variety of techniques became available as investigators
modified these methods for their own experiments. The full
potential of tissue culture was gradually realised and by the
1950's the culture of animal cells was employed in such
diverse areas as virus replication, morphogenetic and
transplantation experiments, the study of neoplasia and more
recently in drug testing, cytogenetic analyses and hybridoma
technology.
The successful growth of cells in culture depends on
the provision of suitable environmental and nutritional
conditions (Paul, 1975; Waymouthet/al19 81; Freshney, 1987). By
far the most important single factor in culturing cells is
the growth medium, whose function is to provide the physical
conditions of pH and osmotic pressure and the complex
chemicals required for growth. The first major contribution
in this area was made by Eagle (1955) who defined the basic
nutritional requirements of cells in culture. This was
followed by the formulation of many different synthetic media
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optimised for different cell types. The basic constituents
and functions of media for animal cells are outlined below.
2.1.1 Media
2.1.1.1 Carbohydrate
Glucose is included in most media as the carbon source
of choice. It is metabolised principally by glycolysis to
produce lactic acid and via the Krebs cycle to form carbon
dioxide. Galactose may be substituted and has the advantage
that its metabolites are less likely to cause acidification
of the medium, which is particularly evident with transformed
cell lines. Sugars can also be replaced by simpler
molecules, for example lactate or pyruvate, which will
satisfy the energy requirements of the cells given an
adequate oxygen supply.
2.1.1.2 Salts and Buffers
Most animal cells require sodium, potassium, calcium,
magnesium, chloride, phosphate and bicarbonate ions for
growth. Sodium and potassium are mainly required for the
maintenance of osmotic pressure, whilst calcium and magnesium
are necessary for certain intracellular enzymes to function
and appear to promote attachment of cells to their substrate.
Lowcalcium levels have been found to favour proliferation of
epithelium and inhibit fibroblast growth in epithelial cell
cultures (Peehl and Ham, 1 980a,b; Tsao e_t a 1 , 1 9 8 2 ; Boyce
and Ham, 1983).
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Of the cations, phosphate is essential for the
production of ATP by the cells, and bicarbonate, which
functions in a number of fundamental biochemical processes,
is the main buffering system in culture. Medium buffered
with bicarbonate does, however, require equilibration with 5%
carbon dioxide in the gas phase. The use of other buffers is
complicated by the fact that the cells have a metabolic
requirement for carbon dioxide and these buffers may
sometimes be used in conjunction with lower concentrations of
bicarbonate. The overall concentration of inorganic ions in
the medium is constrained by the total osmotic pressure in
which the cells can survive. In practice human cells in
vitro can tolerate osmolalities between 260-320 mOsm kg-1
(human plasma is ca.290 mOsm kg-1) (Freshney 1987).
2.1.1.3 Amino Acids
The ten essential amino acids in the mammalian diet are
included in all media plus (usually) cysteine, tyrosine and
glutamine. Non essential amino acids commonly used in the
synthesis of proteins are available commercially and can be
added to media, particularly if cells are cultured at low
clonal density.
2.1.1.4 Vitamins and Organic Compounds
Minimal media contain the B group of vitamins, choline
and i-inositol,the other requirements generally being met by
serum. Polyunsaturated fats, also required by most cells,
are derived from lipids bound to the serum proteins.
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2.1.1.5 Serum
The importance to the medium of serum as a contributor
of factors, many of which are as yet undefined, is
underlined by the requirement of cells for additional
hormones, vitamins, growth factors, non essential amino
acids, and organic compounds, such as linoleic acid and
polyamines, in serum free media.
Serum is composed mainly of binding proteins which
recognise vitamins, lipids and hormones and which may
stabilise and modulate the action of the substances which
they bind.
Serum contains a variety of growth factors, albeit in
low concentrations, essential to cells; epidermal growth
factor (EGF), fibroblast growth factor (FGF), platelet
derived growth factor (PDGF), and mitogen stimulating
activity (MSA). Growth factors are mitogenic and some are
thought to exert their effect by binding to insulin receptors
on cell surfaces thus promoting the uptake of glucose.
Hydrocortisone, a steroid hormone also found in serum, is
known to promote cell attachment, cell proliferation and to
induce differentiation. The concentrations of these and
other factors may vary from one serum batch to another and
the effect of serum batch on cell growth has been widely
recognised (Barnes and Sato, 1980).
Other serum proteins sequester toxic substances (Iscove
and Melcher, 1978) and the purity of the water becomes very
important in serum free media.
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Serum also provides protease inhibitors which protect
cells from damage during the passage procedure, and
substitutes for this function, for example soybean trypsin
inhibitor, must be provided when serum is omitted.
Lastly, serum modifies the surface of the substrate to
which cells attach by depositing a layer of fibronectin (Hook
et a^ 1977) and many cell lines require the addition of a
fibronectin coating if cultured in the absence of serum.
The requirement of virtually all primary and
established cell lines for serum has hampered investigation
of many aspects of cell biology. Cells growing in a defined
medium would be of major importance since they represent the
ideal system for the study of drug and hormone action, growth
and differentiation in the absence of undefined factors.
2.1.2 Substrate
Most cells, excluding some haemopoetic and transformed
cell lines, require to spread out on a substrate in order to
proliferate. A critical parameter for such anchorage
dependence is the density of negative charges on the surface
of the substrate. In this respect glass has been largely
superceded by sterile disposable plastics, the surfaces of
which are charged by etching with sulphuric acid. Attachment
and growth of many cell types is improved by the application
of a number of surface coating materials: PTFE, cellulose
nitrate, collagen, fibronectin, laminin and extracellular
matrix (Lui and Karasek, 1978; Savage and Bonney, 1978;
Gospadarowicz et al 1980; Haw ley-Nelson et a_l 1980; Lillie e_t
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al 1980; Clark et a_l 1985; Lenoir et a^ 1985). Some of
these materials not only improve growth but may promote
differentiation and influence the expression of tissue
specific functions.
2.2 COLTURE OF EPITHELIAL CELLS
Most tissue culture systems were originally designed
for fibroblasts which can be routinely cultivated through
many generations as unchanged diploid cells (Hayflick and
Moorhead, 1961) or indefinitely as transformed cell lines.
Two major problems are associated with the cultivation
of keratinocytes; one is the overgrowth in primary culture
of keratinocytes by the more vigorous stromal elements in
mixed tissues, and the other more exacting problem is the
inability to continuously subculture epithelial cells.
Many approaches to the problem have included seeding
epithelial cells on growth arrested feeder layers, the
provision of biologically relevant substrates and selective
enhancement of keratinocyte growth by manipulation of the
medium or incubating conditions. A series of disparate
techniques, many of which combine these elements, appears to
be emerging for keratinocyte culture, each yielding cells
closely resembling the parent tissue.
2.2.1 Feeder Cell Supports
One of the first reported methods of epithelial cell
culture was pioneered by Rheinwald and Green (1975) and is
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still widely used today. They achieved the successful clonal
growth of human keratinocytes from newborn foreskin and a
murine teratoma cell line (XB) on lethally irradiated feeder
layers of Swiss 3T3 cells. These feeder cells largely
suppress the growth of fibroblasts and remaining contaminants
can be removed by brief exposure in 0.2% EDTA. Colony
formation of human keratinocytes was found to be entirely
dependent on the presence of 3T3 cells although the teratoma
XB line could form colonies but not keratinize if seeded at a
high enough density in the absence of 3T3 cells. Replacement
of feeder cells by 3T3 conditioned medium was also able to
support the growth of the XB line, but human kerat inocytes
failed even to initiate colonies. The authors concluded that
the interaction of the two cell types was essential for the
development of a keratinising epithelium. With the XB line,
conditioned medium which had been diluted to less than 20% of
the incubating medium, showed reduced effectiveness. It was
thought possible that the removal of inhibitors by
fibroblasts was involved in the conditioning, since simple
dilution of growth factors seemed unlikely.
More recently, Eisinger et al_ (1979) have shown that
human epidermis is not dependent on the presence of feeder
cell layers, collagenised substrates, or special nutrients
providing conditions of seeding density, pH and temperature
are optimised. They grew over 200 specimens from eight
anatomical sites with seeding densities of 2.5 x 105 cells
cm-2 in acidic medium (pH 5.6 - 5.8) at 35 - 37°C. They
found, however, that under these conditions only very limited
58
passage was possible. A maximum of 5 transfers was achieved
for foreskin keratinocytes, but less so for other
keratinocytes without the addition of substances which raise
intracellular cAMP. Seeding densities used by this group
were also exceptionally high and may be a limiting factor for
other laboratories. Further problems may also arise in the
overgrowth of keratinocyte colonies by fibroblasts at late
passage in the absence of feeder cell cover.
Lechner et aJL (1980) , for example found that bronchial
epithelial cells still require a feeder layer even in the
presence of additional growth factors in the medium.
Interestingly too, while Lechner et al_ (1 9 80) found, in
agreement with Rheinwald and Green (1975), that cell lines of
mesodermal origin provided the most favourable support for
epithelial cells, Stampfer et a_l ( 1 9 8 0 ) found that
conditioned media from other epithelial cell lines were most
effective at promoting keratinocyte growth from normal human
mammary tissues. The ability of several cell types to serve
as feeder layers for breast and cervical epithelia has also
been noted by Stanley and Parkinson (1979). These may
reflect genuine differences in epithelia derived from
different sites. Despite progression towards identifying
essential factors involved in keratinocyte growth, serial
subcultivation in the absence of 3T3 or other cellular
support has proved very difficult. It seems certain that the
provision of a biologically relevant substrate such as
fibronectin, extra cellular matrix or collagen appears to
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increase plating efficiency. These substrates both improve
cellular attachment (Macaig et al 1981) and may reduce the
serum requirment for clonal growth (Ham and McKeehan 1979;
Lechner et ad 1980). Lillie et a_l (1980) also found that
growth of rat lingual epithelial cells on collagen rafts
which draw up medium by capillary action, show an increase in
the degree of tissue organisation, and synchronous rather
than sporadic keratinisation of the upper layers. The
mircoenvironment, so often overlooked, may be much more
important than previously thought.
2.2.2 Optimisation of Media for Keratinocyte Growth
Attempts to improve media for keratinocyte growth which
would obviate the need for the laborious preparation of
feeder layers were based on two considerations. Firstly, to
define precisely the factors (including those present in
serum) necessary for keratinocyte growth and secondly, to
exclude the possible inductive effects of underlying
mesenchyme when investigating epithelial cell functions in
culture.
In modifying commercially available media, which had
hitherto been developed primarily for fibroblasts,
investigators had to bear in mind that, while enhancing
keratinocyte growth, the medium had to select against
fibroblasts. One of the simplest ways to achieve this was
the addition to commonly used media of compounds which would
specifically inhibit fibroblasts. Sporadic reports of this
nature have appeared in the literature.
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2-2.3 Fibroblast Inhibition
The following methods have been reported to inhibit
growth of fibroblasts.
2.2.3.1 Thimerosal
Braaten et al (1974) successfully used sodium
ethy lmercurithiosalicy late (thimerosal) for the specific
removal of fibroblastoid cells in primary cultures of
pancreas islets with no apparent effect on their endocrine
function. Later, Wagner and Matthews (1975) used thimerosal
to grow pure cultures of endothelial cells without apparent
effects on endothelial cell function. The mechanisms of the
toxic effects of thimerosal to fibrob1astoid cells are
unknown.
2.2.3.2 Spermine Tetrahydrochloride
More recently, Schuster et a_l (1985) reported the
addition of spermine tetrahydrochloride to epithelial cell
cultures derived from hamster cheek pouch. The enzyme amino
oxidase, which is present in higher concentrations in
fibroblasts than in epithelial cells, converts spermine to an
unstable aldehyde and then to acrolein both of which are
toxic. Both thimerosal and spermine, however, have one
drawback in that they are also toxic, although less so, to
non fibroblast cells.
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2.2.3.3 Antibody Mediated Cytotoxicity
A more specific agent which selectively kills
fibroblasts has been developed by Gusterson et a_l (1981).
They raised a monoclonal antibody against fibroblasts which
kills these cells by complement mediated cytotoxicity. While
this may be a promising method of fibroblast control, the
antibody is not yet commercially available and may prove
prohibitively expensive for routine tissue culture.
2.2.3.4 Temperature Sensitivity
A much simpler method for fibroblast control was
adopted by Jensen and Therkelsen (1981). They reported that
reduction in incubator temperature to 32 - 33°C was effective
in inhibiting fibroblast growth with no effect on the growth
rate of human foreskin epithelial cells. Indeed, Marcelo et
al (1978) subsequently found that lower temperatures actually
increase the in vitro lifespan of fully stratified epithelial
cell cultures with no apparent decrease in proliferative
activity. Recently, Arneholt-Bindslev et al^ (1987), reported
that the optimum growth temperature for human oral epithelium
was 34°C.
Other reports, however, (Haw ley-Ne 1 son et a_l 1 980),
have shown that reductions in temperature to 34°C or 31°C
reduced colony numbers respectively to 50% and 10% of that
of the controls. Eisinger et a_l (1979) also reported that
reducing the incubating temperature below 35°C reduced colony
forming efficiency of keratinocytes. The issue remains
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unresolved.
2.2.4 Epithelial Cell Enhancement
Latterly, attempts have been made to specifically
develop media for keratinocytes which allow plating in the
absence of feeder suppport at low seeding densities and which
increase their capacity for serial subcultivation. In a
number of laboratories detailed studies of the conditions
which favour keratinocytes have yielded interesting results.
Fortunately, the requirements of epithelial cells differ
sufficiently from those of fibroblasts to inhibit overgrowth
by fibroblasts in such selective media.
The assessment of growth promoting additives, however,
is complicated by a number of factors. The composition of the
basic medium markedly influences the serum and growth factors
required and this has been extensively reviewed by Barnes
and Sato (1980). A further complication in assessing growth
additives arises from the use of tissue from different
sources. The most common sources of keratinocytes for these
studies are newborn foreskin, oral mucosa, breast epithelium
and in some laboratories transformed epithelial cell lines.
The cells from each of these sources respond differently to
growth additives. Indeed, three established epithelial
breast lines (MCF-7, MDA-231 and ZR-75-1) differ markedly in
their nutrient requirements and these requirements differ
again from those necessary for the primary culture of normal
breast epithelium (Osborne et al 1980; Allegra and Lippman,
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1978; Anderson and Buerking, 1983). Both MCF-7 and ZR-75-1
require insulin and transferrin but the basal medium and
other additives are different. MDA-231, unlike MCF-7 cells,
grown in the same medium were found to be completely
unresponsive to insulin or EGF and it may be that only
certain tumours retain biomolecular capacity to respond to
these hormones.
In addition, few reports take into account possible
synergistic effects of additives or fully investigate dose
dependent relationships of these growth factors confirmed by
Allegra and Lippman (1978), Mather and Sato (1979), Hayashi
et a 1 (1978), Peehl and Ham (1980a,b) and Tsao et a_l (1982).
Allegra and Lippman (1978) showed clearly the biphasic dose
response of the breast cell line ZR-75-1 to some hormones.
Triiodothyronine (T3), for example, stimulated this cell line
at concentrations as low as 1.0 nM to 0.1 uM but the effect
on growth was diminished at higher concentrations (10 uM) and
eventually became inhibitory. Optimal concentrations of
hormones may also change as the medium becomes more defined.
Wu and Sato (1978) found that critical components of the
medium for HeLa cells are hydrocortisone (HC) and EGF.
Aldosterone can, however, replace hydrocortisone and if the
basal medium is replaced by the more intricate medium MCDB
105 then the need for hydrocortisone, insulin and EGF are
eliminated. The fact that the effects of some hormones can
be mimicked by manipulation of the low molecular weight
nutrients leads to speculation that some hormones act in cell
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culture by regulating the balance of nutrients inside the
cell (Holley, 1972). Interpretation of the requirements of a
particular tissue or the results of growth studies therefore
requires careful consideration.
Workers in Ham's laboratory have studied in great
detail the growth requirements of keratinocytes from human
epidermis and have succeeded in producing a medium which
contains no added undefined supplements and which supports
clonal growth at low inoculum densities. They originally
found that the need for a feeder layer or conditioned medium
could be eliminated by the use of medium M199 which was
supplemented by pituitary extracts (PE) , hydrocortisone and
20% foetal bovine serum (FBS) (Peehl and Ham, 1980a).
Subsequently, Peehl and Ham (1980b) found that the medium F12
eliminated the need for pituitary extract and permitted the
use of dialysed foetal bovine serum proteins (FBSP) in place
of whole FBS. Optimisation of the medium composition for
keratinocytes resulted in a new medium designated MCDB 151
and Peehl and Ham ( 1980b) found, in this medium, they could
further reduce the levels of FBSP to less than 1 mg ml-i and
achieve clonal growth. The low levels of calcium (30 uM) and
the higher levels of adenine seemed to be of particular
importance in the medium. Calcium shifted the balance
between multiplication and terminal differentiation in favour
of replication and this has been confirmed by Hennings et a_l
(1980) and Boyce and Ham (1983).
In a later study Tsao, Walthall and Ham (1982)
replaced the FBSP in the medium with a precisely defined
65
mixture of nutrients and further reductions in the size of
the cellular inoculum needed were achieved. Tsao et al^
(1982) had previously found that bovine pituitary extract had
a sparing effect on the amount of FBSP required for the
multiplication of keratinocytes and a reduction in the amount
of hydrocortisone was required at low inoculum densities.
Trace elements, particularly selenium, were also essential in
media with low amounts of total protein. None of the trace
elements were inhibitory and therefore they were included in
all their media thereafter. In the complete absence of FBSP,
it was found that keratinocytes still responded to insulin,
transferrin and hydrocortisone, and EGF was once again
required although the optimal concentration had shifted. The
concentration previously used was inhibitory and was
subsequently lowered. The last undefined supplement was
pituitary extract and this was finally replaced with
phosphoethanolamine (PEtn) which was found to be the active
ingredient of pituitary extract by Kano-Sueoka et al_ (1979).
Although this new medium (MCDB 152) could support clonal
growth of keratinocytes in the absence of any undefined
supplements successful passage was not reported.
In 1983, however, Boyce and Ham first reported the use
of a new medium MCDB 153 which differed from MCDB 152 in its
concentrations of FeS04 and ZnSO^. With the addition of low
levels of EGF, IS, ethanolamine (Etn) , PEtn, and wBPE, they
could serially passage foreskin keratinocytes between 5-7
_ n
times with a cellular inoculum of only 400 cells cm
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compared with Eisinger's required inoculum of 2.5 x 10^ cells
cm-^ in a simpler medium.
It remains to be seen whether keratinocytes from other
sources can also be grown at clonal densities in medium MCDB
153 or whether epithelia from different sources will require
other additives; for example, whether breast epithelium will
continue to require the addition of steroid hormones such as
oestradiol and prolactin (Anderson and Buerhing, 1983). It
seems likely, that as with other cell types, several media
will eventually become available for routine keratinocyte
culture.
2.3 SOBCOLTORE
When cells become a confluent monolayer in primary
culture they can be detached from the Petri dish by
trypsinisation and subcultured (or passaged) either into a
larger vessel, or by plating half the original number of
cells into a dish of the same area i.e. a 1:2 split ratio.
The cells undergo further division and the primary culture
becomes a cell line. With each successive subculture the
cells which proliferate most rapidly and which can withstand
the rigours of subculture procedures gradually predominate.
2.3.1 Ageing or Differentiation
Normal human fibroblasts continue to grow i_n vitro
through a limited number of cell generations but will
eventually die out. The number of population doublings
(usually 20-80) depends on the cell strain and the culture
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conditions but is consistent for a given cell line grown in
similar conditions. This reproducibility of culture lifetime
may be analagous to ageing in vivo. Ageing of cells in vitro
is described as a reduced proliferative capacity that evolves
as a function of serial passages or time in culture
(Schneider and Mitsui, 1976 ; Cristofalo, 1970; Gelfant and
Smith, 1972). An alternative postulated by Bell et ad (1978)
suggests that the phenomenon of ageing i.e. cessation of
proliferation of diploid cells in culture, represents a step
of differentiation and not senescence. They found no causal
relationship between cell divisions and ageing. From
cinematographic histories of cells, and analysis of their
lineages, they found that cells were not required to pass
through a fixed number of divisions before leaving the cell
cycle. Nor did they find that non cycling cells were
moribund. Cultures could be kept alive for up to 14 months
after division had ceased. They proposed that populations of
cells in culture consisted of both cycling and differentiated
cells. At low passage, these cells would be mostly cycling,
whereas at high passage there would be an increasing
population of differentiated cells. Thus when the number of
differentiated cells is greater than the number arising from
cell division, then further division of the cultures in a 1:2
split ratio, or greater, results in an overall decline in
cell numbers.
Cristofalo (1970) argues, however, that cells which
become non-dividers lose the ability to synthesize the
proteins necessary for initiation of DNA synthesis or
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activation of some other aspects of the cell cycle. Iri vitro
therefore, as more cells lose their ability to synthesize
these proteins, the culture will eventually senesce and die
out. Support for these arguments arises from evidence that
growth factors and hormones have been found to prolong the
post-mitotic state of human cells in culture and may also
reverse age dependent changes in cellular metabolism (Leith,
1967; Yuan and Chang, 1969; Cristofalo, 1970; Rheinwald and
Green, 1975). Doubtless in answering the question of whether
eel Is age or merely differentiate iri vitro, a compromise
between these opposing stances will be found.
Continuous or immortal cell lines may arise
spontaneously in some normal murine cultures but generally
only occur in normal human cell lines after treatment with
carcinogenic chemicals or oncogenic viruses. This process is
termed transformation. Transformed cells undergo
morphological and kinetic alterations, some properties of
which are associated with features of malignant cells, for
example an unrestricted capacity for cell division. Again
within Bell's framework, the difference between transformed
and normal diploid cells in culture is the inability of
transformed cells to differentiate rather than some intrinsic
capacity not to age.
2.3.2 Serial Subculture of Keratinocytes
The passage of epithelial cells, like their routine
growth, has proved much more difficult than the subculture of
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fibroblasts. Keratinocytes _in vivo not only divide to give
rise to progeny, but a proportion of these cells move from
the basal layer where division occurs and terminally
differentiate to form the protective layers of skin which are
continually shed and replaced. Differentiation of
fibroblasts in vivo is seen only in specific circumstances
such as the granulation tissue of a wound.
At least, partly because of the commitment to terminal
differentiation, colony forming efficiency of epithelial
cells on transfer is lower than that of fibroblasts. Other
factors may also contribute such as loss of three dimensional
cellular organisation in culture, the loss of suitable cell-
cell interaction and the absence of necessary nutritional
factors.
Indeed, the role of growth factors and steroid hormones
in maintaining cells in a cycling state has been noted in
several culture systems. Leith (1967) proposed that the
addition of hydrocortisone to cell cultures may retard
senescence of cultures by derepression of RNA synthesis.
Although the mechanism of derepression is unclear, addition
of glucocorticoids to several cell culture systems has been
noted to induce formation of specific proteins e.g. alkaline
phosphatase and tyrosine transaminases (Cox and MacLeod,
1962; Pitot et a_l 1964). Griffin and Ber (1969) further
reported that alkaline phosphatase induction by
hydrocortisone in HeLa cell culture occurred exclusively in
the S phase of the cell cycle. If Cristofalo's (1970)
proposed mechanism for the existence of a division initiating
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protein is correct then dividing cells passing through G1 to
S phase of the cell cycle can be rescued from producing non
dividing daughter cells.
Later, Rheinwald and Green (1977) found when EGF was
added to epithelial cultures exponential growth was
maintained for longer. In the absence of EGF between 6-7
transfers were achieved while in the presence of EGF 16-17
transfers were common. Investigation of the mode of action
of EGF showed that it increased colony forming ability before
the growth rate was detectably altered. It was concluded
that there must be a change in the state of the dividing
cells, better enabling them to form new colonies i.e. an
alteration in the generation time rather than an alteration
in the relative magnitude of the dividing fraction.
Cell-cell interation may also be particularly important
since, in the absence of mesenchyme support, there have been
few reports of successful serial subculture. Eisinger et ad
(1979) reported the growth of epithelial cells from many
sources in the absence of dermal components or medium
supplements using high plating densities - 2.5 x 10^ cells
per cm-^. With fewer than 1.0 x 105 cells per cm"^
confluence was not achieved. Cells either failed to grow or
colonies failed to coalesce at this seeding density. Milo e_t
al (1980) have also reported that routine subculture of
newborn foreskin keratinocytes is possible in the absence of
extrinsic factors in the medium and without the use of
conditioned medium or cellular support but again with high
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inoculum densities. Stampfer et al ( 1 9 8 0) passaged
epithelial cells from normal human mammary tissue, grown
initially as organoids in culture, through a maximum of 4
transfers using conditioned medium from other epithelial cell
lines.
Recently, using the considerably more complex medium,
MCDB 153, Boyce and Ham (1983) have achieved serial
subculture of normal human keratinocytes using inoculum
densities of only 400 cells per cm2. This report would seem
to indicate that the presence of mesenchyme cells is not a
critical requirement for keratinocyte culture at low clonal
density but that the feeder effect, given enough
investigation, can be provided directly by the medium.
Reports of subculture in the absence of extrinsic
factors or mesenchyme support do, however, remain isolated
and this may continue to be a problem that will hamper
routine culture of normal epithelial cell lines for some time
to come.
In this study a number of methods were investigated for
growing human oral keratinocytes from gingival biopsies and
from oral squamous cell carcinomas. A medium was developed
which would support keratinocyte growth in vitro, and which
prevented overgrowth of epithelial cultures by fibroblasts
arising from the lamina propria. Populations of cultured
keratinocytes were characterised by light and electron
microscopy to determine their suitability for use in studies
of fibrinolysis. Growth kinetics and karyotypic analyses
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were also performed to study the nature of the cells in
culture.
2.4 COLTORE OF SDSPENSIONS OF ORAL KERATINOCYTES ON 3T3
FEEDER LAYERS
2.4.1 Introduction
A number of methods have been developed for the growth
of keratinocytes in vitro. Suspension cultures may be plated
directly onto plastic or 3T3 feeder layers, and small pieces
of explanted tissue may be grown successfully in culture. In
order for cultures to achieve confluence, keratinocytes must
be plated at high seeding densities (125,000 cells cm"^) when
they are grown directly on plastic (Eisinger, 1979) but this
seeding density may be reduced (12,500 cells cm-2) when grown
on 3T3 feeder cells (Rheinwald and Green, 1975). This latter
method is particularly useful to either greatly amplify
numbers of cultured keratinocytes or, when the biopsies from
which cultures are to be derived are small.
In the present study, the use of lethally treated 3T3
feeder cells for oral keratinocyte culture was investigated
and cultures were treated with Mitomycin C to inhibit cell
division before seeding with oral keratinocytes. It was
necessary to first assess the dosage of Mitomycin C which
would be required to inhibit cell growth, whilst allowing
3T3 cells to remain viable for several days. The
cytotoxicity of Mitomycin C to subconfluent layers of 3T3
cells was determined using a chromium release assay (Wright
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et al^ 1978). Cell proliferation was assessed by thymidine
incorporation and cell viability was determined using trypan
blue staining.
2.4.2 Materials and Methods
2.4.2.1 3T3 Feeder Cells
Swiss albino mouse embryo fibroblasts (CCL-92) were
grown to approximately 75% confluence in the Glasgow
Modification of Minimum Essential Medium (GMEM) as follows:
Glasgow Modification of Minimum Essential
Medium (x 10 liquid)* 10%




Newborn Bovine Serum 10%
♦Unless otherwise stated all media components were obtained
from Flow Laboratories.
**L-glutamine is omitted from all commercially available
media supplied in liquid form and must be added before use.
2.4.2.2 Determination of Cytotoxicity of Mitomycin C to 3T3
Cells using a Chromium Release Assay
3T3 cells were seeded onto 96 well plates and grown to
approximately 75% confluence. The cells were then washed in
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serum free medium and incubated overnight in medium
containing ^Cr - agueous sodium dichromate (sp.act 300
uCi/ugCr Amersham International) at a concentration of luCi
per well. The cells were then washed three times in 600 ul
of serum free medium and serial dilutions of Mitomycin C from
30 ugml"-'- to 3.75 ugml--*- were added to the cells in a final
volume of 100 ul of medium per well. The supernatants were
harvested after lh and counted in an LKB-Wallac 1214 gamma
spectrophotometer. The percentage release of ^Cr into the
supernatant was calculated in the following way:
% cytotoxicity = sample value - spontaneous release
x100
maximum release - spontaneous release
where spontaneous release was determined by incubating 3T3
cells in GMEM with 10% serum and maximum release by lysis of
3T3 cells in 1% sodium dodecyl sulphate (BDH Chemicals).
2.4.2.3 Incorporation of Tritiated Thymidine into Mytomycin
C Treated 3T3 Cells
3T3 cells were plated into 12 well plates and grown to
approximately 60-70% confluence. After treatment with serial
dilutions of Mitomycin C from 30 ugml"''' to 1.875 ugml-1 for
lh at room temperature, the cells were washed three times in
serum free medium and re-fed with GMEM containing 10% serum
and incubated overnight at 37°C. The medium was then
aspirated and the 3T3 cells were incubated with medium
containing tritiated thymidine (sp.act. 5Ci/mMol, Amersham
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International) at a concentration of 2uCi per well for five
hours. The supernatants were aspirated and the cells washed
three times in PBSA. The cells were lysed in 0.025M ammonium
hydroxide for two hours on a rocking platform. To 0.5 ml of
the lysate was added 4.5 ml of Optiphase Highsafe II
scintillation fluid (Pharmacia-LKB) and the components mixed
thoroughly on a whirlimixer. Tritiated thymidine
incorporation into cells was determined by measuring the beta
activity of samples in an LKB-Wallac 1218 liquid
scintillation counter.
2.4.2.4 Growth and Viability of 3T3 Cells After Treatment
with Mitomycin C
3T3 cells were seeded at a density of 10^ cells ml"^
into 75 cm flasks and allowed to plate down (about 2 — 4h).
Cells were treated with Mitomcyin C at concentrations ranging
from 30 ugrnl-* to 3.75 ugml"^ for one hour and then the cells
were washed three times in serum free medium before they were
returned to their normal medium. After 3, 6 and 9 days,
cells were trypsinised in 5 ml 0.25% trypsin and 0.02% EDTA.
The trypsinised cell suspension was added to 5 ml of medium
containing 10% serum and centrifuged for 5 min. at 200g. The
supernatant was aspirated and the cells resuspended in 1 ml
of medium. To 0.1 ml of cell suspension was added 0.1 ml of
trypan blue stain and the cell numbers per flask determined
using an improved Nebauer haemocytometer chamber. Cell
viability was measured by the exclusion of trypan blue from
viable cells.
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2.4.2.5 Trypan Blue Stain
Trypan blue 400 mg
Sodium Chloride 810 mg
Potassium dihydrogen orthophosphate 60 mg
The mixture was dissolved in 95 ml of distilled water,
boiled for 5 min. and allowed to cool. The solution was then
filtered and the pH adjusted to pH 7.2 with 1M sodium
hydroxide. The solution was made up to a final volume of 100
ml.
2.4.2.6 Preparation of Epithelial Cell Suspensions
Pieces of gingival mucosa obtained during routine
wisdom tooth extractions at Edinburgh Dental Hospital were
transported to the laboratory in GMEM on ice and were used
within three hours of surgery. Using aseptic techniques, as
much connective tissue as possible was removed from each
sample and the remainder finely minced using scalpel blades.
The tissue was placed in 0.25% co 1 1 agenase:dlspase
(Boehringer:Mannheim) in calcium and magnesium free PBSA for
3-4 hours. The cell suspension was periodically decanted and
fresh collagenaseidispase added. The cells were harvested by
centrifugation at 200g for 10 min. and the cells seeded at a
concentration of 2 x 10^ cells cm-^ onto 3T3 feeder cells
which had been treated with Mitomycin C (3.75 ugml--'-).
The tissues were placed in medium (see Section 2.4.2.7)
and incubated in a humidified atmosphere of 5% carbon dioxide
and 95% air at 37°C.
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2.4.2.7 Keratinocyte Medium for Suspension Cultures
Eagle's Minimum Essential Medium ( x 10 liquid) 10%
L-glutamine 2.0 mM




2.4.2.8 Preparation of Human Serum
Human serum from one individual was used throughout
these experiments. This was prepared by clotting whole blood
(obtained by venepuncture) overnight at 4°C. The blood was
then centrifuged at 500 g for 15 min. and the serum
supernatant decanted. The serum was then heat inactivated by
heating at 60°C for 30 min., was sterile filtered through a
0.22 urn filter and stored at -20°C in 5 ml aliquots.
2.4.3 Results
2.4.3.1 Release of ^^Cr-Sodium Dichromate from Mitomycin C
Treated 3T3 Cells
The percentage release of ^Cr above background release
was between 10 - 15% for concentrations of Mitomycin C below
7.5 ugml-^ (Fig. 6). Above this concentration, the release
of ^Cr from cells increased from 19% at 15ugml~^ to 35% at
30ugml--'- of Mitomycin C. Toxicity of Mitomycin C, indicated
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Fig. 6 Percentage release of ^Cr sodium dichromate from
Mitomycin C treated 3T3 cells.
by the release of chromium from the cells, was apparent at
all concentrations of Mitomycin C but was greatly increased
at concentrations above 7.5 ugml--'-.
2.4.3.2 Incorporation of Tritiated Thymidine by 3T3 Cells
Treated with Mitomycin C
The results shown in Table 1 and Fig. 7 indicate that
incorporation of tritiated thymidine one day after treatment
of 3T3 cells with Mitomycin C decreased in a dose dependent
manner. No concentration of Mitomycin C studied was
sufficient to completely inhibit tritiated thymidine
incorporation although cells treated with concentrations of
Mitomycin C above 3.75 ugml--'- never reached confluence even
after 10 days in culture.
2.4.3.3 Cellular Proliferation and Viability After Treatment
with Mitomycin C
The number of cells present in cultures after treatment
with different concentrations of Mitomycin C is shown in
Table 2 and Fig. 8. After nine days in culture a slight
reduction in cell numbers was noted after treatment of 3T3
cells with 3.75ugml"'- of Mitomycin C when compared to
untreated cultures. With the lower concentration of
Mitomycin C (1.875 ugml"') the number of cells present
doubled over the culture period and was only slightly less
than that in the untreated cultures.
Trypan blue exclusion staining of cells treated with
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TABLE 1













7.5 216,685 + 8,808
15.0 171,773 +15,082
30.0 133,275 +10,798

























REPLICATION OF 3T3 CELLS AFTER TREATMENT
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3 T 3 cells treated with
Mitomcyin C was studied two and eight days after treatment.
The data in Table 3 indicate that even after treatment with
30 ugml"-'- of Mitomycin C over 85% of the cells remained
viable after two days compared with over 90% in control
cultures. After eight days of culture, however, the
percentage of viable cells recovered after treatment with
concentrations of Mitomycin C above 7.5ugml--'- had fallen to
less than 60% compared with 86% in untreated cultures. In
cultures treated with 3.75ugml-^ Mitomycin C, which was
sufficient to inhibit cellular proliferation, viability of
cells after eight days was just under 70%.
2.4.3.4 Growth of Oral Keratinocyte Cell Suspensions on 3T3
Feeder Cells
Tissue samples obtained from wisdom tooth extractions
were generally small and, after treatment of biopsies with
col lagenase: dispase to obtain single cell suspensions
harvests were usually between 5 x 104 and 5 x 105 cells.
Keratinocytes seeded onto Mitomycin C treated feeder cells
plated down and after several days in culture clones of
epithelial cells were apparent amongst the 3T3 cells (Fig.
9). Of necessity, seeding densities were low, usually in the
order of 2 x 104 cells cm-2 which resulted in clones failing
to maintain proliferation long enough for cells to coalesce
and grow to confluence before senescing.
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TABLE 3
PERCENTAGE VIABILITY OF 3T3 CELLS





2 days 8 days
30 88.7 (370)* 57.3 (293)
15 95.4 (214) 52.1 (301)
7.5 88.5 (570) 57.6 (189)
3.75 90.1 (546) 68.0 (276)
0 93.1 (372) 86.6 (411)
•Figures in parenthesis are numbers of cells counted
Fig. 9 Clones of epithelial cells growing on Mitomycin C
treated 3T3 cells (x400 mag).
Conclusion;
With the techniques used in this study, oral
keratinocyte suspensions were unlikely to provide sufficient
cells for subsequent experiments. The use of explant culture
was therefore investigated.
2.5 EXPLANT COLTORE OF ORAL EPITHELIUM
2.5.1 Introduction
There are a number of reports in the literature on the
growth of oral keratinocytes in culture and the majority of
these have relied on the use of explant cultures (Mlinek and
Buchner, 1975; Gusterson and Monaghan, 1979; Arneholt-
Bindslev et a_l 1 9 8 7). The problem of overgrowth of
epithelial cultures by fibroblasts is well recognised and
approaches to minimising fibroblast contamination have
included brief exposure to trypsin or EDTA (Owens et al_ 1971;
Milo et a_l 1980; Price et a_l 1980), addition of chemicals
which are toxic to fibroblasts to the media (Wagner and
Matthews, 1975 ; Schuster et a_l 1984), alteration in
incubation temperature (Jensen and Therkelsen 1981;
Arneholt-Bindslev et a_l 1987), and the use of selective media
(Macaig et a_l 1981; Tsao et al^ 1982; Boyce and Ham 1 983).
In the present study, a number of methods were investigated
to control fibroblast contamination in explant culture. The
possibility of passage of oral keratinocytes grown in explant
culture was also investigated.
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2-5.2 Material and Methods
2.5.2.1 Explant Culture
Pieces of gingival mucosa were trimmed to remove as
much connective tissue as possible. Tissue was chopped into
fragments approximately 1 mm3 and placed epithelial side up
in culture dishes. Eight to ten fragments per dish were
anchored in place using sterile glass coverslips. The
cultures were grown in MEM supplemented with L-glutamine
(2.0mM), sodium bicarbonate (30mM), penicillin (100 Uml-3),
streptomycin (100 ugml-3) and human serum (10%) (see Section
2.4.2.7).
2.5.2.2 Removal of Fibroblasts from Keratinocyte Cultures
Trypsin/EDTA
Explant cultures of keratinocytes grown for 2 weeks in
vitro were washed in calcium and magnesium free PBSA and
treated briefly with either 0.1% trypsin or 0.2% EDTA.
Cultures were monitored under the microscope until fibroblast
removal was complete. The treated cultures were then washed
twice in serum free medium before re-feeding.
Thimerosal
Cultures were established and after one week the
cultures were incubated in medium containing 0.5 - 1.5 ugml-1
thimerosal for a further two weeks.
Cytotoxic antifibroblast monoclonal antibody
A cytotoxic monoclonal antifibroblast antibody
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(LICR/LON FIB 86) was kindly provided by Dr. B. Gusterson,
Ludwig Institute of Cancer Research, London. The antibody
was prepared in the form of ascitic fluid. The production of
the antibody used in these experiments has been described
elsewhere (Edwards et al^ 1980). The antibody belongs to the
subclass gamma-2b and was raised to fibroblasts derived from
normal human breast using the hybridoma system of
Milstein et al^ (1979).
Explant keratinocyte cultures, after 1-2 weeks in
vitro, were washed twice in serum free medium. The antibody
was added to each culture dish in 2 ml MEM at a final
dilution of 1:400 and incubated at room temperature for 15 -
30 min. Antibody was aspirated and the cultures washed twice
in serum free medium to remove any remaining antibody. Whole
rabbit serum, as a source of complement, was added at a
dilution of 1:20 and incubated for lh at 37°C. Cultures were
washed and returned to their normal medium and cultured for a
further two weeks. Control cultures were treated with
antibody or complement alone.
2.5.3 Results
2.5.3.1 Removal of Fibroblasts from Keratinocyte Cultures
Trypsin/EDTA
Removal of fibroblasts from mixed cultures by exposure
to EDTA was generally found to be unsuccessful. However,
brief trypsinisation of cultures with 0.1% trypsin was
effective if fibroblast numbers were low and fibroblasts were
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not covered by large epithelial sheets growing out from the
explant. Repeated trypsinisation resulted in some epithelial
detachment and damage.
Thimerosal
The addition of thimerosal to epithelial cultures at a
concentration of 1.5ugml"^ was found to be toxic to
epithelial cells on the basis of their morphology in the
microscope and their slower growth rate. Further dilution of
thimerosal to 0.5ugml-^, which was not toxic to epithelial
cells, did not inhibit fibroblast growth.
Cytotoxic monoclonal antibody
This method was found to be successful in the present
tissue culture system only if fibroblast contamination
remained low. Treatment of cultures with cytotoxic antibody
was far less effective in cultures heavily populated with
fibroblasts. In control cultures treated with antibody or
complement alone no removal of fibroblasts was observed.
Cytotoxic antibody often failed to eliminate fibroblasts in a
single treatment. The problem of access of antibody to
fibroblasts growing underneath epithelial outgrowths was
similar to that encountered with trypsin removal of
fibroblasts.
Conclusion;
The failure of these simple measures to reduce
fibroblast contamination in epithelial cultures required the
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investigation of a selective medium to control fibroblast
contamination in these explant cultures.
2.6 THE USE OF A SELECTIVE MEDIUM FOR GROWTH OF HUMAN ORAL
KERATINOCYTES
2.6.1 Introduction
Refinement of selective media for cells in culture is
for the most part labour intensive. The interaction of
growth factors, trace elements and other additives requires
the assessment of their individual contribution in basal
medium and their synergistic or inhibitory effects with the
addition of each defined factor. Each new addition or
deletion to the medium should therefore be tested in a range
of concentrations.
In this study, a basal medium was sought which, with
minimal additions, would support keratinocyte growth but be
selective enough to inhibit fibroblasts. In order to control
the growth of fibroblasts in mixed cultures, the serum
content of the medium was reduced and growth factors which
would favour keratinocyte growth added. Five per cent serum
normally provides the majority of cells with adequate levels
of the B vitamins, other fat soluble vitamins and essential
organic compounds, so no further additions of this nature
were made.
Two further supplements were made to the medium. Non¬
essential amino acids which can normally be synthesized by
cells in vitro, were added to the culture medium as these are
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readily lost from the cytoplasm if the transmembrane
concentration gradient is large. Sodium pyruvate was also
provided as an additional carbon source to the cells. This
is a common addition to commercially produced media e.g.
Ham's F12, which is designed for culturing cells at low
density. Unlike phosphorylated intermediates of glycolysis,
it is readily lost from the cytoplasm to the external medium
if the concentration gradient across the cell membrane is
large. The inclusion of pyruvate in the medium also enables
the cells to increase their endogenous production of carbon
dioxide making them less dependent on the exogenous provision
of carbon dioxide and bicarbonate (Leibovitz, 1963).
The medium was originally buffered in the normal way
with 30mM sodium bicarbonate and by buffering in the gas
phase with 5% carbon dioxide. Bicarbonate has poor buffering
capacity at physiological pH but has low toxicity and a
nutritional benefit to the culture. An additional buffer,
Hepes, which has stronger buffering capacity at pH 7.2 - 7.6,
was added to the medium in the presence of lowered amounts of
sodium bicarbonate. Exogenous carbon dioxide was still
supplied to prevent additional loss of dissolved carbon
dioxide from the medium.
The effect of altering culture conditions, particularly
the reduction in serum content and the addition of growth
factors, was examined by measuring growth rates in primary
cultures. Some authors have reported markedly inhibitory
effects of antibiotics, particularly fungizone (amphotericin
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B) towards epithelial cells in culture (Milo et a_l 1980).
The effect of the removal of antibiotics from the
culture medium was also investigated.
The use of primary cultures meant that different media
could only be compared within cultures from an individual
biopsy specimen.
2.6.2 Materials and Methods
2.6.2.1 Explant Culture
Specimens of gingival mucosa (>200) and specimens of
oral sguamous cell carcinomas (35) were set up in explant
culture as previously described in section 2.5.2 and grown in
a number of media.
Explanted tissues were incubated in a basal medium of
MEM containing L-glutamine (2.0mM), sodium pyruvate (l.OmM),
sodium bicarbonate (lOmM), Hepes buffer (20mM), non-essential
and amino acids (1%) antibiotics penicillin (lOOUml-^),
streptomycin (lOOugml-1) and fungizone (2.5ugml-1). In a
series of experiments the effects of varying concentrations
of serum and the addition of growth factors were assessed
using the following series of media:
(a) basal medium + 10% human serum
(b) basal medium + 5% human serum + lOngml-^ EGF
(c) basal medium + 10% human serum + lOngml--^ EGF
(d) basal medium + 10% human serum + lOngml--'- EGF + 5ugml~l
insu1in
(e) basal medium + 5% human serum + lCngml-1 EGF + O.lmM
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phosphoethanolamine + 5ugml~-'- insulin
(f) basal medium + 5% human serum + 10ngml~l EGF containing
no antibiotics
The number of explants which attached and produced
epithelial outgrowths was measured, and the areas of culture
dishes covered by epithelium measured using a combination of
image analysis and point counting (Dunnill 1698). This is
fully described in Chapter 3 section 3.2.4.
2.6.2.2 Subculture
Near confluent cultures of oral keratinocytes were
trypsinised in 2ml 0.25% tryps in/0.0 2 % EDTA for up to 15
minutes. Medium (6 ml) containing 10% serum was added to the
trypsin/EDTA solution and the cells centrifuged at 200g for 5
min. The supernatant was aspirated and the cells resuspended
in 1 ml of medium containing 5% serum. The cells were
passaged in a 1:1.5 - 1:2 split ratio.
2.6.3 Results
2.6.3.1 Growth of Gingival Oral Keratinocytes in Explant
Culture
Of the explants grown in medium containing 10% serum,
76% of the explants produced epithelial outgrowth compared to
62% in medium containing 5% serum and EGF (Table 4). The
provision of 5% serum appeared to be adequate for attachment
of explants, although the number of explants attaching and
producing outgrowth was slightly reduced. However, the areas
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TABLE 4
THE PERCENTAGE OF EXPLANTS PRODDCING EPITHELIAL OUTGROWTHS
IN MEDIUM CONTAINING EITHER 10% SERUM OR 5% SERUM AND EGF





of epithelial colonies in medium containing 5% serum and EGF
were consistently larger than those grown in medium
containing 10% serum (Table 5, Fig. 10).
Growth of epithelium in either of the above media
appeared to be sub-optimal. In medium containing 10% serum
supplement with EGF, a higher proportion of explants showed
epithelial growth (67%) than those in medium supplemented
with 10% serum only (61%) (Table 6). The areas of outgrowth
in EGF containing medium were also larger in two of the three
patient samples tested (Table 7, Fig. 10) .
Addition of insulin to medium containing 5% serum and
EGF resulted in improved growth rates in epithelial explants,
but these differences were small (Table 8, Fig. 11). A
further addition of phosphoethanolamine (Petn) to this medium
actually resulted in inhibition of epithelial growth when
compared to explants grown in medium containing 5% serum
only (Table 9, Fig. 11). Growth of epithelium in medium
supplemented with 5% human serum and EGF appeared to support
good growth of epithelium. In medium containing 10% serum,
fibroblast contamination was always noted.
The growth of oral keratinocytes in medium containing
5% serum, from which antibiotics were removed at the first
feeding was also investigated. It was found that in nearly
all cases the medium became contaminated, usually with
fungus, after several days in antibiotic free medium. In
those few cultures which remained uncontaminated and in which
areas of epithelial outgrowths were measured, it was found
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TABLE 5
AREAS OF EPITHELIAL COLONIES (mini) GROWN IN MEDIOM CONTAINING
EITHER 10% SEROM OR 5% SEROM AND EGF AFTER 7 DAYS IN VITRO
Biopsy Medium + 5% Serum + EGF Medium + 10% Serum
1. 22.3 + 3.7 10. 1 + 0.2
2. 84.6 +12.0 44.6 +16.6














































THE PERCENTAGE OF EXPLANTS PRODDCING EPITHELIAL COLONIES
IN MEDIUM CONTAINING 5% OR 10% SERUM WITH EGF
Biopsy Medium + 5% Serum
+ EGF
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AREAS OF EPITHELIAL COLONIES (mmi) GROWN IN KEDIDM
CONTAINING 5% OR 10% SEROM WITH EGF
AFTER 7 DAYS IN VITRO




Medium + 10% Serum j
1




123.3 + 18. 1
2. 77.7 + 8.0 235.2 + 119.2
3. 129.1 +60.5 91.4 + 22.3
n»48
TABLE 8
AREAS OF EPITHELIAL COLONIES (mini) GROWN IN MEDIOM
CONTAINING 5% SERUM AND EGF WITH AND WITHOUT INSULIN,
AFTER 7 DAYS IN VITRO
Biopsy Medium + 5% Serum Medium + 5% Serum
+ EGF + EGF + IS
1. 60.1 + 13.5 62.3 + 5.4
2. 65.4 ♦ 8.2 73.6 ♦ 9.1
n»35
TABLE 9
AREAS OF EPITHELIAL COLONIES (mml) GROWN IN MEDIOM
CONTAINING 5% SEROM AND EGF WITH AND WITHOOT INSOLIN
AND PHOSPHOETHANOLAMINE, AFTER 5 DAYS IN VITRO
Biopsy Medium + 5% Serum
+ EGF
Medium + 5% Serum
+ EGF + IS + PEtn
1. 24.8 ♦ 2.9 19.*9 + 1.1
2. 29.5 ♦ 2.9 27.6 + 2.2
3. 31.9 * 6.7 26.9 + 3.0
n*44
that growth was consistently slower without antibiotics than
in antibiotic containing medium (Table 10, Fig. 12).
Good growth of oral keratinocytes was therefore
achieved in the following medium:
Eagle's Minimum Essential Medium (xlO liguid) 10%
L-glutamine 2.0mM
Sodium pyruvate l.OmM






Epidermal Growth Factor lOngm!-*
Human serum 5%
The point counting method used to assess the areas of culture
dishes covered by epithelium and fibroblasts showed that the
percentage area of culture dishes covered by fibroblasts
remained very low in most cases with a mean value of 2.0%
+/- 0.6%. Two of the twenty cultures grown in this medium
showed larger areas of contamination by fibroblasts (10% and
14.9%) and perhaps a more accurate reflection of fibroblast
contamination in these cultures is given by the median value
of 0.5% (Table 11).
Attempts to subculture oral epithelium grown to near
confluence in this medium were unsuccessful even in split
ratios as low as 1:1.5.
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TABLE 10
AREAS OF EPITHELIAL COLONIES (m£) GROWN IN MEDIUM
WITH AND WITHOUT ANTIBIOTICS AFTER 7 DAYS IN VITRO
Biopsy Medium With Antibiotics Medium Without Antibiotics
1. 62.4 + 1.6 38.8 + 8.4
2. 84.5 ♦ 12.3 45.0 *_ 5.5





Fig.12 Areas of epithelial colonies (mm2 +_S.E.) grown in
medium with and without antibiotics.
TABLE 11
PERCENTAGE OF SORTACE AREA OF CULTURE OCCUPIED BY EPITHELIAL
CELLS AND FIBROBLASTS AFTER 3-4 WEEKS IN VITRO ESTIMATED











! i 70.5 0.03 29.1 900
j 2 86.1 0.0 13.9 1188
! 3 82.8 0.0 17.2 1008
! 4 77.6 0.0 20.4 888
5 51.6 2.1 46.2 1044
; 6 72.1 0.0 27.8 1296
j 7 88.1 3.3 8.5 2092
i 8 72.2 10.3 17.6 2194
9 81.8 4.5 13.8 1947
10 88.4 0.05 10.0 198 3
11 80.7 0.3 18.4 1653
12 82.2 0.3 17.2 9060
i 13 78.3 0.05 21.2 : i9 7
14 91.0 0.5 8.5 2 3 46
15 89.7 0.6 8.5 13 43
! 16 56.8 14.9 28.3 2 3 3 6
17 90.6 1.9 7.4 43 26
! 18 83.6 0.0 16.3 19 4 4
! 19 67.1 1.0 31.7 2.0 9 0
| 20 55.6 1.0 43.4 1242
1 Mean 77.3 ♦ 2.6 2.0 ♦ 0.06 20.3 ♦ 2.6 19U
2.6.3.2 Growth of Keratinocytes from Oral Squamous Cell
Carcinomas in Explant Culture
Eighteen (52%) of the oral squamous cell carcinomas
produced epithelial outgrowths in explant culture. The lower
success rate with the tumours stemmed mainly from the higher
incidence of contamination (31%) in these cultures although
some tumours simply failed to grow. Fibroblast contamination
was also apparent in tumours cultured in this medium but
again the rate of contamination estimated in 8 cultures by
point counting remained low 1.4% +/- 1.1%.
Tumour cultures were more readily subcultured than
normal gingival epithelium. In this study, three tumours
which grew rapidly in primary culture were subcultured
through 2-4 passages in a 1:2 split ratio.
Conclusion:
Successful explant cultures of oral keratinocytes were
obtained in a selective medium. Having established that oral
epithelial cells could be cultured in vitro, it was necessary
to ascertain whether or not the characteristics of normal
cells and tumour cells were retained in vitro.
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2.7 CHARACTERISATION OF ORAL KERATINOCYTES GROWN IN VITRO
2.7.1 Introduction
In order to ensure that epithelial cells derived from
non-neoplastic and neoplastic tissues cultured i.n vitro
retained features associated with their tissue of origin, a
number of parameters normally associated with normal and
malignant cells were studied, including ultrastructure,
thymidine labelling and karyotype.
Human epidermis and oral epithelium are composed mainly
of keratinocytes in various stages of differentiation. Cells
arising by division in the basal region of the epithelium
undergo a process of differentiation to form a protective
surface layer. Three types of epithelium are found in the
oral cavity - ortho, para and non keratinized epithelia, each
fulfilling different functions (Squier et a_l 1976). Despite
the differences in the types of keratinization, similar
patterns of differentiation occur in the deeper layers.
Differentiation of orthokerat ini zed epithelium is shown
schematically in Fig. 13. Cells in contact with the basement
membrane overlying the lamina propria form the basal layer.
These cells are primarily responsible for division and
replacement of cells shed at the surface. Above the basal
layer are several layers of isodiametric cells, which,
because of the spiky appearance of their intercellular
attachments, are referred to as the prickle cell layer or
stratum spinosum. The basal and prickle cell layers together
constitute approximately two thirds of the thickness of the
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FIG. 13
Schematic diagram of skin layers.
 
epithelium and only in the remaining layers do clear patterns
of differentiation emerge. During transition of cells from
the basal layer, to the surface, epithelial cells continue to
synthesize and accumulate cytokeratin tonofilaments which
ultimately form the basis of resistance to mechanical injury.
The prickle cell layer is succeeded by larger, much flatter
cells in the stratum granulosum, which synthesize two types
of granule: membrane coating granules (MCG) and keratohyalin
granules (KHG). Membrane coating granules contain lipids and
proteins which are extruded into the intercellular space and
provide a permeability barrier which prevents unchecked
diffusion in either direction. Within the stratum
granulosum, the proteins which comprise keratohyalin granules
contribute ultimately to the cornified envelopes which
package the cytokeratin in the superficial layers of
epithelium. These cells constitute the cornified layer of
stratum corneum and contain dense eosinophilic deposits of
keratin in an envelope of insoluble proteins. This pattern
of differentiation is seen most clearly in orthokeratinized
epithelium of the hard palate (Fig. 14). These cells form
the protective surface and are shed in response to normal
wear. Areas of the oral cavity less prone to mechanical
forces form only parakeratinized epithelium. The surface
cells retain pyknotic nuclei and a distinct granular layer is
often difficult to recognise (Fig. 15). In non-kerat1nised
epithelium it is much more difficult to distinguish clear cut
zones. Cells in the outer layer retain apparently normal




elium from the hard palate.
Prominent granular area







layer is not apparent
and surface cells con¬
tain pyknotic nuclei.
Stained with haematoxy¬
lin and eosin (xl50 mag).
FIG. 16
Non keratinised epithelium from cheek. A granular layer ls
not present and surface cells retain apparently norma
nuclei. The epithelium has a less distinct ridgec
pattern. Stained with haematoxylin and eosin (xl50 mag
 
Differentiation, occurs as cells move from the basal layer to
the cornified layer, and involves other changes which are
only evident in the electron microscope.
Electron micrographs of a gingival biopsy demonstrate
that the basal cells (Fig. 17) are columnar, electron lucent
and relatively undifferentiated. The cells do, however,
contain organelles associated with the basic synthetic
apparatus of the cell (Fig. 18), ribosomes, rough endoplasmic
reticulum and mitochondria being present. Few cytokeratin
tonof i laments are present except at sites of desmosomal
attachment between cells. Within the basal layer are small
elongated darkly staining cells (Fig. 19) with a very low
nuclear to cytoplasmic volume. These cells have been noted
by others (Klein-Szanto and Slaga, 1981) and these may
be artefacts as a result of fixation methods.
The fundamental characteristic of all keratinocytes is
the synthesis of cytokeratin tonofi1 aments. These
intracellular protein strands arrange together to form
tonofibrils. The tonof i lament s are retained with the cell
and are organised into a three dimensional network linked to
desmosomes, which together distribute mechanical stresses
evenly throughout the epithelium (Fig. 20). Desmosomes, the
commonest intercellular junctions, form as a result of
structural modifications of the plasma membrane and occupy
areas of adjacent plasma membranes. Intracellular thickening
can be seen forming attachment plaques, into which the
tonofilaments are inserted (Fig. 21). Desmosomal junctions
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FIG. 17
Gingival biopsy. Section through basal layer and
connective tissue (C). Columnar cells are interspersed
with "dark cells" (x3500 mag).
FIG. 18
Cytoplasm of basal cells containing ribosomes (R), rough
endoplasmic reticulum (E) , mitochondria (M) and few
cytokeratin tonofilaments (T) (xl4,000 mag).
FIG. 19





several cells connect in
(xl4,000 mag).
through desmosomes where
the prickle cell layer
FIG. 21
Gingival biopsy. Desmosomes between two prickle cells.
Intracellular thickening can be seen forming attachment
plaques into which the tonofilaments are inserted. Each
desmosome shares the cytoplasm of two cells (x35,000
mag) .
 
are entirely specific for epithelium.
Changes accompanying differentiation in oral epithelia
are an increase in cell size, as cells move out of the basal
layer into the prickle cell layer, and the synthesis of
additional structural proteins (Figs. 22 and 23). In
gingival epithelium, a granular layer, in which membrane
coating granules and keratohyalin granules would normally be
synthesized, is often difficult to recognise or may even be
absent. However, features associated with differentiation
such as the loss of subcellular organelles and the
accumulation of cytokeratin are usually seen in the upper
layers of cells (Fig. 24).
Electron microscopic examination of tumour cells from
biopsy specimens has shown that a number of alterations in
the subcellular structure of these cells are consistently
associated with a malignant phenotype. Although no single
change is pathognomonic, the spectrum of changes within
tumour cells can be a reliable indicator of malignancy
(Ghadially, 1975). Such changes include enlargement and
marked invagination of nuclei (Ghadially, 1975), and
intranuclear inclusions are much more frequent in tumour
cells (Ghadially and Perry, 1966) although the majority of
these are in fact pseudoinc1usions , which because of
invagination of the nuclear membrane, appear to lie within
the nucleus. Chromatin granules appear in a variety of
tumour cells and may be indicative of aberrant protein
synthesis since these granules have been found after
administration of certain drugs (Meine et al 1971; Daskai
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FIG. 22
Gingival biopsy. Prickle cell layer. Increased
synthetic activity in the stratum spinosum results in
the production of cytokeratin tonofilaments, which group
together to form tonofilament bundles (x4,200 mag).
FIG. 23
Gingival biopsy. Cytoplasm of a cell in the prickle
cell layer. Increased density of tonofi1 aments,
ribosomes and mitochondria are apparent (x28,000 mag).
FIG. 24
Gingival biopsy. No distinct granular layer is present,
however, surface cells are characterised by dense
cytoplasmic tonof i lament s and a loss of subcellular
organelles. Cells at surface of section contain no
nuclei (x2,800 mag).
 
et al. 1975; Norton et al^ 1975). Other subcellular changes
in tumour cells include a reduction in the number of
mitochondria (Lehninger 1965; Fawcett, 1967) as a result of
glycolytic metabolism in the cells. Furthermore, these
mitochondria often have a pleomorphic appearance and are
often biochemically defective (Sordahl et a_l 1969; Pederson,
1970) .
Increased growth rate of tumours is also a consistent
finding in tumours i_n vivo (Kerr et a_l 1983; Hobson and
Denekamp, 1984). The proliferation rate of normal oral
keratinocytes and keratinocytes derived from malignant tissue
was also measured in cultured cells by determining the
thymidine labelling index (TLI).
Changes in chromosomal constitution are also indicative
of malignant cells. I^n v_itro only one spontaneously
transformed human keratinocyte cell line (HaCaT) has been
reported (Fusenig et al 1988). This cell line, derived from
normal human adult skin (back), is aneuploid with 3 distinct
chromosome markers. Despite the rarity of this event,
spontaneous chromosomal abberations do occur during the
culture of normal human keratinocytes (Peters et al_ 1 988).
Using foreskin keratinocytes these authors reported that very
early cultures (from 2 days) exhibit 5 - 10% tetraploid
metaphases and that this number increases steadily during the
first month of culture up to 25%. As cells senesce, however,
the majority of cells in culture are again diploid.
Chromosomal abberations may therefore be more common than
previously thought in primary cultures of keratinocytes.
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2.7.2 Materials and Methods
2.7.2.1 Electron Microscopy of Cultured Oral Keratinocytes
Epithelial explants were grown on Lux permanox culture
dishes (60 mm diameter) which are compatible with EM
solvents. Cells were fixed iri situ in ice cold 4% buffered
gluteraldehyde (TAAB) in 0.1M sodium cacodylate buffer
containing 0.05M calcium chloride and 0.02M hydrochloric acid
(BDH Chemicals). After 24 hours in fixative at 4°C the
cells were rinsed twice in 0.1M sodium cacodylate buffer and
post fixed in 1% osmium tetroxide (BDH Chemicals) in 0.1M
sodium cacodylate buffer for lh. Tissues were dehydrated
through a series of alcohols to absolute ethanol. After
three changes in absolute ethanol for 30 min., tissues were
placed in two changes of epoxypropane (Agar Scientific EM
grade) for 30 min. and then placed in a 50:50 mixture of
epoxypropane: araldite (Agar Scientific) for a minimum of 3h.
Tissues were left overnight at room temperature in fresh
epoxypropane: araldite mixture. The following day tissues
were placed in fresh araldite and placed in a 60°C oven for
two days. Small blocks of tissue (approximately 1 mm^) were
mounted on dowling rod with sealing wax before sectioning in
an LKB ultramicrotome.
Thin sections (gold to silver) were mounted on copper
grids (E200) and stained in 0.2% lead citrate in 0.1N NaOH
for 2 min. followed by washing in distilled water. Grids
were then stained with a saturated solution of uranyl acetate
in 50% alcohol for 10-15 min. in the dark, and rinsed in 50%
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alcohol before viewing in a Joel 100S electron microscope.
2.7.2.2 Cytokeratin Staining
Oral keratinocytes cultured in vitro were stained using
a conventional PAP method which is described fully in section
4.2.1 in Chapter 4. In this procedure a polyclonal antiserum
to cytokeratins (5 + 14), raised in rabbits (Orthoimmune) ,
was used at a dilution of 1:400 in the initial staining
stage (reviewed by Moll et a_l 198 2) ,
2.7.2.3 Autoradiography
Epithelial cultures were pulse labelled withtritiated
thymidine, 20uCi per culture dish, (sp. act 40-60 CimMol-1;
Amersham International) for lh. Control cultures contained
no tritiated thymidine. Labelling was stopped by washing the
cultures in ice cold PBSA and fixing in 10% neutral buffered
formalin. In a darkroom, K5 nuclear emulsion (Ilford) was
melted at 50°C and then diluted 2:1 in 2% glycerol.
Epithelial cells in culture dishes were coated with an even
film of emulsion, allowed to dry and placed in light tight
boxes. After exposure for one week at 4° C, the films were
developed in D19 developer (Kodak) for 3.5 min. and fixed in
Unifix (Kodak) for 9 min at room temperature. The culture
dishes were washed and tissue stained in haematoxylin and
eosin. The number of labelled cells in each culture was
determined from counts of no less than 750 cells in two
discrete outgrowths from each patient culture. The labelled
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cells counted (6 grains per nucleus) were expressed as a
percentage of the total number of cells counted to give the
thymidine labelling index (TLI).
2.7.2.4 Karyotyping
Log phase cultures of oral keratinocytes were treated
with 100 ugml--'- colchicine (BDH Chemicals) for 2h at 37°C.
The medium was then removed and the cultures trypsinised in
the normal way. The cell suspension was centrifuged at 200 g
for 5 min. and the cell pellet gently resuspended in 0.075M
potassium chloride for 4 min. at room temperature. The cells
were centrifuged at 200g for 5 min. and the supernatant
aspirated except for one drop in which the cell pellet was
resuspended. Ice cold methanol: acetic acid (3/1 vol:vol)
was added dropwise with constant agitation up to a total
volume of 3 ml and the suspension left on ice for at least 30
min. The suspension was then centrifuged at 200g for 5 min.
and 3 ml of fresh fixative added. The cells were washed 3
more times in fixative and, after the final wash, the pellet
was resuspended in 0.5 ml of fixative. Drop preparations were
made onto pre-cleaned wet microscope slides from a height of
30 cm. Slides were air dried and stained for 5 min. in
Giemsa stain (BDH Chemicals) and mounted in buffered
glycerol.
From peparations of each of the four cultures of normal
gingival epithelium the first five intact metaphase spreads
were selected and photographed. Photographic enlargements
were made and the chromosomes counted.
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2.7.3 Results
2.7.3.1 Light and Electron Microscopy of Cultured Gingival
Epithelium
Vertical sections through two week old cultured
gingival epithelium showed a structure which is 2-4 layers
thick (Fig 25). A distinct population of relatively uniform
basal cells can be seen on the under surface of the culture.
As the cells moved out of the basal layer they enlarged and
flattened, assuming an appearance reminiscent of prickle
cells i_n vivo. Cells on the surface of the culture retained
their nuclei a feature of cells in non-keratinised epithelium
in vivo.
After 1-4 days in culture, phase contrast micrographs
showed polyclonal cells migrating from part or the whole of
the circumference of the explanted tissue (Fig. 26). Cells
continued to divide for up to six weeks producing a
continuous sheet of epithelium with intercellular bridges
between the epithelial cells which can be clearly identified
(Fig. 27). Very occasionally small circular areas of the
outgrowth remained devoid of cells (Fig. 28). These may have
resulted from contaminating endothelial cells co-migrating
from the explant with the epithelial cells and attempting to
form vessels within the outgrowth. Epithelial cells rarely
grew into these spaces.
Cells frequently migrated from the edge of the
epithelial outgrowths but maintained contact with o^her
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FIG. 25
Vertical section through normal cultured oral epithelium
after four weeks _in vitro. Basal cells (B) attached to
the surface of the dish are columnar in shape. Suprabasal
cells retain their nuclei. Stained with haematoxylin and
eosin (x400 mag).
FIG. 26
Oral epithelial cells in culture migrating from
explanted tissue (Ex) (xlOO mag).
FIG. 27
Confluent sheet of oral keratinocytes after 4 weeks in
vitro (x200 mag).
 
epithelial cells by filopodia (Fig. 29). Microspikes and
lamellopodia, which are smaller than filopodia (Fig. 30) were
also a feature of the lateral edges of marginal epithelial
cells. All such pseudopodia are involved in movement of
epithelial cells, the fluidity and shape of which vary with
the time at which they are photographed.
In the electron microscope, vertical sections through
2-3 week old outgrowths (Fig. 31) showed a similar pattern of
growth to that seen in light micrographs. In these sections
features of differentiation of cells were easier to
recognise. Cells attached to the culture dish contained
nuclei and had a larger cytoplasmic volume than in cells
which had moved towards the surface of the culture. Cells
nearer the surface became elongated and accumulated
cytokeratin filaments. Occasional lipid droplets were found
in these cells.
Sections of this nature were extremely difficult to cut
because of their position at the surface of the araldite
blocks and because of their thinness. Occasionally, in
sections which had been cut more obliquely, keratinocytes
could be seen sloughing from the surface of the culture (Fig.
32). The detachment sites were characterised by numerous
microvilli. Such cells also contained a dense cytokeratin
complement, although the remains of organelles were sometimes
seen including keratohyalin granules.
Tangential sections through cultured cells showed that
keratinocytes possessed well rounded nuclei containing mostly
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FIG. 28
Oral keratinocytes ijn vitro, showing spaces
possibly bound by endothelial cells (xlOO mag).
FIG. 29
Oral keratinocytes _in vitro. Cells migrating at the
edge of an epithelial colony producing filopodia (F) and
flattened lamellopodia (L) or "ruffles" (x200 mag).
FIG. 30
Oral keratinocytes in showing dense




Electron micrograph through cultured oral keratinocytes.
Nucleated cells are present in the basal layer.
Suprabasal cells are elongated, containing keratohyalin
granules (kh) and surface cells contain dense
cytokeratin tonofilaments (xl8,000 mag).
FIG. 32
Keratinocyte sloughing from the surface of the cultured
cells. The detachment of keratinocytes is characterised
by numerous microvilli (xl8,000 mag).
 
euchromatin and one or two nucleoli (Fig. 33). The cytoplasm
of the cells contained cytokeratin, tonofilaments, numerous
free ribosomes, mitochondria, occasional vacuoles and lipid
inclusions. No Golgi bodies were identified in any of the EM
sections of cultured cells.
Desmosomes were identified at all levels in the tissue
but were more numerous in the intermediate cell layers (Fig.
34). In the superficial layers desmosomes were sparse.
Keratohyalin granules were sometimes observed in superficial
cells (Fig. 35).
Many mitoses were observed in cultured cells (Fig. 36).
It was possibly due to the high mitotic activity, leading to
a rapid transition of cells from the basal to superficial
surface of the culture, that insufficient time was available
to cells to synthesise membrane coating granules. These were
not found in cultured cells.
Cells other than keratinocytes may also persist in
sections of cultured keratinocytes; with macrophages, mast
cells and white blood cells being identified in epithelial
cultures (Figs. 37 and 38). These cells were probably
contaminants from explanted tissues. It is not known whether
these cells have the potential to divide under the conditions
pertaining, but on the basis of cell counts from randomly
selected EM grids they constituted less than 3% of the
cultured cell population (Table 12). Other cells such as
melanocytes, Langerhans cells and Merkel cells, which are
normally present in oral epithelium were not identified.
This may reflect their inability to replicate under the
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FIG. 33




Desmosomal junctions between cultured oral keratinocytes





(K)in the more superficial layer in
(xl8,000 mag).
FIG. 36
Cells in mitosis in keratinocyte cultures (x5,600 mag).
 
FIG. 37
Mast cell within keratinocyte culture after 4 weeks in
vitro. Granules display a predominantly scrolled
pattern (x21,000 mag).
FIG. 38
Macrophage within keratinocyte culture after 2 weeks.
Macrophage is bound by keratinocytes which display






































































culture conditions provided. Fibroblasts were known to be a
minor contaminant in cell cultures but were not identified in
the EM sections. Cusp shaped and circular cells were
observed in phase contrast micrographs of cultures of oral
keratinocytes. These were thought to be endothelial cells
arising from capillaries in connective tissue. No Weibel-
Palade bodies were observed in cultured cells, however, these
are often absent in cultured capillary endothelial cells
(Gimbrone et a_l 1979). A proportion of the cells could not
be identified simply because of the plane of section.
2.7.3.2 Light and Electron Microscopy of Cultured Oral
Squamous Cell Carcinomas
In successfully cultured tumours, epithelial cells grew
from the explanted tissue after 1-7 days _in vitro but, more
usually, were apparent after 1-2 days (Fig. 39). Unlike
gingival epithelium, tumour epithelium rarely grew as a
continuous sheet (Fig. 40). The loss of adhesion between
tumour cells resulted in islands of epithelium appearing at
some distance from the explant site. The islands of cells
continued to grow for up to six weeks and in many cases
formed confluent layers of cells (Fig. 41). Subcultures of
tumour epithelium through 2-4 passages had a similar
phenotype to the parent culture (Fig. 42). Primary and
passaged tumour cultures retained an epithelial appearance
with distinctive intercellular bridges between cells.
Tumour cells migrated in a similar manner to normal oral
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FIG. 39
Keratinocytes migrating from the edge of explanted
tumour tissue (ex) after 2 days in vitro, showing the
loss of adhesion between cells (xlOO mag).
Fig. 40
Islands of keratinocytes growing from explanted tumour
tissue after 7 days in vitro. Cells retain the typical
cuboidal appearance of epithelial cells but fail to grow
in a continuous sheet (x200 mag).
 
FIG. 41
Almost confluent culture of oral tumour keratinocytes
after two weeks in vitro (x400 mag).
FIG. 42
Oral squamous cell keratinocytes passaged through one
subculture (x200 mag).
FIG. 43
Isolated group of keratinocytes derived from oral
squamous cell carcinoma extending filipodia,
lamellopodia and microspikes (xlOOO mag).
 
keratinocytes by the extension of pseudopodia. Figure 43
shows an isolated group of tumour cells displaying filopodia,
lamellopodia and microspikes.
Under the electron microscope the epithelial origin of
the tumour cells was confirmed. Figures 44-46 show
tangential sections through three of the cultured tumours.
The cells possess cytokeratin tonofilaments and display
desmosomal junctions with adjacent cells.
Nuclei of malignant cells were often markedly irregular
with frequent invaginations of the nuclear membrane. This
was not a consistent feature of all the cultured tumours
examined but tumour cell nuclei very often had irregularities
in shape (Fig. 46) and were sometimes very bizarre (Fig. 47) ,
with pseudoinclusions not uncommon. Figure 48 shows a
nucleus containing cytoplasmic contents, the inclusion being
partly membrane bound although some cytoplasmic membrane is
lost due to the angle at which the section was cut. This
pseudoinclusion contained granules in the cytoplasm which
were probably lipid filled, some of the lipid being lost
during fixation. Ribosomes and endoplasmic reticulum were
also present.
Two forms of chromatin with different densities were
found in nuclei; a dense heterochromatin and an electron
lucent euchromatin. Although the distribution varied from
one cell to another, little difference was observed when
cultured normal and malignant cells were compared (Figs. 33
and 44). Chromatin granules, which are found in a number of
tumour cells, were not identified in cultured oral
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FIGS. 44-46
Sections through keratinocytes from cultured oral




Highly invaginated nucleus of cultured keratinocyte
derived from oral squamous cell carcinoma (x5,600 mag).
FIG. 48
Pseudoinclusion in the nucleus of a cultured




Increased numbers of nucleoli with marked
irregularities in shape and size were seen in a number of
cultures (Figs. 44 and 46). Nucleolar margination which
facilitates cytoplasmic exchange also frequently occurred in
tumours (Fig. 44). Many of the tumour cells frequently had
irregularly shaped and swollen mitochondria with flooding of
both matrix and intracristal space (Fig. 49). This feature
was never observed in cultures of non-neoplastic epithelium.
Desmosomes were present in cells in all cultured tumours, but
when compared with normal cells, the desmosomes had a
reduced complexity with little or no tonofilament structure
(Fig. 50).
Generally the cytoplasm of cultured tumour cells
contained ribosomes, rough endoplasmic reticulum and
lysosomes. As in normal cultured epithelium, no Golgi bodies
were found.
Tumour cell populations, like normal cultured
keratinocytes were essentially pure epithelial cell
outgrowths. Based on the presence of desmosomes and
tonofilaments, almost 97% of the cells identified in randomly
selected grids were keratinocytes (Table 13). Occasional
leucocytes were seen migrating through the tissues.
2.7.3.3 Cytokeratin Staining
Not all tumour cell cultures could be examined by
electron microscopy and because of the variation in cellular
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FIG. 49
Mitochondria within cultured oral squamous cell
carcinoma are typically pleomorphic and swollen, with
flooding of the intracristal space (xl8,000 mag).
FIG. 50
Poorly developed desmosomal attachments between cultured

































































morphology of cultured tumour cells at least one culture dish
per patient was stained for cytokeratin using an
immunoperoxidase staining techinique. All of the cultures
examined in this way stained positively for cytokeratin. In
each culture almost all of the cells stained with cytokeratin
antibody (Fig. 51) although a small population of
unidentified cells showed equivocal staining (Fig. 52).
Cultures containing only fibroblasts were grown concurrently
and all failed to stain with the cytokeratin antibody.
2.7.3.4 Autoradiography
In cultures the mean grain density over control cells
incubated without thymidine was 1 grain per nucleus. Less
than 0.1% of the cells had 5 or more grains over a nucleus
and therefore a detection limit of 6 grains per nucleus was
set which constituted a labelled cell (Fig. 53).
During the four week culture period, the thymidine
labelling indices in cultures of normal gingival epithelium
ranged between 8.9% and 12.9% with a mean labelling index of
11.4% (Table 14, Fig. 54). Between four and six
weeks in vitro the thymidine incorporation into S phase cells
fell to 0.5%. Little cell division was apparent in these
cultures on visual inspection.
In tumour cutures TLI's ranged from 13.0% to 35.9% with
a mean value of 21.6% +/- 3.3% (Table 15, Fig. 54). Tumour
cultures had significantly higher TLI values (Mann-Whitney U
Test p=0.006) than cultures of normal gingival epithelium.
No attempt was made using this small sample size to
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FIG. 51
Cultured keratinocytes from oral squamous cell
carcinoma, stained with a polyclonal antibody raised to
human cytokeratin (xlOO mag).
FIG. 52
Population of cultured cells derived from oral squamous
cell carcinoma showing different morphology with dendritic
cells showing equivocal staining with polyclonal antibody
raised to human cytokeratin (xlOO mag).
 
FIG. 53
Autoradiograph of cultured keratinocytes. Silver grains
cover the nuclei of labelled cells (x200 mag).
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THYMIDINE LABELLING INDICES (TLI) OP CULTURED ORAL
SQUAMOUS CELL CARCINOMAS AFTER 4 WEEKS IN VITRO
Biopsy Labelled Cells Total Cells TLI (%)
T 3 734 2046 35.9
T 9 81 580 13.9
T 25 102 1352 13.0
T 28 150 903 16.6
T 32 1275 4160 30.6
T 36 1341 7548 17.8
T 37 1226 5146 23.8
Mean 21.6+3.3
correlate variations in TLI of tumours with patient age or
sex or staging of the tumour (Table 16).
2.7.3.5. Karyotype
In cultures of normal gingival epithelium seventeen of
the metaphase spreads had a normal chromosomal number (Figs.
55-57). Two of the twenty metaphase spreads were found to be
hypomodal with a chromosome number of 45 (Fig. 58) and one
metaphase spread had a hypermodal chromosome number (Fig.
59) .
The several attempts made to obtain good metaphase
spreads from oral tumour cultures all resulted in poor
spreads with marked condensation of the chromosomes.
Reduction in the time in which cells were incubated in
colchicine to synchronise the cultures, and shorter
incubation time in hypotonic solution to swell nuclei prior
to spreading, failed to resolve these problems.
Conclusion:
Keratinocyte cultures from gingival epithelium retained
features associated with the parent tissue. Keratinocytes
migrated from explanted tissue and underwent cell division
forming an ordered stratifying epithelium in
Thymidine labelling indices of gingival epithelial cultures
remained constant during the first four weeks of growth but
decreased as cells senesced after six weeks _in VLtro.
Polyploid cells were noted in cultures of normal gingival
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TABLE 16
HISTOLOGY Or TPMOPR SPECIMENS OSED IN MEASOREMEWT OF THYMIDINE
LABELLING INDICES IN VITRO
Sample
Number
Age Sex Site Histology
T3 72 F Cheek Poorly differentiated
squamous cell carcinoma
of buccal mucosa
T9 78 F Tongue Poorly differentiated
squamous cell carcinoma
of tongue
T25 56 F Tongue Well differentiated,
Keratinizing squamous
cell carcinoma of tongue





T32 58 F Mouth Well differentiated,
keratinizing squamous
cell carcinomas. Site
of origin uncertain as
carcinomas extensive
T36 72 F Alveolar
mucosa
Squamous cell carcinoma
arising in floor of
mouth and alveolar
mucosa
T37 78 M Tongue Carcinoma-m-s ltu
developing into squamous
cell carcinoma of torque
FIGS. 55 AND 56
Metaphase spreads from keratinocytes cultured from
gingival biopsies (xlOOO mag).
 
FIG. 57
Paired chromosomes from keratinocyte cultured from














Chromosome number in twenty representative
oral keratmocytes cultured from gingival
mucosa.
FIG. 59
Hypermodal chromosome number found in keratinocyte
cultured from gingival biopsy (x200 mag).
 
epithelium but this may simply be related to a failure of the
cells to divide.
A spectrum of subcellular changes was observed in
epithelium cultured from oral squamous cell carcinomas.
These changes were similar to those previously observed by
others in histological studies of tumour sections. Thymidine
labelling indices in tumour tissue varied but were generally




The _in vitro growth of normal human keratinocytes has
tradionally been very difficult, due both to the inadequacy
of available media and the problem of fibroblast overgrowth.
Researchers initially overcame these difficulties by the use
of lethally irradiated or Mitomycin C treated 3T3 feeder
layers (Rheinwald and Green, 1975; Rheinwald, 1981) which
probably served several functions. The growth rate of cells
in culture is subject to two distinct influences. At low
cell densities, growth rate commonly increases with cell
density. Different mechanisms may contribute to this "feeder
effect" (Gaunt and Subak-Sharpe 1977) including both contact
with other cells or the extracellular matrix secreted by
them, and by the diffusion of molecules from feeder cells.
These molecules may be specific growth factors or simple
compounds such as non-essential amino acids which may be lost
from cells if there is an appreciable concentration gradient
in low density cultures. The presence of lethally treated
feeder cells also results in the inhibition of contaminating
fibroblasts in epithelial cell suspensions, preventing the
overgrowth of epithelial cultures by mesenchymal cells.
The growth of oral keratinocytes on feeder layers was
investigated in the present study. Treatment of 3T3 feeder
cells, which had grown to 50-75% confluence, with
concentrations of Mitomycin as low as 3.75 ugml--'- was found
to inhibit proliferation of the cells without being toxic to
109
them. DNA synthesis continued although the cells were
incapable of completing cell division. After 7-10 days these
cells became granular in appearance with pyknotic nuclei and
their detachament from the surface of the culture flask was
apparent. After this time, however, replicating
keratinocytes would normally be expected to have replaced 3T3
cells on the surface of the culture. Cell harvests from
gingival biopsies were, due to the quantity of available
tissue, low and, of the cells harvested by enzyme digestion,
only a proportion were capable of further division. Bearing
this limitation in mind, it was found that, even with seeding
densities of 5 x 104 - 1 x 105 cells cm-2 gingival
keratinocytes were incapable of forming colonies which would
maintain replication for a sufficient time for coalescence to
occur.
A further problem relating to the use of feeder cells
in the present study arose from the influence of dermal
components on keratinocytes. It has recently been reported
that co-cultivation of plasminogen activator producing cells,
particularly with cells of mesenchymal origin, can result in
the disappearance of plasminogen activator from the culture
medium (Hoal et a_l 1983; Liu et al_ 1984). This may be the
result of the production of protease nexins by mesenchymal
cells (Farrell and Cunningham, 1986), which bind covalently
to serine proteases leading to their internalisation and
subsequent degradation. Certain other cell types such as
human lung fibroblasts, virally transformed cell lines and
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endothelial cells (Sprengers and Kluft, 1987) have also been
found to produce fast acting inhibitors of plasminogen
activators. Therefore, despite the fact that the feeder
cells in successfully generated keratinocyte cultures are
short lived i_n vitro, their effects on the production of
plasminogen activator by keratinocytes are unclear.
Other modulating effects of 3T3 cells also remain
largely unknown. In murine species connective tissue
influences on epithelia have recently been established.
Mackenzie and Dabelsteen (1986) found that in heterotypic
recombinants of epithelia and connective tissue from various
sites, an altered expression of blood group antigens on
epithelia occurs in some matches. Sub-epithelial tissues,
are, therefore, capable of signalling redirection of the
pattern of phenotypic expression and some epithelia are
capable of responding. Whether 3T3, or any other feeder
cells, are capable of signalling such changes to
keratinocytes in culture is uncertain.
Growth arrested feeder layers are not an absolute
reguirement for the growth of all human keratinocytes,
particularly if the media and conditions of pH, temperature
and seeding density are optimised. Several procedures for
growing replicative cultures of different types of human
keratinocyte have been reported (Stanley and Parkinson, 1979;
Eisinger et a_l 1979; Lechner et a_l 1983; Assilineau et a_l
1986; Arnehol t-Binds lev et al^ 1987). However, all of these
require high seeding densities, usually in the order of
magnitude of 10^ cells cm"^ (Eisinger et al 1979) and reports
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of keratinocyte growth at low seeding densities in the
absence of feeder layers are still rare (Tsao et al_ 1983;
Boyce and Ham, 1983).
Relatively few studies have been published on
the i.n vitro growth of human oral keratinocytes (Mlinek and
Buchner, 1975; Birkeda1-Hansen et al^ 1980; Gusterson and
Monaghan, 1979; Taichman et al_ 1979; Arneholt-Binds lev
et al 1987) and most of these authors have relied on the
generation of primary cultures from explants grown in a basal
medium such as MEM, DMEM or M199 supplemented with
antibiotics and 10% serum.
In the present study, explant culture was investigated
as a method of cultivation of oral keratinocytes and it was
found that the provision of MEM containing 10% serum in
explant cultures of gingival mucosa resulted in significant
fibroblast contamination after 2-3 weeks growth irt vitro.
Methods used to remove fibroblasts from these cultures were
unsuccessful and a medium was developed which would favour
keratinocyte growth and inhibit fibroblasts.
In developing a medium for this work two problems had
to be resolved. Firstly, overgrowth of epithelium by
fibroblasts had to be limited because of the potential
production by fibroblasts of protease nexins or fast acting
inhibitors of plasminogen activators. Secondly, many growth
factors and hormones commonly added to cultures, in order to
selectively stimulate keratinocyte growth, markedly affect
plasminogen activator synthesis (Vassalli et al 1976; Rifkin,
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1978; Lee and Weinstein, 1978; Gross et a_l 1983 a and b;
Sudol, 1985) so requiring their use to be selective.
Reduction of the serum concentration to 5% of the total
volume of medium was sufficient to inhibit fibroblast growth,
but growth of keratinocytes was characteristically slow
producing small epithelial colonies approximately 1 cm in
diameter. A number of growth factors and hormones were
therefore considered for inclusion in the medium.
Steroid hormones, particularly hydrocortisone have been
shown to markedly stimulate keratinocyte growth _in vitro
(Macaig et al^ 1980; Peehl and Ham, 1980 a and b; Tsao et a_l
1982). However, hydrocortisone and its synthetic' analogues
have been shown to inhibit biosynthesis of uPA and tPA by
cells in vitro (Rifkin 1978). Induction, by hydrocortisone,
of an intracellular regulatory molecule which inhibits either
plasminogen activator gene transcription or mRNA translation
is thought to be involved in this process. This effect may
be prolonged requiring up to 72h for recovery of plasminogen
activator synthesis by cultured cells (Rifkin, 1978). The
use of hydrocortisone was therefore excluded. It is
generally agreed that cAMP is the secondary messenger for
these hormones. Cholera toxin which increases cAMP levels in
cultured cells has been shown to stimulate tPA production by
Schwann cells iji vitro (Alvarez-Builya and Valinsky, 1985).
The long term effect of cholera toxin on PA production has
not been documented and its use was not investigated in the
present study.
Of the polypeptide hormones, EGF is a common addition
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to keratinocyte cultures (Eisinger et 1979; Macaig et a_l
1980; Rheinwald, 1981; Tsao et al_ 1982; Boyce and Ham,
1983) and optimum stimulation of proliferation of these cells
has been reported with nanogram guantities of EGF. Down
regulation of EGF receptors following EGF treatment of
cultured cells is correlated with an increase in plasminogen
activator activity (Lee and Weinstein, 1978; Gross et a_l
1983a; Hamilton et al 1984). Using the epidermoid
carcinoma cell line A431, Gross et a_l (1983b) reported that
removal of EGF from previously down regulated cells resulted
in recovery of total cellular EGF binding activity and
concurrent loss of plasminogen activator activity.
Plasminogen activator levels in these cultures began to fall
immediately on the removal of EGF with half maximal loss
within 5h. Such a rapid response to the removal of EGF from
these cultures did not preclude its use in this study.
The addition of EGF (lOngml-^) to MEM containing 5%
serum was sufficient to achieve a more rapid and prolonged
growth of gingival keratinocytes in explant culture.
Keratinocytes grew more readily in this medium than in medium
containing 10% serum alone. Both these media were, however,
sub-optimal since, in medium containing 10% serum which was
further supplemented with EGF, greater growth of
keratinocytes was achieved than in medium with 5% serum and
EGF or 10% serum alone. Two other additives, with no
reported effects on plasminogen activator synthesis, were
tested for use in conjunction with EGF. Insulin is
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stimulatory for a large number of cells i.n vitro (Mather et
al 1980) but its use in gingival keratinocyte cultures
produced only a small increase in colony growth. Insulin is
normally used in culture at levels far in excess of
physiological concentrations because it is rapidly
inactivated at 37°C, particularly in serum free medium.
This may account for its limited effect in these cultures.
One further supplement, phosphoethanolamine, was tested in
conjunction with EGF and insulin at a concentration
previously reported to stimulate foreskin keratinocyte growth
in MCDB152 medium (Tsao et al^ 1982). In the present study,
this mixture of additives was found to be inhibitory to
keratinocyte growth when compared to medium containing only
EGF and 5% serum. Fibroblast contamination had also
increased in this more complex medium with over 29% of the
colonies showing fibroblast contamination compared with less
than 10% in medium containing only EGF. Using a point
counting method, fibroblast contamination was estimated in
the first twenty keratinocyte cultures grown in EGF
containing medium. The areas of culture dishes covered by
fibroblasts remained low with a median value of 0.5%.
Therefore, this medium was utilised in all subsequent
experimentation.
As expected reduction of serum from 10% to 5% reduced
the plating efficiency of explanted gingival tissue in vitro.
In practice, however, the reduction was too small to consider
the use of coated substrates. Between 60-70% of the explants
regularly attached to the substrate and formed epithelial
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colonies, this being sufficient to give good coverage of the
culture dish.
Using this method just over 50% of oral squamous cell
carcinoma biopsies were successfully grown in explant
culture. This compares favourably with results in other
laboratories (Johns et aJ 1982; Schiff and Schugar, 1984;
Mattox et al_ 1984). Mattox et aJL (1984) found that only 36%
of head and neck tumours grew in a soft agar cloning assay -
35% failed to grow and 29% were contaminated. Johns et a_l
(1982) achieved a slightly higher success rate with 51% of
their head and neck tumours producing epithelium, but again
there was a high contamination rate. As these authors found,
contamination of biopsy material was a major factor in the
failure to grow explant cultures of oral carcinomas in the
present study. Even in the absence of contamination,
however, fewer tumour specimens than gingival specimens were
cultivated iri vitro. Often many of the cells within a tumour
mass are not viable, perhaps as a result of anoxia or
previous therapy., and further cell losses probably occur
during surgical procedures. Investigation of improved media
and culture conditions for growth of these tumours _in vitro
is essential. Optimising media for tumours is complicated by
autocrine secretion of growth factors by tumour cells
(DeLarco and Todaro, 1978). This may vary from tumour to
tumour and the addition of exogenous growth factors,
including those present in serum, may actually inhibit growth
in vitro.
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In the present study, passage of oral keratinocyte
cultures was singularly unsuccessful. Subculture of
keratinocytes from primary cultures in split ratios as low as
1:1.5 failed to produce confluent cultures. Other workers
growing oral keratinocytes have reported similar findings.
Taichman et a_l ( 1 9 7 9 ) reported passage of normal oral
keratinocytes through two to four subcultures using the 3T3
feeder technigue, with an estimated cloning efficiency of
1.5%. Without feeders, cloning efficiency dropped to 0.002%.
Recently Arneholt-Binds lev et a_l ( 1987) developed a new
subculture technigue. They found that passaging cells in a
1:2 split ratio was unsuccessful, but if secondary cultures
were initiated using a drop culture technigue, with seeding
densities of 10^ cells per 20 ul drop, successful subculture
through six passages could be achieved. This finding is
important since it allows experimentation with passaged
cultures without the inconvenience of inter-pat i ent
variation.
Passage of keratinocytes derived from oral squamous
cell carcinomas was less difficult. In three cases serial
cultivation of tumours was achieved through 2-4 passages.
Again the production of endogenous growth factors by tumour
cells may provide essential elements lacking in the tissue
culture medium. Improvement of cell culture conditions and
media for these cells must be a priority since both the long
and short term requirements of the cells have not been
satisfied.
Boyce and Ham (1983) reported that human foreskin
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keratinocytes could be serially cultured through 7 passages
in MCDB 153 with seeding densities as low as 400 cells cm-2
in the absence of 3T3 cells, conditioned medium, surface
coatings or serum. Fibroblasts are reported to be inhibited
in this medium. Such low seeding densities could be of
considerable value in the culture of oral keratinocytes where
biopsy material is often limited. There is nothing
intrinsically novel about this medium which contains water,
salts, buffers, bulk organic ions, trace elements, amino
acids and a number of organic substances to replace serum.
However, even this complex medium cannot be considered
minimal. It is not known, as yet, whether the components of
this medium fully satisfy all the short term growth
requirements of all keratinocytes. Although serial culture
can be achieved at low seeding densities in MCDB 153, cells
can still only be passaged through a very limited number of
subcultures before senescing. Long-term requirements of
keratinocytes in this medium have still not been met.
Of interest is the defined nature of the medium which
allows precise investigation of drugs or hormones _in vitro in
the absence of undefined supplements which may interfere with
the action of the agent studied. Primary or passaged cells
grown in this medium do not, however, produce cultures which
are a good ^n XiEE° model for skin. Low calcium
concentrations in this medium shift the normal pattern of
differentiation, maintaining unstratified cultures. The
addition of calcium and serum does induce differentiation
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while in their absence proliferation of cells is optimised.
Indeed, despite the quality of the medium, since its original
description in 1983 it has been adopted by very few other
laboratories (Cuono et a_l 1986; Pittlekow and Scott, 1986)
for keratinocyte culture. Problems of water purity, the cost
of tissue culture grade components, and the complexity of the
method for making the medium have obviously not been resolved
in other laboratories.
2.8.2 Characterisation of Oral Keratinocytes In Vitro
Epithelium in vitro grows with a distinctive
morphology. Cells plated either as single cell suspensions,
or outgrowths from explanted tissue produce cultures WLth a
typical pavement-like structure and the epithelium eventually
forms a confluent polarized ordered epithelium.
The structure of primary cultures of human oral
keratinocytes was typical of cultured keratinocytes grown in
other systems (Gusterson and Monaghan, 1979; Marcelo et a_l
1980; Arnehol t-Binds lev et a_l 1987), and over 90% of the
cells _in vitro contained conspicuous cytokeratin
tonofilaments and desmosomes - structures only associated
with epithelial cells. Basal cells which attached to the
culture dishes retained a more squamous appearance than basal
cells iri vivo. Supra-basal cells showed varying degrees of
differentiation which was characterised by an increased
accumulation of cytokeratin tonofilaments, a reduction in the
number of desmosomes and lysis of subcellular organelles.
Occasionally accumulations of keratohyalin granules were
119
observed in cells growing just beneath the sloughing layer,
indicating a similar pattern of organisation to that
expressed .in vivo.
Tumour epithelial cells, cultured in the same
conditions as normal oral keratinocytes, varied markedly in
their degree of differentiation, probably reflecting the
heterogeneity of tumour populations and their growth pattern
prior to explantation. Again over 90% of the cells cultured
from tumour explants featured either desmosomes or
cytokeratin t ono f i 1 a m en t s or more usually both, thus
confirming the squamous origin of the tissue. All tumour
cultures, however, showed irregularities not associated with
the growth pattern of normal cells in vitro. Increase in the
size and irregularity of nuclear shape is a common feature in
histological sections of tumour (Ghadially, 1975). In the
present study, many cultured cells showed highly invaginated
nuclei, which often resulted in the appearance of pseudo-
inclusions in the nuclear matrix. Similarly nucleolar
alterations occur in tumour cells, and an increase both in
the size and numbers of nucleoli within the nuclei of
cultured oral squamous cell carcinomas was observed.
Nucleolar margination, often associated with intense
synthetic activity, was frequently seen in cultured tumour
cells. The deep invagination of the nuclear membrane may be
another form of nucleolar margination which facilitates
nucleo-cytoplasmic exchange. The predominance of glycolytic
metabolism _in vitro generally reduces the numbers of
120
mitochondria observed in these cells. The oral squamous cell
carcinomas cultured in this study were no exception.
However, perhaps the most consistently observed abnormality
in these cells was both the pleomorphism associated with
mitochondria and flooding of the cristae in the mitochondrial
matrix which has been observed in histological sections of
tumours by others (Sordahl et a_l 1969; Pederson, 1970).
Tumour cells i^n v_it.ro largely contained very
rudimentary desmosomal complexes which reflected the poor
adhesion observed between these cells in the light
microscope. Few cells contained markers of differentiation
with keratohyalin granules, Golgi complexes and rough
endoplasmic reticulum being sparse. These ultrastructura 1
abnormalities indicate a departure from normality. Similar
changes were also observed in epithelium cultured from the
excision margins of tumours in which epithelium appeared
macroscopically normal. These subcellular changes may prove
to be a useful indicator of the "normality" of cells at the
excision margins of tumours.
2.8.3 Thymidine Labelling Indices
The thymidine labelling indices, as a measure of the
proliferative activity of normal cultured oral keratinocytes
remained relatively constant during the first four weeks in
vitro with TLIs ranging from 8.9-12.9%. After six weeks
there was a marked decline in the thymidine labelling index
which was probably related to senescence of the cells.
121
Albers et a_l ( 1 9 8 6 ) similarly found using both
autoradiography and flow cytometry that 8% of their
keratinocytes were in the proliferative pool. Gusterson and
Monaghan (1979) also reported a sharp decline in the mitotic
activity of their oral buccal keratinocytes in explant
culture after 6 weeks _in vitro, but their initial TLI value
was higher (27%) after a 2h pulse label. Marcelo et a_l
(1980) reported TLI values of between 10-30% for cultured
mouse keratinocytes over a period of 2-25 days .in vitro.
Their labelling period of 12h was considerably longer than
that used in the present study (lh), and probably encompassed
populations of cells entering into more than one S phase of
the cell cycle in the labelling period.
Incorporation of 3HTdR showed a focal distribution in
the oral keratinocytes. This confirms the observations of
Gusterson and Monaghan (1979), but is contrary to the report
of Karasek et a_l (1966). The most widely accepted model of
epidermal cell renewal is that of Potten (1981) who envisaged
two classes of replicating cells. He argues that stem cells
are capable of extensive renewal and amplifying cells, which
arise from stem cells, undergo limited division before
terminal differentiation. Cell division in oral epithelium
in vivo is also not evenly distributed thoughout the basal
layer but occurs in regular clusters (Squier et al_ 1976). In
epithelium with a complex connective tissue interface such as
attached gingiva, cell division often occurs in clusters at
the tips of rete ridges. Focal areas of mitotic activity of
oral keratinocytes in vitro and in vivo would accomodate the
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EPU model of Potten.
Unlike normal cultured oral epithelium, tumour cell
labelling was not focally distributed. Focal areas may have
been more difficult to visualise in very actively replicating
cultures, but even in tumour cultures with lower TLIs, focal
labelling was still not readily apparent. Cultured tumours
had significantly higher TLI values than normal cultures but
too few oral squamous cell carcinomas were grown in the
present study to correlate histological staging, patient age
or sex with tumour growth. However, it is interesting that
those patients with most frequent recurrences of tumours
showed highest labelling indices (35.9 and 30.6) of cultured
tumour cells _in vitro. The release of tumour cells from
normal growth constraints in vivo is therefore reflected
in v_itro. Tumour cells in the absence of modifying
influences _in vivo, continue to show an abnormally high
turnover rate and this would suggest some permanent change in
the underlying metabolism of the cells.
2.8.4 Karyotyping
Karyotypic analysis is of great importance in
monitoring changes in chromosome constitution which occur
in culture. In the present study, the karyotype of cultured
gingival epithelial cells was normal in 17 of the 20 selected
metaphase spreads. Two of the twenty cells were hypomodal,
but it is uncertain whether this was due to inadequate
preparation or whether this was a real phenomenon. Wenger et
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al (1984) suggest that to rule out a rare event a Poisson
probability can be used. Based upon a 95% confidence limit
for a Poisson distribution of one event, the probability of
finding two similar events require 0.015x = 2, where x = 19
cells (Rao et al_ 1966). Two non modal cells within this
population is therefore highly significant, however, it was
considered that larger numbers of cells should be screened
to rule out hypomodality as a feature of cultured oral
keratinocytes.
Hypermodality was identified in one cell in the
metaphase spreads and was unlikely to result from inadequate
preparation, particularly as the spread was well defined.
Polyploidy has also been observed in cultures of human
foreskin keratinocytes (Peter et al_ 1988). In their study
tetraploid cells appeared after only two days in culture, and
these increased in number from 10-25% of the cells present
during the first month of culture (unpassaged). Although
changes in chromosome number were found to accumulate during
the early culture period, adapted populations of
keratinocytes stabilised again at the diploid level after one
to three months in culture. Structural chromosomal
aberrations, mostly gaps and breaks, were common in cells
throughout the whole culture period of three months.
In one study in which karyotpic analysis of
keratinocytes grown from buccal mucosa in explant culture was
performed, no chromosomal abnormalities were found in
keratinocytes from five patients after 20 - 25 days _in vitro
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(Arnehol t-Binds lev et al_ 1987). These authors, however,
report the growth of oral keratinocytes at 34° C. Since
Peter et a_l (1988) found that elevated culture temperature
(40°C) enhanced the appearance of chromosomal abnormalities
in foreskin keratinocyte cultures, it may be that growth of
keratinocytes at lower temperatures reduces the frequency of
chromosomal alterations.
The results in the present study agree with those of
Peter et al_ (1988) but the functional significance, if any,
of polyploid cells in these cultures in unknown.
The diploid chromosome constitution is the result of
natural selection acting on the organism as a whole where
complex demands must be met. In contrast, in tissue culture
selective advantage operates simply in favour of the fastest
growing cells. This may result in chromosome aberrations
where omission of mitosis entirely (polyteny) results in DNA
duplication cycles which follow one another or alternatively,
aberrations in the mitotic process might result in the fusion
of daughter nuclei. Such mitoses are termed polyploidizing.
Brodsky and Uryaeva (1969) postulated that in culture
metabolic resources are finite and therefore performance of
some functions must be inhibited at the epigenome level. In
the cultured tissues they investigated, they found that the
molecular basis of polploidy resulted from competition of
different metabolic pathways for a lacking metabolite or in
translational competition. Whether this is the basis for




In the present study a medium was developed in which
keratinocytes from gingival mucosa and oral squamous cell
carcinomas could be grown in explant culture and which was
suitable for use in studies of plasminogen activators in
cultured cells. Reduction of the serum content of the medium
and addition of EGF effectively controlled fibroblast growth
in the majority of the cultures, which grew as relatively
pure populations of epithelial cells. Some differentiation of
gingival epithelial cells was apparent in vitro, and although
less complex that in vivo, cells moving from the basal layer
to the more superficial layers became elongated and
accumulated keratohyalin granules and cytokeratin
tonofilaments. A loss of subcellular organelles was also
noted in superficial cells although complete dissolution of
nuclei was not apparent.
Proliferation i.n vitro, assessed by thymidine
labelling, was similar to that reported for other non¬
neoplastic keratinocytes and remained between 9-13% during
the first month of culture. In karyotypic analysis of
cultures, 5% polyploid keratinocytes were identified
in vitro. This has been shown by others to be common in
keratinocytes cultured from normal skin and that these
cultures stabilise again at the diploid level.
Cultures were more difficult to establish from oral
squamous cell carcinomas, than from normal gingiva. Once
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established, however, the tumour cultures grew more
readily iri vitro and the thymidine labelling indices of
tumours were much higher than those of gingival
keratinocytes. Tumour cells could also be subcultured
through at least 2-4 passages. In order to confirm that
tumour cells retained features associated with malignant
cells in vivo, cultured tumour keratinocytes were examined
ul trastructural ly. Tumour cells showed a spectrum of
ultrastructural abnormalities, which have been observed
in histological sections of tumours. These include
invagination of nuclear membranes, increased freguency of
pseudoinclusions, increased size and numbers of nucleoli, and
reduced numbers and complexity of desmosomal junctions. In
normal and neoplastic cultured cells mitochondria were
generally reduced in number, but in tumour cells mitochondria
were often pleomorphic and swollen, a feature never
associated with cultured gingival keratinocytes. This tissue
culture model was therefore suitable for the study of




FIBRINOLYTIC ACTIVITY OF ORAL EPITHELIUM
3.1 INTRODUCTION
Plasminogen activator has been demonstrated by
fibrinolytic autography and immunocytochemistry in epithelium
in a number of sites from a variety of mammalian species.
Plasminogen activator of an undetermined type has been shown
by autography to be present in rat, guinea pig and rabbit
epidermis (Smokovitis and Astrup, 1978), squamous epithelium
of the uterine cervix (Todd, 1964), and in rat and human
oral epithelium (Wunschmann and Astrup, 1974; Southam and
Moody, 1981; Southam, Moody and Kowolik, 1981; Birkedal-
Hansen and Taylor, 1983). More specifically, urokinase type
plasminogen activator has been detected in epithelium from
kidney tubule, ductus deferens, mammary gland and lung
(Larsson et al^ 1984), from human prostate (Camiolo et a_l
1984) and from glomerulus and kidney convoluted tubule
(Nakamura et al^ 1984; Angles-Cano et al^ 1985).
Functional studies on these enzymes, which are products
of different genes, have indicated that tPA is primarily
involved in the maintenance of fluidity in the extracellular
environment, most notably in thrombolysis. uPA is considered
to be responsible for localised proteolysis during cell
migration and tissue remodelling in both normal and
pathological processes (Dano et al 1985).
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It has been suggested that keratinocyte plasminogen
activator may facilitate the normal differentiation events of
nuclear dissolution (Myhre-Jensen and Astrup, 1971; Green,
1977) and evidence that nuclear destruction is a plasmin
assisted process supports this concept (Green, 1977; Ossowski
et a_l 1979). Further evidence that plasminogen activators
are involved in the terminal differentiation events of
keratinocytes comes from i_n vitro studies. Isseroff et a_l
(1983) and Morioka et a_l (1985) found that plasminogen
activator activity produced by cultured keratinocytes
increases at confluence, the greatest activity being found in
cells consisting mainly of cornified envelopes shed from the
culture. Other investigations have shown that uPA may also
be involved in cell migration. Fibrin and fibronectin which
are present under migrating cells of re-epithe 1 la 1ising
wounds gradually disappear from the basement membrane after
wound healing (Clark et aj_ 1982) and it is possible that
their degradation is the result of plasminogen activator
activity in epithelial cells. Krystosek and Seeds (1985)
have shown that cultured cells including neurons, a
malignant neural line and transformed fibroblasts deposit
plasminogen activator on growth substrata, including collagen
coated plastics, where it is strategically well placed to
participate in local degradation of components of the
extracellular matrix. The finding by Morioka et al_ (1 985)
that uPA accumulates in wounded keratinocyte cultures at the
newly formed wound edge within 16h supports the postulate
that uPA is involved in cell migration and wound healing.
129
Both Morioka et a_l (1985) and Hashimoto et al (1 985)
demonstrated that the plasminogen activator produced in
cultures of neonatal foreskins is predominantly of the
urokinase type.
3.1.1 Plasminogen Activators in the Oral Cavity
Plasminogen activator activity of human oral epithelial
cells was first demonstrated in cells obtained from buccal
smears (Birn and Fejerskov, 1971; Wunschmann-Henderson and
Astrup, 1972). Fibrinolytic autograph studies by Southam
(1981) and Southam, Moody and Kowolik (1981) showed that
while fibrinolytic activity could be demonstrated in intact
oral epithelium it could not be demonstrated in relation to
epithelium from all parts of the mouth; epithelium from
dorsal and ventral tongue, the cheek, palate and gingival
sulcus showed activity but gingival epithelium (and
epidermis) did not show activity. The authors showed that
lysis occurred on fibrin plates in potassium thiocyanate
(KSCN) extracts of epithelia from all sites, although lysis
did not occur in all the saline extracted fractions. These
findings were in agreement with those of Albrechtsen (1958)
and suggested that the activator enzymes in saline extracts
of tissue represent those enzymes immediately available from
a tissue _in vivo and that saline extracts contain only the
activator demonstrable by autography. The failure to
demonstrate lysis in all sites with fibrinolytic autography
was therefore simply a reflection of insufficient activator
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present in the tissue for detection with the technique and
not an inability of the tissue to produce activators. No
functional differences in the levels of plasminogen
activators in the various sites using human tissues were
determined.
Birkedal-Hansen and Taylor ( 1 9 8 3) have also
demonstrated fibrinolytic activity in rat tongue epithelium
by autography. From cultured rat tongue keratinocytes they
separated three electrophoretically distinct activators - uPA
(Mr-48KDa = Mrt55KDa in humans), tPA (70-75KDa) and a high
molecular weight activator (95-105 KDa) which has been found
in other epithelial cultures (Wilson et al^ 1980).
Human saliva also contains plasminogen activator which
is derived from the cellular component. Soluble activator
cannot be demonstrated in the supernatants of mixed, parotid
or submandibular salivas (Moody, 1982) - resuspended salivary
pellets showing fibrinolytic activity only in association
with epithelial cells and cell fragments. Goldstein e_t a_l
(1971) reported that normal viable polymorphs from peripheral
blood contain a small amount of plasminogen activator, but
leucocytes at concentrations present in saliva in a healthy
dentulous mouth cannot produce measurable lysis on a fibrin
plate. Fibrinolytic activity has been ascribed to bacteria
present in the mouth, however, Moody (1976) showed that
bacteria can at the most make only a minor contribution to
the fibrinolytic activity of saliva.
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3.1.2 The Role of Plasminogen Activators in Epithelium
The role of plasminogen activators in epithelium in
relation to normal and disease processes has not been firmly-
established, but the following roles have been suggested.
3.1.2.1 Post-Operative Healing
The surgical observation that blood clots rarely
persist in the oral mucosa is consistent with the idea that
local fibrinolytic activity in the mouth is a feature of
healing. Although no direct evidence is available, it is
reasonable to assume the fibrinolytic activity in
regenerating epithelium enhances the ability of the
epithelium to grow beneath fibrin clots (Linjen and Collen,
1972) .
3.1.2.2 Post-Extraction Infection
Material removed from post-extraction sockets shows
significantly higher fibrinolytic activity in "dry sockets"
than it does in normal healing sockets (Birn, 1970). This is
thought to be due to activators released from alveolar bone
rather than from the oral epithelium (Bjorlin et ad 1986) .
3.1.2.3 Chronic Periodontal Disease
Periodontal disease, the principal cause of tooth loss
in adults, is characterised by gingival infiltration with
inflammatory cells which ultimately results in the loss of
connective tissue. Micro-organisms are the primary
aetiological agents in the disease (Ellison et al_ 1 970) and
individual organisms eg. Actinomyces viscosus, when used
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singularly as contaminants can produce the disease in germ-
free rats (Guggenheim et al_ 1964).
The mechanisms by which plaque organisms can elicit
inflammatory periodontal disease are not fully elucidated.
Both antibody and cell mediated immune responses to the
bacteria associated with plaque have been reported in man
(Evans et al_ 1 9 66 ), but whether or not these actually
contribute to the pathogenesis of the disease is unknown.
Several bacteria, including Actinomyces viscosus and
other plaque organisms, are among the agents which can
activate complement by the alternative pathway. Activation
of complement generates mediators of acute inflammation and
factors chemotactic for polymorphs and macrophages are also
generated (Alper, 19 74). The component C3a is highly
cytotoxic for a number of cell types, and could contribute to
the fibroblast cytotoxicity which is an early feature of the
periodontal lesion. Another cleavage product, C3b, induces
the secretion of hydrolytic enzymes such as elastase,
collagenase and other broad spectrum proteases from
polymorphs and macrophages which could further contribute to
tissue breakdown. Activation of the terminal components of
complement leading to the synthesis of prostaglandin E also
provides a mechanism by which bone resorption may occur.
In view of these findings a role for plasminogen
activators in local pathological processes in gingival
epithelium is not hard to envisage. Plasminogen activator
was always found, by Southam et a 1. (1981), to be present in
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gingival pocket epithelium on fibrinolytic autographs.
Plasminogen itself is present in saliva (Moody, 1982) and a
mechanism therefore exists for the generation of plasmin in
the gingival crevice. Plasminogen is also present in
extravascular gingival tissue and can permeate the oral
mucous membrane (Brandtzaeg, 1973; Genco et a_l 1974). Thus
plasmin, which is capable of activating complement by either
the alternative or classical pathways, generated in this way
provides another mechanism of tissue destruction. Plasmin
generated in the gingival crevice can also activate latent
collagenases which may intensify the disease process
(Paranjpe et: al_ 1980). In addition, plasmin released in the
gingival crevice or pocket may also enhance the bleeding
tendency by the production of fibrin degradation products
which themselves have anticoagulant properties (Marder,
1971). Indeed a dialysable peptide fraction occurring as
the result of fibrin degradation has immunosuppressive
activity and this may further alter local tissue responses in
gingivitis.
3.1.2.4 Pemphigus
Evidence suggests that the intra-epithe 1 ia 1 bullae in
pemphigus result from the pemphigus antibody stimulating
keratinocytes to release plasminogen activator which then
converts serum derived plasminogen to plasmin. The plasmin
in turn digests the intercellular attachments between
keratinocytes (Friedman, 1986). Morioka et a_l ( 1 984 , 1 987)
further showed that acantholysis induced in skin explants in
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the presence of pemphigus IgG can be blocked by anti-
urokinase antibody.
3.1.2.5 Malignancy
Tumour invasion and metastasis is a multi-stage process
involving detachment of cells from the primary tumour,
penetration of the basement membrane, and movement of cells
via the blood or lymph system to the target organ.
Epithelial tumours, in particular squamous cell carcinomas,
must therefore be able to degrade basement membrane
constituents and connective tissue. For many years tumour
tissues have been shown to have substantial fibrinolytic
activity which may be involved in extracellular proteolysis
(Fischer, 1925; Goldhaber et al_ 1947; Astedt et al_ 1971).
However, it is now well established that normal tissues from
a number of anatomical sites - epidermis, bone, brain,
uterus, ovaries, and testes (Dano et al 1985) produce
plasminogen activators which are involved in normal
physiological processes. What remains unclear is whether or
not altered plasminogen activator synthesis, either
qualitatively or quantitatively, is involved in the
malignant potential of tumours. Some research has indicated
elevated levels of plasminogen activators of a non determined
type in extracts of tumour homogenates compared to the
equivalent normal tissue (Nagy et al^ 1977; Chylak and Brdar,
1983; Soszka and Olszewski, 1986). However, tPA is found in
endothelial cells of many blood vessels and is likely to be
found in extracts of most tissues. Furthermore, the use of
135
fibrin assays to detect plasminogen activators which are
known to augment the activity of tPA (Hoylaerts et al^ 1982)
may result in an overestimate of fibrinolytic activity in
certain tumours or an underestimate of fibrinolytic activity
in a primarily uPA producing tumour when compared to normal
tissue. Recently, for example, O'Grady et al (1985) found
that the total plasminogen activator in breast tumours did
not significantly differ from normal breast tissue, but uPA
was significantly higher in malignant tissue. Similarly,
Markus et a_l (1980) found, using a non-fibrin assay, a 2.5-
4.3 fold increase in plasminogen activator in homogenates of
lung tumours compared with adjacent normal tissue. In this
case the plasminogen activator was mostly in the uPA form in
tumour samples while tPA was the dominant species in normal
tissue. Evers et a_l (1982) and Camiolo et al^ (1984) also
reported 2-4 fold increase in homogenates of breast and
prostate tumour tissue compared with normal adjacent tissue
using an azocasein assay. At least 80% of the plasminogen
activator in the tumours was in the uPA form. Findings such
as these emphasize the need to identify the types of
plasminogen activators present within the tissue and the use
of appropriate assay procedures.
Further evidence that fibrinolytic activity in tumours
is involved in tumour growth and invasion comes from i_n vitro
studies. Increased plasminogen activator activity is an
early and concomitant event in the transformation of many
cell lines (Unkeless et a_l 1973, 1974; Ossowski et a_l 1 973 ;
Goldberg et al 1974; Balduzzi and Murphy, 1975; Goldfarb
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and Quigley, 1978; Miskin et a_l 1978; Ramshaw et al_ 1986).
In these cases this activator was determined by its Mr to be
uPA (Granelli-Piperno and Reich, 1978, Dano and Reich, 1978,
Dano et al_ 19 80).
Such increases in fibrinolytic activity may account for
a number of cellular alterations associated with neoplastic
transformation. Changes in morphology develop with the onset
of plasminogen activator synthesis (Ossowski et al^ 1973).
Quigley et al^ (1979) found that cell clustering and formation
of dense cellular aggregates by phorbol ester transformed
cells was the result of plasminogen activator and not of
plasmin although no other substrates for plasminogen
activator were at that time known. More recently Keski-Oja
and Vaheri (1982) detected a protein (Mr-66,000) of the
cellular matrix which seems to be a plasmin independent
cellular target for urokinase. Later Del Rossi et al_ (1985)
isolated receptors for urokinase on the cell surface of
normal and transformed cells, although a function for the PA-
receptor complex was not suggested.
Other studies have failed to show a consistent
correlation between plasminogen activator activity and
transformation (Mott et a_l 1974; Wolf and Goldberg, 1978 ;
Hinuma et al_ 1985). However, the failure at the time to
identify the types of plasminogen activator in their
experimental systems and the failure to appreciate the
presence of PA-inhibitors or pro-enzymes may require a re¬
investigation of these data.
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Despite equivocal results, additional evidence from
studies on tumorigenicity and metastatic potential of
transformed cells further implicates plasminogen activators
in tumour biology. Pollack et a_l (1975), Laug et a_l (1975)
and Siskin et al^ (1980) all reported good correlation between
the acquisition of plasminogen activator activity and the
growth of neoplastic cells in semi-solid media or tumour
formation in immuno-compromised animals. Ossowski et a_l
(1980) also found that Hep-3 cells which were tumorigenic
and metastasized in chick embryos released greater quantities
of plasminogen activator than a subline which had lost its
tumorigenicity. In other studies the correlation was less
pronounced. Jones et a_l (1975b) found that several clones of
human osteosarcoma which had high plasminogen activator
activity produced tumours in immunosuppressed hamsters while
others did not. Similar results were obtained by Gallimore
et al (1977) using adenovirus transformed human lines and
Montesano et a_l (1977) using transformed epithelial liver
cells lines. Again few of these studies, however, meet the
requirements for reliable quantitation of plasminogen
activators. Only one study to date has provided conclusive
evidence of a causal role for plasminogen activator mediated
tissue degradation and metastasis by a tumour (Ossowski et a_l
1983). The authors found that by transplanting a human uPA
producing tumour line (Hep-3) onto the chor10a11 anto l c
membrane of chick embryos, that antibodies which specifically
inhibited human (but not chick) uPA decreased metastasis to
the lung. A series of parallel experiments, showed »hat
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inhibition of metastasis was found to be the result of uPA
activity and not other immunological mechanisms. These
findings would suggest that uPA is involved in the very early
stages of metastasis.
Considering the evidence which suggests that a
correlation may exist between fibrinolytic activity in
tissues and neoplasia, there is only one report in the
literature on the occurrence and distribution of PA in
malignant disorders of the oral cavity. Ljunger et a_l (1984)
immunologically identified both uPA and tPA in association
with malignant neoplasms and compared these to normal
tissues. Unlike other studies of normal oral mucosa, tPA was
identified only in vessels of the underlying dermis. This is
surprising since plasminogen activator has been detected by
others in oral epithelial tissues (Birn and Fejerskov, 1971;
Southam and Moody, 1981; Southam et al_ 1981)
Birkedal-Hansen and Taylor, 1 9 8 3), and uPA has been
identified in epithelium from other sources including
bladder, kidney tubule epithelium, pneumocytes and mammary
gland epithelium (Larrson et a_l 1984). Plasminogen activator
activity in oral tumours was also confined to tumour vessels
and not to the epithelial component. The majority of PA
activity was quenched using anti-tPA antiserum, however, a
small fraction of the activity was identified as uPA.
Similar results were achieved by Weiss and Beller (1969),
Svanberg et a_l ( 1975) and Newstead et a^ (1976) who found
that fibrinolytic activity was mainly confined to vessels
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within tumours using the fibrin overlay technique, although a
few studies have demonstrated plasminogen activators within
carcinomas (Peterson and Zettergen, 1975; Peterson et a_l
1975) .
The failure to demonstrate lysis in fibrinolytic
autographs may be due to the presence of inhibitors in these
tissues. Hashimoto et a_l (1985) demonstrated the presence of
a fibrinolytic inhibitor in extracts of normal human
epidermis. B i r k e d a 1 - H a n s e n and Taylor ( 1 9 8 3 ) also
demonstrated the presence of sufficient plasminogen activator
inhibitor in supernatants from cultured rat tongue
keratinocytes to completely ablate endogenous activator
activity. Similarly inhibitors have been detected in culture
fluids from endothelial cells (Sprengers et al_ 1984 ; Van
Mourik et a_l 1984), hepatocytes and hepatoma lines (Sprengers
et a 1 1985), granulosa cells (Ny et a_l 1985), transformed
fibroblasts and human blood platelets (Schleef et a_l 19 8 5).
The inhibitor designated PAI-1 (to distinguish it from
placental inhibitor PAI-2) inhibits both uPA and tPA,
although very little is known about its physiology.
Immunological data from assays of PAI-1 and PAI-2 are
currently lacking.
More recently the development of specific antibodies to
tPA and uPA has allowed immunocytochemical localisation of
plasminogen activators in tumour tissues. In the few studies
so far reported uPA has been detected in human prostatic
tumours (Camiolo et a_l 1984), melanoma cells (Markus e_t a_l_
1984), and murine Lewis lung tumours (Skriver et al 1984) and
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colonic tumours (Burtin et a_l 1985; Khoga et al_ 1985).
Markus et a^ (1983) and Khoga et a^l (1985) also reported uPA
reactivity in human colon tumours with consistent and intense
staining at the luminal edge of the tumour cells which form
the glands, in desquamated cells and in transitional areas
between normal and tumour epithelium, morphological
transition being reflected in the appearance of staining for
uPA. Tissue type PA was found only in the stroma, in
particular in the endothelial linings of capillaries and
veins that penetrated the stroma. In contrast, Burtin et al_
(1985) demonstrated plasminogen activator activity in some
but not all human colonic tumours. They also found that both
types of activators were present in tumour cells and that the
staining at best was very weak. The production of more
specific, higher affinity antibodies may resolve these
issues.
Evidence, though equivocal, seems to indicate a role
for plasminogen activators, particularly uPA, in tumour
growth. Until now many studies have failed to identify the
types of plasminogen activators present in tissues or explore
the presence of plasminogen activator inhibitors in assay
systems. In addition, the recent isolation of pro-enzymes of
plasminogen activator (Kielberg et aJL 1985) has meant that a
reassessment of their contribution may be important in
establishing a role for plasminogen activators. The
recognition that tPA activity is strongly enhanced by the
presence of fibrin (Hoylaerts et al 1982) makes it important
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to ensure that assay methods will detect and distinguish the
types of activator present in any tissue. Methods of
detecting plasminogen activators are clearly important to our
understanding of their biological processes. Simple
extracts of whole tumours fail to take into account the
heterogeneity of the tumour population and the contribution
of each cell type to the total plasminogen activator pool.
To a certain extent these problems have been overcome by the
use of cultured cell populations. However, the problem of
selection of particular populations of cells _in vitro is
evident (Wilson and Dowdle, 1980), and is particularly true
of established cell lines.
In addition, the synthesis of plasminogen activators is
influenced by physiological concentrations of certain
hormones and other biologically active compounds such as EGF
(Lee and Weinstein, 1978), calcitonin (Simms et a_l 1981;
Sudol, 1985), corticosteroids (Rifkin, 1978; Mira-y-Lopez et
al 1983, Busso et a_l 1986), parathyroid hormone and
prostaglandin (Hamilton et a_l 1985), interleukin-1 (Mochan et
al 1986) and beta-transforming growth factor (B-TGF) (Laiho
et al 1986). Autocrine secretion of some of these compounds
by tumours in vitro may be a complicating factor.
Clearly the use of monoclonal antibodies for
localisation of both types of plasminogen activator will help
to resolve some of the problems previously encountered. The
future use of immunologically based assays such as
radioimmunoassays and enzyme linked immunosorbent assays,
which are currently being developed, may allow better
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interpretation of data without the complications of
proenzymes or inhibitors.
3.1.3 Assay and Detection Methods for Plasminogen Activators
3.1.3.1 Direct and Indirect Assays using Natural Substrates
Direct methods to measure PA involve the hydrolysis of
esters such as p-guanidinobenzoic acid which results in a
stable covalent complex between the ester and the activator.
Molar concentrations of the activator can be measured by the
amount of alcohol moiety released from the ester. Available
active site titrants are not, however, specific for PA and
can be released by other proteases. Such methods are
therefore mostly used in the analysis of purified
preparations of PA. Furthermore, the amplification of the
response achieved by measuring plasmin in indirect systems is
lost.
Most assay methods rely on indirect quantification of
the enzyme activity of plasmin, generated by conversion of
the proenzyme plasminogen. This can be done using a variety
of natural substrates such as casein, gelatin or fibrin.
The most widely used substrate for the quantification
of PA is fibrin, and the most commonly used assay is the
fibrin plate assay. Samples containing plasminogen activator
placed on the fibrin film, which contains plasminogen as a
contaminant, cause areas of lysis due to plasmin activity.
These can be measured and compared with serial dilutions of a
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standard preparation of urokinase or streptokinase. It must
be noted, however, that the activation of plasminogen in the
fibrin plate can result from activity of other enzymes. The
assay is extremely sensitive (-10 to -16 mol uPA: Jensen and
Astrup, 1983) and is particularly sensitive to tPA because
activation of plasminogen by tPA is stimulated by fibrin
(Hoylaerts et a_l 19 82). Refinements of the fibrin plate
assay involve labelling fibrin with either 1^25 or H3 an(j
measuring the release of radioactive isotopes into the
culture supernatant.
In addition, assays using iodinated fibrin are capable
of detecting the inactive proenzyme, pro-uPA (Larrson et a_1
1984) when plasmin free plasminogen is used. Trace amounts
of plasmin activate proactivator without measurably
influencing radioactivity released by PA (Skriver et a^L
1982). Assays with and without trace amounts of plasmin can
therefore be run in parallel.
3.1.3.2 Direct and Indirect Assays using Synthetic
Substrates
Recently developed synthetic peptides have been used to
quantitate PA activity by measuring the optical density of p-
nitroaniline released from the substrate as a result of
catalysis by plasmin. The substrate S2251 is the most
commonly used for this purpose although, like plasminogen
containing fibrin, it is not monospecific. By comparison
with other tripeptide substrates, however, it is more
sensitive by several hundred fold to plasmin than to trypsin,
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thrombin or kallikrein (Soria et al^ 1978). Synthetic
substrates for plasminogen activator (rather than plasmin)
have also been developed. In these systems, plasminogen
activator hydrolyses amide and ester derivatives of arginine
and lysine in different tri-peptides again derivatised with
p-nitroaniline. Despite their particular usefulness in
measuring activation of proenzymes, some of these substrates
are not specific for plasminogen activators. Furthermore,
many of these substrates are not inhibited by antibodies
against activators, thus limiting their usefulness in
distinguishing between uPA and tPA activity (Dano et al.1985).
3.1.3.3 Zymographic Detection of Plasminogen Activators
In this process, samples containing plasminogen
activator are electrophoresed in sodium dodecyl sulphate -
polyacrylamide gels (SDS-PAGE). Inactivation of the enzymes
by SDS is at least partially reversible by thorough removal
of SDS after electrophoresis in non ionic detergent
(Granelli-Piperno and Reich, 1978). The polyacrylamide gel is
then overlaid with a (plasminogen containing) fibrm/agarose
film into which uPA and tPA diffuse. The electrophoretic
process separates uPA and tPA and gives an estimate of their
Mr. Furthermore, activators and inhibitors not covalently
bound are separated electrophoretica1 ly, thus removing a
factor which complicates many other assay systems.
Distinction between uPA and tPA can further be enhanced by
incorporation of specific antibodies into the agarose overlay
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film (Dano, 1980). Immunoblotting of SDS-PAGE gels has also
been useful in distinguishing one chain and two chain forms
of uPA in tissue lysates (Skriver et a_l 1984) and as a
control of specificity of immunocytochemical staining.
3.1.3.4 Radioimmunoassays and Enzyme Linked Immunosorbent
Assay (ELISA)
Assay methods which rely on enzymatic activation suffer
from the drawback that inhibitors of PA or plasmin may be
present in the biological fluids which interfere with the
assay. Immunological assays directly measure PA, providing
that inhibitors are not competing with antibody binding.
Several radioimmunoassays for uPA (Huber et al_ 1984)
and tPA (McGregor and Prowse 1983; Ureden and Blomback,
1984) have been described with sensitivities of -10 to -15
mol. A number of ELISAs are also available for human
plasminogen activator. Some of these assays now employ
monoclonal antibodies to uPA and tPA (Herion et a_l 1983 ;
Holvoet et a_l 1985), the use of which avoids the disadvantage
of using radioisotopes or polyclonal antisera. The ELISA for
tPA does not yet distinguish between one chain and two chain
forms, although the presence of inhibitors has not been found
to affect the detection of tPA in this type of assay.
3.1.3.5 Immunocytochemistry
Reports of immunocytochemical localisation of tPA and
uPA are just beginning to appear in the literature. The
production of better and more specific antibodies to the PAs
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which will detect the very low levels often found in tissues
are still required. Such a technique may supercede the use of
the familiar fibrinolytic autograph (Todd, 1959) for the
localisation of PAs within tissues. In order to distinguish
tPA from uPA using autographs, specific antibodies must be
used in any case, either during a pre-incubation period or by
their incorporation into the film. Immunocytochemica1
techniques have the other advantage that PA production can be
localised to a particular cell. By double labelling it may
also be possible to detect whether one cell produces both
types of plasminogen activators or whether different cells
produce different plasminogen activators.
3.1.3.6 Summary and Objectives
Elevated plasminogen activator secretion, particularly
uPA, by tumours has been correlated in a number of studies
with invasion, metastases and tumorigenicity of malignant
cells. The data are, as yet, equivocal but this may be the
result of inappropriate methods of detection of the different
types of activator, PA-inhibitors and proenzymes of
plasminogen activators in samples.
The aims of the present study were therefore as follows:
1. To determine, using fibrinolytic autography staining of
sections of gingival mucosa and oral squamous cell
carcinomas, whether plasminogen activators could be
detected in tissues in vivo.
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To immunologically identify any activators present in
tissues by inclusion of antibodies to uPA and tPA into
fibrinolytic autographs and by immunofluorescence
staining of sections.
To establish using epithelium grown _in vitro from
gingival epithelium and oral squamous cell carcinomas
whether plasminogen activator activity is elevated in
tumour epithelium compared to normal epithelium, as
shown by the fibrin plate method.
To investigate the use of a non-fibrin based assay, the
S2251 chromogenic substrate assay, to measure
plasminogen activator activity.
To determine using sodium dodecyl sulphate
polyacrylamide gel electrophoresis (SDS-PAGE) the types
of plasminogen activators produced by cultured
epithelium. uPA from human urine has been shown to
contain at least two active molecular forms - one with
an Mr of 55,000 and an active lower molecular weight
form which is a degradation product of the Mr-55,000
form (Soberano et a_l 1978). Several studies have shown
that cell culture fluids contain uPA like activators
with Mrs of 35 , 000, 55 , 000 and 80,000 - 200,000 (Astedt
et a_l 1977, Vetterlein et a_l 1979; Bobbitt et a_l
1980; Wilson et a_l, 1980). Tissue type plasminogen
activator is also present in some culture supernatants
and can be separated from uPA on the basis of
size - Mr-70,000 and by immunological identification
after the inclusion of specific antisera to uPA or tPA
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into the zymogram detector gels.
The presence of PA-inhibitor complexes and unbound
inhibitors in culture fluids will be investigated in
zymograms detector gels after SDS-PAGE.
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3.2 MATERIALS AND METHODS
3.2.1 Fibrinolytic Autographs
Frozen sections of fresh gingival mucosa, including
sulcus epithelium (10 specimens) and frozen sections of oral
squamous cell carcinoma (15 specimens) were examined by
fibrinolytic autography. Cultures of normal oral epithelium
(8 specimens) and epithelium from oral squamous cell
carcinomas (4 specimens) were also examined in situ by
fibrinolytic autography. Cultures were grown in Lux permanox
culture dishes, which were compatible with clearing agents
used in staining procedures.
Fibrin films were made by evenly mixing 2% human
fibrinogen (Kabivitrum, Grade L lyophilised) in 0.15M veronal
acetate buffer (pH 7.4) with thrombin (Sigma 50 NIH units
ml~l), 10:1 vol/vol over 5um frozen sections on slides or
over cells in culture dishes. A volume of 0.02 ml of
fribinogen per cm2 was required to give films of 0.03 mm
final thickness. The films were incubated for 2-3 days at
4°C before fixation in 10% neutral buffered formalin for at
least lh. The films were stained with Azure A, dehydrated,
cleared in xylene and mounted. The presence of plasminogen
activator was visualised as a clear area in the stained film.
Immunological identification of the type of activators
produced by cells was determined by pre-incubation of the
sections and cell cultures with polyclonal antibodies to uPA
and tPA at a dilution of 1:100 (1 mgml"^; Biopool, Sweden).
Control fibrin films were made by using essentially
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plasminogen free fibrinogen (Sigma).
Veronal acetate buffer was prepared from concentrated
stock buffer containing 1.5M sodium acetate and 1.5M sodium
diethyl barbiturate. Working buffer was made by mixing 25 ml
of veronal buffer with 25 ml of 0.1N HC1 and adjusting the
final pH to 7.4. This solution was made up to a final volume
of 500 ml for use.
3.2.2 Immunofluorescence Staining
Normal gingival tissue (10) and tumour specimens (15)
obtained at surgery were frozen in OKT mountant (Miles
Scientific) in a stream of carbon dioxide vapour. Sections
5um thick were cut in a cryostat and fixed in methanol for 10
min. Monoclonal antisera to uPA and tPA, raised in mouse
(Monozyme), were diluted 1:10 to 1:50 in phosphate buffered
saline and applied to the sections. Sections were incubated
at room temperature for 1-2 hours in humidified boxes. In
control sections non-immune serum or phosphate buffered
saline replaced the primary antibody. The sections were
washed three times in phosphate buffered saline and then
covered with fluoresceinated rabbit anti-mouse antibody at a
1:10-1:50 dilution (Dakopatts) for thirty minutes. The
sections were then washed and stained with 1% haematoxylin
and after rinsing with water were mounted in buffered
glycerol.
Fluorescent slides were examined with a Leitz Dialux
microscope (filter 12 , 450-49 Onm) and photographs were taken
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using XPI 400 ASA film in either UV light or normal
illumination.
3.2.3 Culture of Normal and Malignant Oral Epithelium
and Fibroblasts
Cultures of epithelium from gingival mucosa and oral
sguamous cell carcinomas were obtained as previously
described in section 2.6.2. Chapter 2. Fibroblast cell lines
from gingival mucosa and oral squamous cell carcinomas were
obtained from epithelial cultures, which had become overgrown
by fibroblasts. These were subjected to brief trypsinisation
in 0.25% trypsin and 0.02% EDTA. The supernatants,
containing predominantly fibroblasts, were harvested and
diluted in an equivalent volume of GMEM containing 20% FCS
and centrifuged at 200g for 5 min. The supernatant was
aspirated and the cells resuspended in GMEM containing 10%
FCS and plated into 60 mm diameter culture dishes.
Fibroblasts were routinely subcultured in a 1:2 split ratio.
3.2.4 Estimation of Cel1 Density in Cultures
Prior to collection of culture supernatants and cell
lysates, the number of cells in each culture dish was
estimated. Outgrowths of epithelial cells, clearly visible
on the culture dishes were outlined in permanent pen and the
areas of these outgrowths measured using a semi-automatic
image analyser (Kontron MOP AMOl). Where epithelial cultures
were almost confluent, the entire area of the culture dish
was calculated. However, throughout cultured epithelium,
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spaces occurred in and between colonies and the actual
surface area of the dish covered by epithelium was then
estimated using a point counting method (Dunnill, 1968).
Under the microscope, the epithelial outgrowths were scored
along a bilateral transect (Freshney, 1987) for the presence
of epithelial cells. A running mean of the percentage of the
culture dish covered by epithelium was constructed for each
biopsy sample cultured. Point counting continued until the
running mean was stable (800 - 4000 points). In every tenth
field, the number of epithelial cells per mm2 was counted
using a 1:9 graticule. From these measurements the
percentage area of the dish covered by epithelium multiplied
by the number of epithelial cells per mm2 gave an estimate of
the number of epithelial cells per culture dish.
For confluent oral fibroblast cultures, the number of
cells per mm2 in every tenth field of a bilateral transect of
the culture dish was determined and this number was
multiplied by the entire surface area of the culture dish.
3.2.5 Collection of Serum Free Cell Culture Supernatants
and Cell Lysates
Cultures of normal and malignant epithelial cells after
either 2 weeks or 4 weeks growth in. vitro were washed several
times in phosphate buffered saline for 2h. Cultures were re-
fed with serum free MEM supplemented with 0.5% bovine serum
albumin (BSA) but containing no EGF. The cultures were f hen
incubated at high relative humidity at 37°C in an atmosphere
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of 5% carbon dioxide and 95% air for 1 to 4 days. After this
period of incubation culture supernatants were collected and
centrifuged at 400g for 10 min. to remove cellular debris.
The supernatants were then lyophilised.
The cultures were then washed twice in phosphate
buffered saline and 1 ml of 2M potassium thiocyanate (KSCN)
was added to each culture dish to lyse the cells. The
cultures were then left at room temperature for 30 min, the
cells mechanically scraped off the culture dish and the
lysate containing fragmented cells was homogenised in a
Griffiths tube homogeniser. The resultant lysate was
centrifuged at 400g for 10 min. to remove cellular debris and
the lysates lyophilised. In certain cultures cycloheximide
(10 ugml-^) was added to the serum free culture medium during
the incubation period before cell culture supernatants and
lysates were collected.
Before assays for plasminogen activator were performed,
in order to standardise samples after their lyophi1isatIon,
the supernatants and lysates were resuspended in distilled
water in a volume equivalent to 10^ cells ral"^. Further
concentration or dilution of the samples was carried out,
when necessary, to ensure that areas of lysis produced on
fibrin plates fell within the range of streptokinase and
urokinase standards.
3.2.6 The Standard Human Fibrin Plate
Stock fibrinogen was made by dissolving lg of human
fibrinogen (Kabi, Grade L) in 100 ml of 0.015M Tris buffer pH
7.8. The solution was stored in 10 ml aliquots at -20°C.
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For each fibrin plate 1 ml of stock fibrinogen was added to 9
ml of Tris buffer and 0.2 ml of 0.1 M CaCl2 i-n a 90 mm
diameter petri dish. The diluted fibrinogen was clotted
using 0.2 ml of bovine thrombin (Sigma) (50 NIH units ml~^)
by gentle mixing. The plates were left for 20 min. at room
temperature on adjustable pre-levelled tables and were either
used immediately or stored at 4°C for up to 3 days. Test
solutions (30 ul) were applied to the surface of the fibrin
plates. One 30 ul aliquot of urokinase (Leo Labs) at a
dilution of 5 units per ml was applied to every fifth plate
as an internal standard. The plates were incubated for 19h
at 37°C on their pre-levelled tables. Areas of lysis were
visualised by the addition of one drop of 0.01% bromothymol
blue dye (diluted vol/vol in absolute ethanol and 0.5 N NaOH)
to the test site. Areas of lysis were measured in two
perpendicular diameters. Control plates contained epsilon
amino caproic acid (eACA) at a final concentration of 10-3M.
Calibration of fibrin plates was carried out by adding serial
dilutions from 20 - 0.03 U ml-* of streptokinase (Kabivitrum)
and urokinase (Leo Labs) to the fibrin plates. After
incubating the plates for 19h at 37°C, the area of lysis in
each of the five replicates was measured in two perpendicular
diameters. The calibration equation was calculated from the
linear regression of log concentration of activator against
the area of lysis.
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3.2.7 Chromogenic Substrate Assay S2251
The substrate assay was adapted from the method of
Friberger et a_l (1978) for microtitration plates. The assay
was plasminogen dependent relying on activation of
plasminogen by activators present in the test samples to
generate plasmin. Plasmin then catalyses the following
reaction:
Sample + plasminogen
H-D-Va1-Leu-Lys-pNA + H20 H-D-Val-Leu-Lys-OH + pNA
Using a flat bottomed 96 well microtitration plate, 50
ul of test sample was added to 50 ul of plasminogen (Flow
Labs) diluted in water to a final concentration of 0.06 U ml-1
The reactants were incubated at 37°C for 10 min. After
this 100 ul of chromogenic substrate (final concentration 3
mM in Tris buffer 0.05 M; pH 7.4), was added to each well
and the plate was incubated at 37°C. The release of p-
nitroaniline(pNA), catalysed by plasmin was measured
spectrophotometrical ly in a Multiskan spectrophotometer at
405 nm. The reaction was monitored until the end pomt was
reached. An internal calibration was performed in each
plate. Serial dilutions of streptokinase (Sigma) and
urokinase (Leo Labs), from 25U ml~^ to 0.02U ml~^, were
applied to plates and linear regression analyses performed.
Possible interference with absorbance readings at 405 nm, in
the S2251 chromogenic substrate assay, by phenol red
containing medium, was assessed at different pHs.
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3.2.8 Sodium Dodecyl Sulphate - Poly aery1amide Gel
Electrophoresis (SDS-PAGE)
Unless otherwise stated all chemicals were obtained from BDH
Chemicals and were Electran grade.
3.2.8.1 Preparation of slab gels
Slab gel plates were pre-cleaned overnight in chromic
acid, rinsed in running water and then ethanol. The clean
plates were laid on paper towels and the inner aspect of each
plate swabbed thoroughly with ethanol and allowed to air dry.
The glass plates were separated with 1.5 mm Teflon spacers
and the assembled plates clamped with metal clips positioned
over the spacer positions. The clamped plate assembly was
held vertical during the pouring of the gels.
3.2.8.2 Separating ge1
30 % acrylamide: 0.8% bis acrylamide 20 m 1
0.75 M Tris-HCl pH 8.8 30 m 1
10% SDS 0.6 m 1
Distilled water 6.4 ml
N,N,N^,N^-Tetramethylethylenediamine(TEMED) 40 ul
1% ammonium persulphate 3.0 ml
The gels were polymerised using the TEMED-Ammonium
persulphate system. All the components except TEMED were
mixed thoroughly and degassed. TEMED was added and the
solution gently but evenly mixed and poured into the plates.
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The gel was immediately overlaid with 1% SDS and allowed to
polymerise for 0.5 - 1.0 h.
the 1% SDS was poured off
stacking gel solution:
3.2.8.3 Stacking gel
30% acrylamide: 0.8% bis acrylamide 1.6 ml
1M Tris-HC1 pH 6.8 2.0 ml
10% SDS 0.16 ml
Distilled water 11.4 ml
TEMED 24 ul
1% Ammonium persulphate 0.8 ml
The components were mixed and degassed as before and
the stacking gel poured on top of the separating gel.
Immediately, a perspex comb was fitted between the glass
plates into the stacking gel which was left to polymerise for
1-2 h. The comb was then carefully removed and the sample
wells created by the comb rinsed with reservoir buffer. The
bottom gel spacer was removed and the plates mounted in the
electrophoresis apparatus (Bio Rad Slab Gel Electrophoresis
Model 220). Reservoir buffer was added to the lower reservoir
and any air bubbles removed from the bottom of the gel to
ensure uniform electrical contact between the buffer and the
gel. The top reservoir was then filled with running buffer
before loading the samples.
After the gel had polymerised
and the surface rinsed with
158
3.2.8.4 Running Buffer
Concentrated stock running buffer was made by mixing
60.6g Tris with 288g glycine in 2L of distilled water.
Running buffer was made by diluting 200 ml of stock buffer in
1.8L of distilled water and adding 20 ml of 10% SDS.
3.2.8.5 Sample preparation
Proteins contained in cell culture supernatants and
lysates were dissociated by incubation of 25 ul of test
sample with 25 ul sample buffer containing 2% SDS, 8M urea,
40 mM iodoacetimide and 0.2M Tris (pH 8.0). After incubation
for 30 min. at 37°C, the samples were made 10% with respect
to glycerol containing 0.00025% bromphenol blue tracker dye.
The samples (10 ul) were loaded into the sample wells formed
in the stacking gel. Where appropriate tumour supernatants
were diluted 1/5 or 1/10 before loading samples. The
electrophoresis system was connected to a power pack and the
gels were run at 20 Ma for 3-4h until the dye front had
reached the bottom of the gel. Rainbow molecular weight
markers (Amersham International) with molecular weights
ranging from 14,300-200,000 daltons were run concurrently in
a number of gels.
3.2.8.6 Zymogram overlay
The polyacrylamide gels were washed in 1 L of 2.5%
aqueous Triton-X-100 for lh and then repeatedly rinsed with
distilled water and the gels were carefully laid onto
indicator gels. Fibrin agarose indicator gels were prepared
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by mixing 16 ml of 1% agarose (LKB) solution boiled for 10
min and cooled to 42°C, and 4 ml of fibrinogen (2 mgml-*) and
120 ugml-* of plasminogen were added. Thrombin (120 ul of 10
Uml-*) was added to the solution which was poured onto 10 mm
x 15 mm gel electrophoresis films and allowed to form a firm
gel.
The acrylamide gel-indicator gel sandwich was placed
in sealed humidified containers overnight at 37°C. Areas of
lysis in the indicator gels produced by plasminogen
activators were visualised as clear areas in the fibrin film.
Control zymograms were prepared with plasminogen free fibrin
(Sigma). Immunological identification of plasminogen
activators in gels was carried out by incorporation of
antibodies to uPA and tPA into the zymogram overlays. A 0.4%
solution of tPA (5 mgml-^) or uPA (5 mgml"^) was added to
each zymogram.
Additionally, fibrinolytic inhibitors could be detected
in zymograms, in which the fibrin was completely lysed in the
zymogram during the incubation period by the addition of
urokinase at a concentration of 0.075 Uml-*. Inhibitors
present in samples resulted in opaque zones in the zymograms




Frozen sections of human gingival mucosa showed lysis
over crevice epithelium and over vessels in the connective
tissue. Pre-incubation of sections with polyclonal antisera
to uPA and tPA indicated that lysis over crevice epithelium
was due to the presence of both urokinase and tissue type
plasminogen activators (Figs. 60 and 61). More extensive
lysis was observed after pre-incubation of sections with
antibodies to uPA than with antibodies to tPA indicating that
the majority of the lysis resulted from tPA activity. Lysis
over vessels in the connective tissue was also mainly due to
tissue activator (Figs. 62 and 63). No lysis was observed in
sections coated with plasminogen free fibrin or in sections
which had been pre-incubated with antiserum to both uPA and
tPA. Lysis was therefore due to the presence of plasminogen
activators and not plasmin or other proteolytic enzymes.
Lysis occurred over each of the eight cultures of
normal gingival epithelium and was confined mainly to the
circumference of the epithelial outgrowths (Fig. 64).
Virtually all of the plasminogen activator activity in
cultures was inhibited by the inclusion of antiserum to uPA
into the fibrin films. Infrequently very small areas of
lysis occurred over cultures coated with plasminogen free
fibrin or in fibrin films in which uPA and tPA antiserum had
been incorporated. This lysis may have been due to the
production of plasmin or other proteolytic enzymes by
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FIG. 60
Lysis in fibrinolytic autograph over gingival crevice
epithelium after pre-incubation of sections with anti-urokinase
antibodies (x40 mag).
FIG. 61
Lysis in fibrinolytic autograph over gingival crevice




Lysis in fibrinolytic autographs of gingival mucosa occurring
over vessels. Pre-incubation with anti-uPA antibodies does not
markedly inhibit lysis (x40 mag).
FIG. 63
Lysis in fibrinolytic autographs of gingival mucosa occurring
over vessels. Sections pre-incubated with anti-tPA antibodies
do not inhibit all lytic activity (x40 mag).
 
FIG. 64
Fibrinolytic autograph of normal cultured gingival epithelial
cells. Lysis occurs mainly at the migrating edge of epithelial
colonies (x200 mag).
 
inflammatory cells present in the cultures (see Chapter 2).
In addition plasmin may have been converted from trace
amounts of plasminogen bound to cells, previously incubated
in serum containing medium. This activity was, however, very
low and was only evident after prolonged incubation of the
cultures (i.e. 4 or more days at 4°C).
In frozen sections of oral squamous cell carcinomas no
lysis was observed over tumour epithelial cells (Fig. 65).
Lysis in these sections, where present, was confined to
endothelial cells in vessels and the major part of the
fibrinolytic activity was quenched by pre-incuba t ion of
sections with antiserum to tPA. No lysis was observed over
sections which were coated with plasminogen free fibrin or
after pre-incubation of sections with antiserum to uPA and
tPA, indicating that lysis was due to plasminogen activators.
Lysis was observed over one or two epithelial cells in
only one epithelial outgrowth established from a biopsy of an
oral squamous cell carcinoma (Fig. 66). In the remaining
three biopsies of oral squamous cell carcinomas, no
fibrinolytic activity was observed in 36 of the epithelial
outgrowths from explants.
3.3.2 Immunofluorescence Staining
The results of staining of frozen sections of gingival
mucosa and of oral squamous cell carcinomas with different
concentrations of antibody to uPA and tPA are shown in Table
17. Maximum intensity of staining was achieved with
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FIG. 65







































dilutions of 1:10 to 1:20 of the primary antibody and a 1:10
dilution of the secondary antiserum. Staining became
progressively weaker with lower dilutions of primary
antibodies and no staining was observed with dilutions below
1:50. No background staining was observed in the absence of
primary antibody or in sections treated with non-immune
serum.
In gingival mucosa, immunofluorescence was observed in
vessels stained with antiserum to uPA and tPA. No
fluorescence was observed in gingival epithelium in
immunostained sections.
In the specimens of tumour sections examined in this
way a number showed immunofluorescence in endothelium and
connective tissue after staining with antiserum to uPA (Fig.
67) and in endothelial cells lining vessels after staining
with tPA and uPA antiserum (Fig. 68). In sections from four
of the fifteen specimens, fluorescence was observed in
isolated tumour epithelial cells after staining with
antiserum to uPA or tPA but staining was always very weak
(Fig. 69-72). No fluorescence was observed in sections in
which primary antiserum was replaced with phosphate buffered
saline or non immune serum.
3.3.3 In Vitro Assays for Plasminogen Activator
3.3.3.1 Estimation of cell number in vitro
An estimate of cell numbers was made for all cultures
used in the experiments described in this chapter. Figure
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FIG. 67
Immunofluorescence in connective tissue in a section of an
oral squamous cell carcinoma after staining with antibodies
to uPA (x200 mag).
FIG. 68
Immunofluorescence in vessel endothelium in a section of an
oral sqaumous cell carcinoma after staining with antibodies
to tPA (x200 mag).
 
FIG. 69
Section of oral squamous cell carcinomas stained by indirect
immunofluorescence with antibodies to uPA (x200 mag).
FIG. 70
Light micrograph of Fig. 69
 
FIG. 71
Section of oral squamous cell carcinoma stained by indirect
immunofluorescence with antibodies to tPA (x200 mag).
FIG. 72
Light micrograph of Fig. 70
I
73 shows an example of results obtained for cultures from one
patient biopsy. In this example over 1700 points were
counted in order to demonstrate a stable mean percentage area
of the culture dishes covered by epithelium. The range of
points which had to be counted before a stable mean was
obtained for each series of patient cultures ranged between
800-4000 points (see Table 11).
3.3.3.2 Calibration analyses of the fibrin plate assay
A linear regression analysis of log concentration of
activator (as x) against area of lysis (as y) was performed
for streptokinase and urokinase (Figs. 74 and 75). The
calibration equation was linear across the range of
concentrations for streptokinase (r^ = 0.96). Lysis of
substrate by urokinase was only linear in the range
1.25 Uml-* - 25U ml-* (r^ = 0.85). Below 1.25U ml-1, no
discrimination could be made between plaminogen activator
activity and background lysis caused by buffer.
These calibration equations were used throughout this
study. In each experiment urokinase and streptokinase (5
Uml-*) were added to every fifth plate to ensure
reproducibility of the assay. When the lyophilised samples
from cultured epithelium were resuspended, the concentration
of plasminogen activator in the samples was adjusted, where
necessary, to ensure their assay within the established
linear part of the scale. The fibrin plate was more





























































Fig.75Calibrationequ tiofplasminogenbyur kinasein fibrinplateanalyses.(±SD,n=s)
was therefore used as a standard reference in subsequent
experiments using the fibrin plate assay.
3.3.3.3 Calibration and characterisation of the chromogenic
substrate assay
Linear regression analyses of the log concentration of
activator against absorbance (Fig. 76) indicated that good
linearity was observed in the concentration range 0.19 -25.0U
ml"* for both streptokinase (r^= 0.98) and urokinase (r^ =
0.91). Using lower dilutions of activators 0.019U m1~* to
2.5U ml"-*- activation of substrate by streptokinase and
urokinase reached a plateau (Fig. 77). Sensitivity of this
assay was therefore similar to the fibrin plate method.
Possible interference in absorbance readings at 405 nm
in the S2251 assay by phenol red contained in the medium was
then assessed. If phenol red was present, the optical
density was slightly reduced at pH 7.0 across the range of
concentrations of streptokinase used (Fig. 78). This
reduction could, however, be minimised if the background
reading was subtracted at the beginning of the assay. At pH
7.4, however, the colour of the supernatants altered from
orange/red to bluish/red and the absorbance readings at 405
nm were markedly altered (Fig. 78). Using concentrations of
streptokinase between 1.5 - 25U ml~^, considerable quenching
of absorbance occurred (Fig. 78). With lower dilutions of
streptokinase an increase in absorbance, compared to the non
phenol red containing control was observed. This assay was



























































































3.3.4. Fibrin Plate Analysis of Oral Keratinocyte Culture
Fluids
Cell lysates collected from two week old cultures of
normal gingival epithelium showed little or no cell
associated activity (Table 18 Fig. 79). Levels of
plasminogen activator secreted into the medium were higher
with a mean value of 5.1U/107 cells after one day in serum
free medium. Variation between samples was considerable with
concentrations of activator ranging from 0.5 - 23U/107 cells.
After two days in serum free medium more cultures
expressed cell associated activity (Table 19 Fig. 79) but
overall activity remained low (<1U/107 cells). Plasminogen
activator activity in supernatants, however, increased
substantially over the two day period from a mean value of
5.1U/107 cells to 28.2U/107 cells. Inter-patient variation
persisted in supernatants harvested after two days with
plasminogen activator activities ranging from 0-236.2 U/107
cells.
In gingival epithelium cultured for four weeks in
vitro, cell associated plasminogen activator activity was
only slightly increased when compared to keratinocytes grown
for two weeks iri vitro (Table 20 Fig. 80). Plasminogen
activator activity in supernatants, however, increased from
less than 2U/107 cells after one day in serum free medium to
a mean value of 244.6U/107 cells after two days in serum free
medium. Marked variation in activities in supernatants was
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TABLE 18
FIBRIN PLATE ANALYSIS OF PLASMINOGEN ACTIVATOR ACTIVITY
OF NORMAL ORAL KERATINOCYTES AFTER 2 WEEKS IN VITRO.
SAMPLES WERE HARVESTED AFTER 1 DAY IN SEROM FREE CONDITIONS
Sample N? Activity (Units/10^ cells)
Lysates Supernatants




5 3.6 8 . 6
6 0 4 . 1
7 0.2 2 . 1
8 0 0 . 4
9 0.8 1. 0
10 0 0.4
TABLE 19
FIBRIN PLATE ANALYSIS OF PLASMINOGEN ACTIVATOR ACTIVITY
OF NORMAL ORAL KERATINOCYTES AFTER 2 WEEKS IN VITRO.
SAMPLES WERE HARVESTED AFTER 2 DAYS IN SERUM FREE CONDITIONS









8 0.9 236 .2
9 0.1 47.5
10 1.1 36.9




FIBRIN PLATE ANALYSIS OF PLASMINOGEN ACTIVATOR ACTIVITY
OF NORMAL KERATINOCYTES AFTER 4 WEEKS IN VITRO.
SAMPLES WERE HARVESTED AFTER 1, 2 AND 4 DAYS
IN SEROM FREE CONDITIONS
Activity (Units/107 cells)
Day Harvested Sample No.
Lysates Supernatants
1 day 1 0.7 2 . 1
2 1.1 1.6
3 1.2 0 . 7
4 0.1 0 . 9
5 0.7 3 . 1
2 days 1 1.6 3 . 0
2 1.9 17 . 1
3 0 47 . 5
4 3.6 14 . 6
5 0.2 372 . 4
6 0.6 47 . 0
7 0.2 1427.0
8 0 8 . 0
9 0.9 264 . 4
4 days 1 0.21 216.3




























Fig.79 Plasminogen activator activity in cell lysates and
culture supernatants from normal oral keratinocytes



























Fig.80 Plasminogen activator activity in cell lysates and
culture supernatants from normal oral keratinocytes
cultured for four weeks in vitro.
still apparent in four week old cultures ranging from
3.0U/10^ cells to 1427U/10^ cells. Despite the ten fold
increase in plasminogen activator in four week cultures
(244.6U/10^ cells) compared to those found in two week old
cultures 28.2U/10^ cells) these differences were not
statistically significant (Mann-Whitney U Test p=0.1), and
probably results from the large inter-patient variation in
samples. Accumulation of plasminogen activator in
supernatants from four week old cultures was also examined
after four days in serum free medium. After four days cells
in serum free culture conditions appeared granular,
accumulated intr acy top 1 as m ic vacuoles and many cells
contained pyknotic nuclei. Data for only two samples are
therefore shown (Table 20, Fig. 80) and these fell within the
range of plasminogen activator activity found in supernatants
harvested after two days. No further data for this time
point were collected. On control fibrin plates containing
10~^M epsilon amino caproic acid, which inhibits plasminogen
activator activity, no lysis was observed on plates after
incubation with any of the samples. Furthermore, no
plasminogen activator activity was detected in culture
supernatants after cultures were incubated during the two day
period with the protein synthesis inhibitor eye 1ohexim ide
indicating that plasminogen activator present in samples was
synthesised de novo during the sample collection period.
Plasminogen activator activity in tumour cultures grown
for four weeks in vitro was measured after two days in serum
free medium. The data in Figure 81 and Tables 21 and 22
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TABLE 21
FIBRIN PLATE ANALYSIS OF PLASMINOGEN ACTIVATOR ACTIVITY
OF ORAL SQOAMOOS CELL CARCINOMAS AFTER 4 WEEKS IN VITRO.




1 0.7 8 . 2
2 0 9 . 8
3 0 0
4 0.2 8 . 8
5 0.6 0
6 0.9 6 . 4
7 0.5 0
8 0.2 2 . 1
TABLE22

































































indicate that cell associated plasminogen activator activity
from tumour cell lysates was low and was within the range of
values found in cultured gingival epithelium (mean value
0.4U/10^ cells).
Plasminogen activator activity in cell free culture
supernatants was absent in three of the eight cultures
examined and overall activity remained low (mean value
4.4U/107 cells). This activity was significantly lower
(p=0.05 Mann-Whitney U Test) than that found in cultures of
normal oral kerat inocytes grown for four weeks i.n vitro
(Table 22, Fig. 82).
3.3.5 Fibrin Plate Analyses of Normal and Malignant Oral
fibroblast culture fluids
Cell associated plasminogen activator activity was
detected in 2 of the five confluent cultures (passage 2) of
fibroblasts from non-neoplastic gingival mucosa (Table 23).
Activator activity in these cultures was less than 1U/107
cells. No plasminogen activator activity was detected in any
of the culture supernatants after two days in serum free
medium.
Tumour cell lysates and culture supernatants from
confluent cultures of fibroblasts (passage 2) contained no




























Fig.82 Plasminogen activator activity in culture
supernatants from normal oral keratinocytes cultured
for two and four weeks ^n vitro and from oral
squamous cell carcinomas cultured For four weeks in
vitro.
TABLE 23
FIBRIN PLATE ANALYSIS OF PLASMINOGEN ACTIVATOR ACTIVITY
OF NORMAL AND TOMOOR FIBROBLASTS FROM ORAL MUCOSA
AFTER 4 WEEKS IN VITRO.
SAMPLES WERE COLLECTED AFTER 2 DAYS IN SERUM FREE CONDITIONS
Sample N? Activity (Units/107 cells)
Lysates Supernatants
Normal Oral 1 0 0
Mucosa











3.3.6 Analysis of Culture Lysates and Supernatants from
Normal Gingival Keratinocytes by SDS-PAGE
Cell lysates from six cultures of normal gingival
keratinocytes grown for two or four weeks _in vitro were
examined after SDS-PAGE. The activities of these samples
measured by fibrin plate assay are shown in Table 24. In
cell lysates, in which no activity was detected on fibrin
plates, no activity was present in zymogram overlays of SDS-
PAGE gels (Fig. 83). Absence of lysis was therefore not due
to the presence of inhibitors in these lysates. In two
lysate samples, which contained plasminogen activator
activity (<1U/10^ cells by fibrin plate assay) zones of lysis
were apparent in the zymograms. These bands co-migrated with
the uPA standard.
Of thirteen supernatants collected from cultures grown
for two and four weeks in vitro, and which contained varying
amounts of activity on fibrin plates (Table 24) all showed
bands of lysis in zymograms which co-migrated with the uPA
standard (Fig. 84). The observed bands of lysis could be
inhibited by the incorporation of antibodies to uPA into the
zymogram overlay gels. Four of the thirteen cultures also
showed bands of lysis as a result of high molecular weight PA
complexes (Mrt200,000) (Fig. 84). These areas of lysis were
also inhibited by the inclusion of antibodies to uPA but not
tPA in the zymogram overlay gels. The presence of high
molecular weight bands did not appear to correlate with the
culture age, the time after which the supernatants were
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TABLK 24
ZYMOGRAPHIC ANALYSIS OF PLASMINOGEN ACTIVATOR ACTIVITY IN
CULTURES OF NORMAL GINGIVAL KBRATINOCYTES
Age of Days in Sample Fibrin Activity present in




2 1 (b) LI 0
2 2 L2 0 — -
2 2 L3 0 - —
2 2 L4 0 -
4 2 L5 1 ♦ _
4 2 L6 1 ♦ -
2 1 (b) S1 1 ♦
2 1 S2 1 ♦ -
2 1 S3 1 ♦ -
2 1 S4 1 ♦ *
2 2 S5 2 ♦ >
2 2 S6 3 ♦ -
2 2 S7 3 •f *
2 2 S8 3 •f -
4 1 S9 1 ♦ -
4 2 S10 4 •f -
4 2 Sll 4 ♦
4 2 S12 4 ♦ -
4 2 S13 5 ♦
(a) Activity on Fibrin Plates 0 - No activity
1 - 0-1 u/io; cells
2 - 2-10 U/107 cells
3 - 11-20 U/107 cells
4 - 21-100 U/107 cells
5 - > 100 U/107 cells
(b) L ■ Lysates (c) - lmw Low Molecular Weight
(b) S ■ Supernatant - hmw High Molecular Weight
uPA
(5Uml 1)
L 1 -4 L 5
FIG. 83
Plasminogen activators in lysates from cu
keratinocytes after SDS-PAGE.
uPA S6 S 8 S5 S7 S11
(5Umr1)
FIG. 84
Plasminogen activators in supernatants from cultured gingival
keratinocytes after SDS-PAGE.
collected or the activity of the samples on fibrin plates
(Table 24).
Of twelve samples which were assayed using plasminogen
free zymogram overlay gels, none showed lysis, indicating
that fibrinolytic activity was the result of plasminogen
activator.
3.3.7 Analysis of Culture Supernatants from Tumour Keratino-
cytes by SDS-PAGE
Of the eight supernatants from keratinocytes derived
from oral squamous cell carcinomas, five showed low
-J
fibrinolytic activity on fibrin plates (ClOU/lO7 cells) and
three showed no fibrinolytic activity (Table 21 + 25)-After SDS-
PAGE analysis of these supernatants using a 10 ul sample
loading, very large zones of lysis were apparent in zymograms
from two of the supernatants (T6 and T8) (Fig. 85) and these
had to be diluted 1/10 (Fig. 86). When compared with
supernatants of gingival keratinocytes, showing similar
activities on fibrin plates, the areas of lysis on zymograms
of the culture supernatants were much higher than those
produced by gingival keratinocytes on zymograms. This
suggests that plasminogen activator inhibitors (PAI) are
present in the oral squamous cell carcinoma culture
supernatants.
When the culture supernatants were diluted 1/5 or 1/10
before analysis with SDS-PAGE two of the supernatants T5 and
T7 which had shown no activity on fibrin plates showed lysis
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HMWuPA
T 8 T 6
- uPA
FIG. 85
P lasminogen activator activity in undiluted culture
supernatants from oral squamous cell carcinomas (T6 and T8)
after SDS-PAGE.
T6 T 8 uPA
5U/ml
FIG. 86
Plasminogen activator activity in diluted culture
supernatants from oral squamous cell carcinomas (T6 arid T8)
in zymograms (Fig. 87). Only one tumour cell supernatant
(T3) showed no activity on either fibrin plates or in
zymogram detector gels. In all tumour supernatants (except
T3) zones of lysis Mrt55,000 were apparent and co-migrated
with the uPA standards. These supernatants also showed bands
of lysis as a result of high molecular weight PA-complexes
(Mr-200,000). These complexes could be PA-PAI complexes
which show fibrinolytic activity only after SDS-PAGE
manipulations. In one of the supernatants (T8) another band
of lysis (Mr = 110, 00 0) was also apparent in the zymogram gel
(Fig. 88).
Further analysis of the tumour supernatants was carried
out by incorporation of antiserum to uPA and tPA into the
zymogram detector gels. The majority of fibrinolytic
activity was quenched by incorporation of antiserum to uPA
into gels (Fig. 88). Anti-uPA antiserum inhibited zones of
lysis Mr~55,000 and lysis due to the high molecular weight
complex (Mr-200,000) (Fig. 88).
Not all lysis was inhibited by antiserum to uPA. In
all the supernatants (except T3) small bands of lysis were
observed due to tPA activity. These bands were inhibited by
the incorporation of antiserum to tPA (Fig. 88). In addition
one tumour supernatant contained a high molecular weight
complex Mrr110,000. The fibrinolytic activity of this
complex was quenched by the addition of anti-tPA antiserum
into the zymogram. On the basis of its electrophoretic
mobility and immunological identification it was presumed to




Plasminogen activators in diluted
oral squamous cell carcinomas (T4,
culture supernatants from
T5 and T7) after SDS-PAGE.
FIG. 88
Identification of plasminogen activators in tumour culture
supernatant (T8) after incorporation of antiserum to uPA and
tPA into zymogram overlay gels.
TABU 25
ITNOGBAFBIC ABALT8I8 OP PLASM IMOGMI ACTIYATOB ACTIVITT IM TPMOOK
CPLTPBB 80PBBMATAMTS
Sampl* No. Fibrin Plat*
Activity
(0/107 calls)
Activity Pr*s*nt on D*t*ctor Gals
LMW-uPA HMW-UPA tPA
T1 8.2 ♦ ♦ ♦
T2 9.8 ♦ ♦ ♦
T3 0 - - •
T4 8.8 ♦ ♦
T5 0 ♦ ♦
T6 6.4 ♦ ♦ +
T7 0 ♦ ♦
T8 2.1 ♦ ♦ +
1
3.3.8 Analysis of Culture Lysates and Supernatants from
Fibroblast Cultures from Gingival Mucosa and Oral
Squamous Cell Carcinomas by SDS-PAGE
Two culture lysates and supernatants from fibroblasts
from normal gingival mucosa, which contained no activity on
fibrin plates, and oral squamous cell carcinomas were
assayed after SDS-PAGE. No lysis due to uPA, tPA or high
molecular weight PA complexes was detected in these samples.
Furthermore, in zymogram detector gels, in which
plasminogen activator had been added to lyse the fibrin
during the incubation period, no opaque zones due to the
presence of free PAI could be detected in these samples.
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3.4 DISCUSSION
In fibrinolytic autographs of gingival epithelium uPA
and t PA were immunologically identified in crevice
epithelium. Larger zones of lysis, due to the action of tPA
were apparent over crevice epithelium but it is now well
established that the activity of tPA is greatly enhanced by
fibrin (Matsuo et ad 1981? Hoylartes et al^ 1982), a property
not shared by uPA. Thus smaller areas of lysis in crevice
epithelium, as a result of uPA, may not reflect relative
amounts of activator secreted by these cells.
Lysis was never found over keratinising gingival
epithelium, a finding supported by others using human and
rodent tissue (Southam and Moody, 1981? Southam et a 1_ 1981?
Ljungner et al 1984). The absence of fibrinolytic activity
may have been due to the absence of activators or it may
arise from the presence of proenzymes to activators or
plasminogen activator inhibitors (PAI) in these tissues.
Proenzymes of uPA and tPA have recently been identified in
human urine, plasma and cells in culture (Eaton et al_ 1983 ?
Kasai et al 1985? Kielberg et al_ 1985). In common with
other proenzymes, these are activated by limited proteolysis
and this activation represents another step in the plasmin
cascade at which control over proteolysis can be exerted.
Fibrinogen preparations contain trace amounts of plasmin and
therefore theoretically proenzyme, if present, should be
detected in fibrinolytic autographs. Nevertheless, some
commercial preparations of fibrinogen can contain trace
amounts of inhibitors which can quench plasmin activity and
173
enrichment of the fibrinogen with plasminogen may be required
(Gurewich et a_l 1984). Despite this many preparations of
fibrinogen, in this and other work, have been used without
detection of proenzyme activity in keratinising epithelium.
Immunofluorescence studies of gingival epithelium also
indicated an absence of free plasminogen activator in
keratinising epithelium. No fluorescence was observed
anywhere in the epithelium after staining with antibodies to
uPA and tPA. Positive staining was detected in vascular
endothelium with both uPA and tPA. No staining for uPA or
tPA was observed in crevice epithelium in these sections. It
may be that plasminogen activators, shown to be present in
fibrinolytic autographs, are leached from tissues during
staining procedures. Furthermore, fibrinolytic activity is
markedly enhanced by fibrin, thus low levels of tPA in
sections may be sufficient to cause lysis in autographs, but
may not be present in sufficient quantity to detect by
immunofluorescence. Again, it is possible that plasminogen
activators are present in trace 1 1 u 1 ar 1 y as proenzyme.
However, it has been noted that monoclonal antibodies to
plasminogen activators can recognise determinants in the
proenzyme form (Nielsen et a_l 1982). Thus proenzyme should
also be detected if present. If plasminogen activators are
present in keratinising gingival epithelium, they may be
bound to inhibitors and these are unlikely to be detected by
immunofluorescence or fibrinolytic autography. Inhibitors to
both uPA and tPA have been found in cornified cells in skin
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(Hibino et a_l 1984) and may also be present in keratinising
layers of oral epithelium. Antibodies to PAI have recently
been produced in another laboratory (Busso et a_l 1987) and
these may help clarify a role for plasminogen activators in
epithelium.
It is clear from this and other studies that
plasminogen activators are present in certain areas of
epithelium. Lysis due to plasminogen activators has been
observed in epithelium in other areas of the mouth, most
notably in lip, cheek and soft palate (Myhre-Jensen and
Astrup 1971; Southam et a_l 1982) and lysis was observed to
arise in the prickle cell layer. A number of roles for
plasminogen activators in epithelium have been postulated.
Green (1979), for example, found that nucleated squames
collected from supernatants of cultured keratinocytes which
were then further incubated, require the presence of
plasminogen containing medium for nuclear digestion to occur.
He suggested that normal differentiation and cellular
dyshesion is a plasmin assisted process. This is difficult
to reconcile with previous work which indicated that free
plasminogen activator arises not in the cornified layers of
epithelium but in the prickle cell layer (Southam et a_l 1981)
and with the finding that cornified cells contain inhibitors
to both uPA and tPA (Hibino et a_l 1984). It may be that the
balance between activator and inhibitor production rn vivo is
sufficient to allow cellular dyshesion to occur, but that
insufficient activator is generated in these tissues to be
detected by fibrinolytic autography or immunostaining.
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Further support for the role of activators in differentiation
arises from in vitro work since levels of plasminogen
activators have been shown to increase in cultured
keratinocytes as they stratify and differentiate (Isseroff et
al 1983 ; Birkeda 1-Hansen et al^ 1983 ; Morioka et a_l 1985).
Plasminogen activator has also been implicated in
cellular migration. Morioka et al^ (1985) found abundant
plasminogen activator in cells migrating at the edges of
epithelial cultures. This has been confirmed in this study
by fibrinolytic autographs of cultures of oral epithelium, in
which zones of lysis were freguently detected at migrating
edges of epithelial outgrowths. Morioka et al^ (1985) further
showed that uPA accumulated in keratinocytes in vitro at the
cut edges of wounds deliberately made in cultures. Other
cell types including neurones migrating across culture
surfaces also deposit plasminogen activator which Krystosek
and Seeds (1986) considered a component of substrate adhesion
material. It is possible that lysis arising in prickle cells
in oral epithelium as a result of plasminogen activators is
involved in migration of cells as they proceed from the basal
to cornified layers.
Whatever the precise function of plasminogen activators
in epithelium, their presence in oral epithelium
(Southam et a_l 1981), glomerular and kidney tubule
epithelium, ductus deferens and prostate epithelium (Camiolo
et al 1984) and cultures or epithelium from numerous tissues
(Dano et a_l 1 9 8 5) would suggest that they are normal
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components of epithelia and have a key role in the biology of
normal epithelia.
In the present study no lysis was observed over tumour
cells in fibrinolytic autographs of frozen sections of
biopsies of oral squamous cell carcinomas. Lysis was mainly
confined to vessel endothelium. This is consistent with the
observation of Ljunger et al (1984) who also found no
fibrinolysis over epithelial cells in autographs of oral
squamous cell carcinomas. In other similar studies,
fibrinolytic activity in autographs of endometrial
adenocarcinomas, benign and malignant ovarian tumours and
human colon tumours, lysis was also confined to blood vessels
(Weiss and Beller, 1969; Swanberg et a_l 1975; Newstead et
al 1976).
Immunofluorescence staining for uPA and tPA, performed
on tissue sections from the same patient biopsies, showed
very weak staining for uPA and tPA. Staining was infrequent
and usually in isolated cells. Possibly low levels of
antigen in tissues or complexing of plasminogen activators
with PAI in tissues, combined with the monospecificlty of the
antibodies contributed to such poor staining in these
sections. Despite the weakness of staining it was
consistently present particularly after staining with anti-
uPA antibodies, and was absent if staining was carried out
with non-immune serum. Brighter fluorescence was observed in
vascular endothelium after staining with both tPA and uPA and
in connective tissue after staining with uPA. uPA has been
detected in connective tissues by others (Larsson et a_l_ 1 984)
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and plasminogen activator production by tumour cells may not
be a pre-requisite for invasion into surrounding tissues, if
uPA is also present in connective tissue elements.
Few immunocytochemical studies using antiserum to uPA
and t PA have been carried out. Of these, most have
indicated that uPA is exclusively produced by tumour cells
(Markus et al^ 1 9 8 4 ; Khoga et al 1 9 8 5) and these
observations are consistent with many in vitro studies.
Burtin et al_ (1985) demonstrated the presence of both uPA and
tPA in tumour cells in human colon carcinomas. They found,
using monoclonal antibodies to uPA and tPA that staining in
tissues was weak and intermittent, but where staining did
occur it was most intense in small isolated foci of tumour
cells in the invasion zone and the staining was predominantly
for uPA. No improvement in staining was obtained in these
tissues when immunoperoxidase staining techniques were used.
In the studies of Markus et a_l (1984) and Khoga et a_l
1985) the authors achieved a more consistent staining of
colon carcinomas using an immunoperoxidase staining
technique. Abrupt changes in staining were seen in the
transitional areas with staining intensity for uPA faithfully
reflecting morphological transion to carcinoma. No tPA was
isolated in tumour cells in these studies. The differences
in patterns of staining in similar tumours may result from
different antisera being used by different groups.
The presence of plasminogen activators in tumour
sections does not necessarily indicate a role for such
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enzymes in tumour invasion. However, their presence and
evidence from many other studies that increased plasminogen
activator synthesis is correlated with malignant
transformation of cells makes this a reasonable hypothesis.
Examples of this correlation are too numerous to cite
(reviewed by Dano et al^ 1985) , however, this relationship is
not absolute (Chibber et a_l 1975; Wolfe and Goldberg 1976;
Whur et al_ 1980; Hinuma et a_l 1985). In some tissues,
particularly epithelium, both normal and malignant cells
appear to contain high levels of plasminogen activator (Mott
et al^ 1974; Wilson and Dowdle 1978 ; Wilson et a_l 1980).
Wilson and Dowdle (1978) found in a series of cultures
derived from normal, reactive and neoplastic tissues, that
there was no consistent relationship between plasminogen
activator production and neoplasia. However, in the light of
recent discoveries of proenzymes and plasminogen activator
inhibitors, much of this type of data needs to be re¬
evaluated.
Unlike fibrinolytic autographs of cultured gingival
epithelium, all of which showed extensive lysis particularly
at the migrating edges of epithelial outgrowths, lysis in
oral squamous cell carcinomas was observed only in a small
group of cells in an epithelial outgrowth from one patient
biopsy. Again, this apparent lack of plasminogen activator
activity was unexpected, particularly in view of the numbers
of reports emphasising the increase in plasminogen activator
synthesis in cell cultures of neoplastic origin and in
transformed cell lines (Dano et al 1985). However, some cell
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cultures of neoplastic origin have been found to lack
detectable plasminogen activator activity especially when
analysed soon after the establishment of the culture (Wilson
and Dowdle 1978; Gronow and Blenheim, 1983). In the present
study, it cannot be evaluated from fibrinolytic autographs
alone whether low fibrinolytic activity is due to production
of small amounts of plasminogen activators or the concomitant
release of plasminogen activators and inhibitors.
Epithelium grown in vitro from gingival mucosa and oral
squamous cell carcinomas allowed comparisons of the levels of
plasminogen activators in near pure populations of non¬
neoplastic and tumour epithelium.
The medium used to culture keratinocytes contained
epidermal growth factor, which is also present in small
quantities in serum. Epidermal growth factor is known to
induce plasminogen activator synthesis (Lee and Weinstein,
1987) but PA synthesis is rapidly down regulated after the
removal of EGF (Gross et al 1983b). Serum has also been
shown to contain other modulators of plasminogen activator
activity in addition to growth factors, hormones and plasma
protease inhibitors (Levin and Luskotoff, 1980). These
authors found, using bovine aortic endothelial cells, that
plasminogen activator activity increased with cell density,
but decreased by 70% - 80% after the addition of fresh serum
during routine feeding. No such inhibition was observed if
cultures were simply washed and the same medium returned to
the cells, or by the addition of other proteins. The authors
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postulated that plasminogen activator production by bovine
aortic endothelial cells _in vitro was subject to negative
control by suppressors within serum. By dialysing or acid
treating serum, it was found that neither steroid hormones
nor serum inhibitors were involved in the suppression of
plasminogen activator activity and the identity of the
molecule(s) remains unclear. However, suppressors must in
some way be inactivated or degraded during cell growth, the
cells thus being released from the suppressed state. In view
of these findings, plasminogen activator production by oral
epithelial cells was determined in basal medium containing
only 0.5% bovine serum albumin.
Proteolytic activity in culture fluids was initially
assessed by the fibrin plate method. Plasminogen activator
activity was plasminogen dependent indicating that lysis was
due to plasminogen activators and not other non-specific
proteases.
Not all cell lysates expressed plasminogen activator
activity on fibrin plates and in lysates which did contain
activity, little difference was observed after two or four
weeks growth iri vitro. Levels of cell associated activity
were always low.
The majority of plasminogen activator detected in
cultures was secreted into the culture medium. Levels of
plasminogen activator in cultures of gingival kerat1nocytes
grown for two weeks _in vi^tro increased four fold in
supernatants collected after two days, compared to * hose
collected after one day in serum free medium. It may be ' hat
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there is a lag phase for the synthesis of plasminogen
activators. Indeed, inclusion of the protein synthesis
inhibitor, eyeloheximide, into serum free supernatants
completely ablated production of plasminogen activator in
cultures. Plasminogen activators must therefore be
synthesised de novo.
Gingival keratinocytes after four weeks iri vitro,
secreted far higher levels of plasminogen activators into
supernatants over a two day period, than two week old
cultures. This is in agreement with the findings of
others (Birkeda 1-Hansen et al^ 1983; Morioka et al^ 1984)
and again suggests the involvement of plasminogen activator
in some aspect of terminal differentiation in oral epithelial
cultures. Despite a ten fold difference in the levels of
plasminogen activators observed in four week old cultures
compared to two week old cultures, this increase was not
statistically significant and probably reflects the large
inter-patient variation. Wilson and Dowdle (1978) also noted
large inter-sample variation in cultures of epithelium from a
number of tissues. This was particularly pronounced in
kidney epithelial cultures in which activities ranged from
190U - 3,700U/10^ cells/24h. Levels of activity found in
gingival epithelial cultures ranged from 23U - 1427U/107
cells and were comparable to those found in Wilson and
Dowdle's study. Wilson and Dowdle attributed their findings
to experimental variables; however, in the absence of
sufficient patient data it is difficult in this study to
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speculate whether these differences reflect innate i.n vivo
differences, correlated with patient variables such as donor
age and health or whether they result from experimental
variables. Certainly, despite all attempts to keep protocols
uniform, Wilson and Dowdle found that not only did
plasminogen activator levels vary substantially in primary
cultures, but these also varied markedly in the same cultures
after routine passage. No attempts were made in their study
to evaluate levels of inhibitors in these cultures.
Cell associated plasminogen activator activity in four
week old cultures of tumour derived keratinocytes did not
differ greatly from levels of activity found in normal
keratinocyte cultures. Plasminogen activator activity in
tumour supernatants was, however, significantly lower (Mann-
Whitney U Test p=0.05) than that measured in normal culture
supernatants by the fibrin plate method. These findings
contradict the majority of data concerning plasminogen
activator production by cells both i_n vivo and i^n vitro, in
which a strong positive correlation has been observed between
malignant transformation and increased synthesis of
plasminogen activators (Ossowski et al^ 1973; Unkeless et a_l
1974; Soszka and Olzsewski 1986). These comparisons have
often been made using normal and virally transformed
fibroblast cell lines. Fibroblasts in 9enera 1 ly
produce little or no detectable enzyme whereas epithelial
cultures produce varying amounts of enzyme (Wilson and Dowdle
1978). Differences in plasminogen activator activity between
normal and neoplastic epithelium may therefore be less
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pronounced.
In addition, fibrin potentiates tPA activity and
variations in plasminogen activator activity produced in
assays may result from the use of a fibrin based method of
detection. In the present work the use of a non-fibrin based
assay, the S2251 chromogenic substrate assay, was
investigated. The cleavage of bonds in the substrate by
plasminogen activator generated plasmin, releasing p-
nitroanaline, which was measured at 405 nm. However, phenol
red pH indicator, which is added to most commercially
available media, interfered with absorbance readings at this
wave length. In the presence of phenol red indicator, over
the pH range 7.0 - 7.4 no marked differences in absorbance
readings were observed. However, at pH7.4 and above, a
marked interference in absorbance readings was demonstrated
in phenol red containing medium. The adjustment of pH in
small samples of culture supernatant in this work was
not feasible so S2251 substrate was not used to assay the
activity in the culture specimens.
Neither the fibrin plate nor the S2251 assay
distinguish between the types of plasminogen activators
present in the samples being tested. Furthermore, activity
in the samples may be masked by the presence of PA
inhibitors. The separation of activators from inhibitors and
further immunological identification of activators was
therefore carried out by SDS-PAGE. Samples of cell lysates
and supernatants from normal gingival keratlnocytes
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displaying a range of activities on fibrin plates, were
analysed after SDS-PAGE. Of the six cell lysates examined in
this way only those samples which expressed fibrin plate
activity showed zones of lysis on zymogram detector gels.
These bands co-migrated with the urokinase standard. No
other lytic bands were detected in the zymograms of
epithelial cell lysates even after prolonged incubation (4
days). The absence of fibrin plate activity therefore
appeared to be due to the absence of cell associated
plasminogen activator activity in these samples. No
definitive assay of pro-activator activity in these samples
was undertaken but it would seem unlikely that proenzyme
would remain unactivated by plasmin contaminants in
plasminogen enriched detector gels. The plasminogen added
to overlay gels was known to contain approximately 0.01 unit
of plasmin per unit of plasminogen, in addition to the
plasminogen already present in the fibrinogen preparation.
Thirteen supernatants from cultures of gingival
keratinocytes were also analysed by SDS-PAGE. These
supernatants had a wide range of fibrin plate activities (<1U
- > lOOOu/1p7 cells). All cell culture supernatants displayed
bands of lysis which co-migrated with the urokinase standard
(Mr-55,000). This activator was positively identified in
these samples by the inclusion of antibodies to urokinase
into the detector gels. No activity due to tPA was apparent.
Faint bands of lysis, at a position in the gel
indicating a much lower e1ectrophoretic mobility, wpre
present in four of the thirteen samples. These bands could
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all be inhibited by anti-urokinase antibody. The presence of
these bands was not obviously correlated with the age of the
culture, the time at which the samples were harvested or the
fibrinolytic activity expressed on fibrin plates.
Several other groups have shown that primary cultures
of normal human foreskin keratinocytes produce mainly uPA
(Wilson et a_l 1980; Hashimoto et a_l 1985; Morioka et a_l
1985). In addition Wilson's group showed that uPA was the
major activator in cultures of bladder, thyroid, skin and
oesophageal epithelium and in mixed cultures of glial and
neuronal elements. Bands of lysis relating to activators
with lower electrophoretic mobilities were also observed in a
minority of their cultures. The appearance of these bands
has been attributed to dimerisation or aggregation of the
lower molecular weight forms of activators. However, Cieplak
and Hart (1986) have shown that these bands are stable in SDS
and resistant to reduction or thermal degradation. These
complexes, therefore, would not appear to represent
aggregates or disulphide linked dimers or oligomers.
As a result of mixing experiments using radio-iodmated
urokinase, Cieplak and Hart (1986) found, in human urine,
that the presence of high molecular weight forms of PA were
the result of complexes between low molecular weight forms of
PA and a binding component. Electrophoretic analysis of
125 i - labe1led high molecular weight uPA complexes (HMWuPA)
suggested that the binding component had an approximate Mr of
40,000. An inhibitor role was suggested for the binding
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component, as serine protease inhibitors were unable to
inhibit the formation of these complexes.
A number of inhibitors have been suggested to form
these complexes. Protease nexins released by fibroblasts
have an Mr-40,000 and bind covalently to uPA and thrombin
(Baker et a^ 1980). Hoal et al_ (1983) also identified an Mr
=40,000 - 50,000 molecule produced by fibroblasts, which
forms SDS stable complexes with tPA, and is therefore
functionally distinct from protease nexin. More recently,
specific fast acting inhibitors which form stable complexes
with uPA and tPA have been identified in human plasma
(Sprengers and Kluft 1987).
These PA-PAI complexes have no inherent fibrinolytic
activity. However, after manipulations performed during SDS-
PAGE the complexes exhibit activity on zymogram overlays. It
is unclear whether this is due to some dissociation of the
complexes or intrinsic activity after SDS-PAGE. Such
complexes often require more prolonged incubation for their
presence to be observed as they express much lower activity
than an equivalent amount of free activator.
Plasminogen activator inhibitors are produced by a
number of cell lines including epithelial cells, endothelial
cells, human hepatocytes, hepatoma lines, granulosa cells and
melanoma cell lines (Wilson et a_l 1980; Van Mourik et a_l
1984; Sprengers et a_l 1985; Ny et aJL 1985; Schleef et a_l
1985). It remained a possibility that some of the inhibitor
present in cultures was derived from contaminating
fibroblasts in epithelial cultures. Fibroblast contamination
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estimated in epithelial cultures used for plasminogen
activator assays was low < 3% of the area of the culture.
In the present study, very low amounts of cell
associated plasminogen activator (x = < 0.2 U/107 cells) were
detected in lysates from only two pure fibroblast cultures
of gingival mucosa by the fibrin plate assay. Also no PA
activity was detected in any of the supernatants. The
contribution of plasminogen activators by fibroblasts in
vitro must, therefore, be very low. In those samples
expressing no cell associated fibrinolytic activity, no
plasminogen activator or PAI complexes were detected by SDS-
PAGE in either supernatants or lysates. However, it is
possible that uncomplexed inhibitor might be produced by
fibroblasts in the cultures. In order to detect free
inhibitor in fibroblast culture fluids, zymogram overlays
containing urokinase were applied to SDS-PAGE gels. No free
inhibitor was found in samples from pure cultures of
fibroblasts. The contribution of plasminogen activators or
PA-inhibitors produced by fibroblasts to the overall activity
displayed by epithelial cultures must therefore be
negligible.
Plasminogen activators were identified in all tumour
supernatants, with the exception of one sample T3 which will
be excluded from further discussion. Plasminogen activators
were so abundant in tumour samples after SDS-PAGE separation
of activators from inhibitors, that all samples had to be
diluted five to ten fold before assaying. All the tumour
188
supernatants contained low molecular weight uPA which co-
migrated with the urokinase standard (Mr~55,000). These
bands were positively identified in all tumour supernatants
by the inclusion of antibodies to uPA into the zymogram
detector gels. All of the tumour supernatants analysed in
this way also contained much smaller amounts of free tPA
resulting in faint bands of lysis with an Mr-70,000. These
bands were only narrowly separated from uPA bands and were
positively identified by the inclusion of antibodies to
either uPA or tPA into the detector gels. Despite the strong
association between the production of uPA in tumours (Markus
et a 1 1984; Camiolo and Greco 1986) and in tumour and
transformed cell cultures (Dano et a 1_ 1980; Wilson et al_
1980; Mira-y-Lopez et al_ 1983; Ossowski et a_l 1 9 8 3), a
number of reports indicate that uPA may not be uniquely
produced by tumour cells _in v_itro (Wilson et al_ 1 9 8 0 ;
Schleuning and Reich 1983; O'Grady et al^ 1985). Wilson et a_l
(1980) characterised plasminogen activators in neoplastic
cultures from a number of carcinomas and found that while the
predominant activator was uPA, in a small number of
supernatants tPA was also identified. Similarly O'Grady et
al (1985) found that benign breast tumours and carcinomas
both contained uPA and tPA, but uPA was significantly higher
in the malignant group.
Tissue plasminogen activator was identified by
immunofluorescence in the present study, in isolated cells in
sections of oral squamous cell carcinomas, from which cell
cultures were derived. It would therefore seem reasonable to
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postulate that epithelial cells may be capable of
synthesising tPA in vitro. There is a possibility that small
amounts of tPA could be secreted by other cell contaminants
(for example leucocytes), in epithelial cultures derived from
oral squamous cell carcinomas. However, in view of the
numbers of these cells present in cultures this seems
extremely unlikely. Furthermore, similar cells formed
contaminants of gingival keratinocyte cultures where no tPA
was detected in supernatants.
Unlike culture supernatants from gingival
keratinocytes, all tumour supernatants showed the presence of
one or more bands with lower electrophoretic mobilities which
caused lysis in detector gels. These PA-inhibitor bands (Mr
-200,000) caused zones of lysis which were larger than
those found in supernatants from gingival epithelium and were
inhibited by anti-urokinase antibodies. In one tumour
supernatant a narrow band with an approximate Mr of 110,000
was detected in zymograms. This was inhibited by antibodies
to tPA and was presumed to be PAI-1.
The nature of the inhibitor complexed to uPA is
uncertain and further work is required to establish the
precise Mr of these complexes. Recently it has been reported
by Booth et a_l ( 19 87) that an inhibitor complex with an
apparent Mr of 180,000 is present in blood samples from
volunteers after exercise and this was shown to be due to a
complex with CI inhibitor; however, this complex was tPA
related. Complexes with alpha-2 macroglobulin with a similar
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Mr have also been detected using these techniques (Booth,
pers. comm.).
The possibility that significant amounts of inhibitor
could be synthesised in these cultures by tumour fibroblasts,
which are sometimes present as a very minor contaminant (< 2
% cover), was excluded after assaying culture fluids from
pure cultures of tumour fibroblasts. None of the tumour
fibroblast lysates or supernatants contained plasminogen
activator, PA-inhibitor complexes or free inhibitor after
SDS—PAGE analysis. PA inhibitors in these cultures must
therefore be synthesized by epithelial cells.
In Summary
Plasminogen activators, uPA and tPA, were detected in
sections of normal oral epithelium by fibrinolytic
autography, where they may function in cell migration or
terminal differentiation of epithelium. Although the precise
role of plasminogen activators in epithelium remains unclear,
their presence in oral epithelium and epithelium from other
anatomical sites suggests some normal function of plasminogen
activators in this tissue.
Plasminogen activators could not be detected, in
fibrinolytic autographs over sections of oral squamous cell
carcinomas, in epithelial cells. However, very weak
immunostaining for uPA and tPA, in occasional epithelial
cells in these sections, was observed and it may be that
concomitant secretion of inhibitors in tumour tissue masks
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the presence of plasminogen activators in oral squamous cell
carcinomas.
Based on the observations of others, the hypothesis
that increased plasminogen activator activity is correlated
with neoplasia, was investigated using an iri vitro model in
which levels of plasminogen activator in virtually pure
populations of normal and malignant oral keratinocytes could
be compared.
In fibrinolytic autographs of cultured epithelium,
extensive lysis was observed in all cultures of normal
gingival keratinocytes, while lysis was virtually absent in
cultures of tumour epithelium. This observation was
confirmed when plasminogen activators secreted by normal and
malignant epithelium were assayed by the fibrin plate method.
Plasminogen activator activity was significantly lower in
tumour cultures than in gingival keratinocyte cultures after
four weeks growth iri vitro. Since all supernatants from
gingival keratinocyte cultures contain uPA, and since uPA was
the predominant activator in tumour cultures, the differences
in enzyme activities were not as the result of a tPA bias
introduced by using the fibrin plate method.
After SDS-PAGE analysis of the culture fluids it became
apparent that, once plasminogen activators were separated
from inhibitors, tumour supernatants contained abundant
plasminogen activator activity which was masked by the
presence of inhibitors in these cultures. Unlike normal
gingival keratinocytes, which secreted uPA, tumour cultures
secreted both activators but predominantly uPA. PA-inhibitor
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complexes were also detected in all tumour supernatants but
the identity of the precise inhibitors involved is still
uncertain.
If PA secretion by tumour cells is involved in tumour
invasion, then it seems reasonable to suggest that it must be
present in sufficient quantities to facilitate the process of
invasion. PA-inhibitor production by tumour tissue may
therefore cast doubt on the role of plasminogen activators in
the tumour invasion zone. However, it has been shown that
various hormones eg. EGF, TGF-beta and calcitonin can
stimulate PA synthesis (Lee and Weinstein, 1978; Dayer et a_l
1981; Sudol 1985; Laiho et a_l 1986). Since some tumour
cells are capable of synthesizing these hormones the balance
between PA and PAI synthesis may be altered in X_LX°*
Furthermore, the finding that plasminogen readily binds to a
number of cell types and to extracellular matrix, and that
its cleavage to plasmin once bound on these surfaces protects
plasmin from inhibitors (Silverstein et a_l 1985b; Knudsen et
al 1986) suggests that the overall amount of inhibitor
present in tissues may not limit the process of tumour
invasion.
In this study the presence of plasminogen in sections




PLASMINOGEN IN ORAL EPITHELIUM
4.1 INTRODPCTION
The process of tumour invasion is generally considered
to involve the production and release of proteases capable of
degrading basement membrane components (Liotta et a_1 1985),
and plasmin generated by proteolytic cleavage of plasminogen
by activators has been assigned a major role in the breakdown
of these complex matrix components (Jones and DeClerk, 1980,
Laug et a_l 1983; Mignatti et a_l 1986). The sites of
synthesis and storage of plasminogen are therefore crucial to
the question of tumour invasion.
The major site of synthesis of circulating plasminogen
has still not been firmly established, although one study has
identified the liver as the major organ of plasminogen
synthesis in man (Raum et a_l 1980). In terms of neoplastic
invasion localised synthesis or storage of plasminogen within
or near the location of the tumour may be of greater
importance. Few reports on the localisation of plasminogen
to sites other than the liver have been reported and these
include eosinophils (Barnhart and Riddle, 1963),
granulocytes (Prokopwicz and Stormorken, 1968), epidermis
(Isserof and Rifkin, 1983; Nakagawa et al^ 1984) and vascular
and extracellular areas outside seminiferous tubules
(Saksela, 1986). Such studies indicate that localised
plasminogen synthesis can take place .in vivo and 'hese
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reservoirs of plasminogen may be involved at sites of tumour
invasion.
De novo synthesis of plasminogen need not be a
prerequisite for fibrinolytic activity at these sites.
Plasminogen has been shown to bind to the surface of a number
of cell types and to extracellular matrix elaborated by cells
in vitro (Bogenmann and Jones, 1983; Miles and Plow, 1985;
Hajjar et a_l 1986; Knudsen et a_l 1986).
Hajjar et al_ (1986) found that glu-plasminogen binds to
human umbilical vein endothelial cell (HUVEC) monolayers in
vitro. Binding occurs in a concentration dependent manner
and is saturable at physiological concentrations (2uM).
Plasminogen binding to these cells was 70-80% inhibited by
eACA which suggests that binding is mediated through lysine
binding sites. In their system plasminogen was activated by
tPA in a high affinity-enzyme interaction (Km=5.9nM), and
plasminogen on the cell surface was activated with a 13 fold
greater efficiency than fluid phase plasminogen. Similar
results have been reported in the circulatory system
(Bachmann and Kruithof , 1984). Fluid phase plasminogen
activation is kinetically unfavourable and immobilisation of
plasminogen on fibrin clots via lysine binding sites makes
activation of plasminogen possible at circulating
concentrations. Such a mechanism, both in the vascular
system and within tissues, may serve to promote and localise
plasminogen activator activity. Plasminogen binding was
found, by Hajjar et al (1986), to be relatively surface
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specific with lower levels of binding to human fibroblasts,
poor binding to smooth muscle cells (SMC) and no binding to
bovine endothelial cells, indicating that species specificity
may be critical in this interaction. They also found that
the binding of unrelated proteins, such as albumin, to HUVEC
layers was negative although other kringle containing
proteins with lysine binding capacities were positive. Miles
and Plow (1985) have reported that plasminogen also
specifically binds to both resting and thrombin stimulated
platelets in vitro. Again, plasminogen bound to the surface
of the platelets was activated much more readily by tPA, uPA
and SK than fluid phase plasminogen. Plasminogen also bound
to granulocytes and lymphocytes present in their i_n vitro
system. Miles and Plow postulated the presence of a
fibrinogen related plasminogen receptor based on the number
of plasminogen binding sites. No such binding sites were
detected on HUVEC monolayers as fibrinogen could not be
immunologicaly identified on the cell surfaces. The
plasminogen binding sites on HUVEC were unidentified (Hajjar
et a_l 1986). It is worth noting that not all authors have
demonstrated plasminogen binding to cells (Bauer et a_l 1984)
although the use of sub-physio1ogic concentrations of
plasminogen and the use of human plasminogen with porcine
endothelial cells may explain this discrepancy.
Knudsen et a_l (1986) further reported that plasminogen
was capable of binding not only to cells but also to
extracellular matrix (ECM) synthesised .in
endothelial cells. Such cells secrete a complex array of
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glycoproteins and glycoasminoglycans which contribute to the
formation of basement membranes (Martinez-Herandez and
Amenta, 1983) and these matrix constituents include
fibronectin, laminin, collagen and thrombospondin. Knudsen's
groups previously demonstrated, in a fibrin free system, that
plasminogen binds with high affinity to thrombospondin
(Silverstein et al^ 1 9 8 5 a) and to histidine rich
glycoproteins (Silverstein et al^ 19 85b) and that tPA
specifically bound to the thrombospondin-plasminogen complex
(Leung et al_ 1984). Using the more biologically relevant
substrate ECM, they have reported that plasminogen binding
was specific, saturable at physiological concentrations and
was lysine binding site dependent. Activation of plasminogen
in this system was equally efficient by tPA and two chain uPA
and, as expected, surface bound plasminogen was a much better
substrate than fluid phase plasminogen. Of particular
importance to neoplastic invasion was the finding that
plasmin generated on the ECM surface was protected from the
fast acting inhibitor alpha-2-antiplasmin. This would result
in the prolongation of proteolytic activity on the matrix
since fluid phase plasmin is readily inactivated by a number
of inhibitors (Wiman and Collen, 1977). Of interest, too,
was the observation that N-terminal cleavage of Glu to Lys
plasminogen occurred quickly in this system. Lys-plasm inogen
is a much better substrate for tPA and, even in the fluid
phase, considerable activation can take place (Wiman and
Collen, 1977). Efficient generation of plasmin on ECM may be
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due to a much higher Lys/Glu ratio. Several investigations
have shown that neoplastic cells are capable of degrading
endothelial or SMC generated matrices and that such breakdown
is usually plasminogen dependent (Jones and DeClerk, 1983;
Laug et al_ 1983; Bogenmann and Jones, 1983) although this is
not always the case (Kramer et al_ 1982).
Plasminogen has been detected by immunofluorescence
staining in the basal layer of skin (Isseroff and Rifkin,
1983) but there are no reports of its location in oral
mucosa. In the present study, the localisation of
plasminogen in normal oral mucosa and oral squamous cell
carcinomas was undertaken by i m m u n o p e r o x i d a s e and
immunofluorescent staining techniques.
Chemical alteration of tissue during routine paraffin
embedding procedures often reduces reactivity of tissues
during subsequent immunoperoxidase staining. Fixation,
particularly by cross-1 inking fixatives, is known to reduce
the antigenicity of some tissues (Pearse, 1980; Mepham,
1982). Clearing agents such as xylene also have an
extracting process on cell cytoplasm (Zeitoun and Lehy, 1970)
and a deleterious effect on tissue immunoreactivity
(Matthews, 1981). Despite these drawbacks many antigens
frequently survive formaldehyde fixation and paraffin
embedding (Burns et a_l 1 974). The use of frozen (cryostat)
sections avoids the problems of chemical alteration of
tissues during paraffin embedding procedures. However,
although immunofluorescence can be carried out on unfLxed
sections, in practice, fixation is often necessary to
198
maintain the integrity of the tissue during staining.
Immunoperoxidase staining of paraffin embedded sections,
however, has definite advantages over immunofluroescence
staining using frozen sections: for example, permanent
preparations are obtained which can be studied by
conventional light microscopy, better morphological
preservation is achieved than with cryostat sections and
retrospective studies can be performed.
Immunoperoxidase staining was, therefore, used
initially in the present study in attempts to determine the
presence of plasminogen in sections of oral mucosa.
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4.2 IMMONOPEROXIDASE STAINING
4.2.1 Materials and Methods
Specimens of oral mucosa (12), salivary gland (4),
breast (2), and kidney (1) were fixed overnight in either 10%
neutral buffered formalin or Bouin's fixative and processed
for paraffin embedding. Sections were cut at 5 urn and placed
on slides pre-cleaned in chromic acid and coated with 0.1%
poly-L-lysine (MW 24,000; Sigma) and dried for at least 24h
at 37°C. Sections were deparaffinised in two changes of
xylene and processed through alcohol to 70% methanol.
Endogenous peroxidase activity was blocked by placing
the slides in 3% H2O2 in methanol for 30 min and then washing
in running tap water for 5 min. Non-specific binding of
unwanted antibodies in the serum was inhibited by pre¬
incubation of the slides in a 20% solution of normal swine
serum (Flow Labs) in Tris buffered saline (TBS) pH 7.6 for
15-30 min. This solution was drained off the slides and the
primary antibody-antiserum to human plasminogen, raised in
rabbits (Dakopatts), was applied to the sections at dilutions
from 1:25 to 1:200 for 30 min at room temperature. The
sections were then washed in two changes of TBS for 15 min.
and the bridging antibody, swine anti-rabbit Ig (Dakopatts),
was applied to the sections in a 1:30 dilution for 30 min.
The sections were again washed in two changes of TBS for 15
min. and covered with rabbit antiperoxidase-peroxidase
conjugated antibody (Dakopatts) at a 1:100 dilution for 30
min. After a final wash in TBS the sections were reacted
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with 0.005% H2C>2 in 3.3 diaminobenzidine tetra-hydrochloride
(0.5 mgml"*1) in Tris-HCl buffer pH 7.6 until a brown colour
was apparent. Sections were lightly counterstained in
Mayer's haematoxylin and mounted in DPX mountant (BDH
Chemicals).
Tissues were studied initially in this way but
subsequently further sections were " trypsinised" after
blocking with H202 in methanol, by placing in 0.1% trypsin
diluted in pre-warmed 0.1% calcium chloride for varying times
up to 60 min at 37° C followed by thorough washing in running
water.
In control sections primary antibody was either absent
or replaced with non-immune serum at dilutions from 1:25 to
1:100.
Antibodies to human plasminogen were also removed from
antiserum by affinity chromatography. Ten milligrams of
human plasminogen (Sigma) was dissolved in 2 ml of sodium
bicarbonate buffer (0.1M pH 8.3) containing 0.5 M NaCl, which
was then dialysed against two changes of the same buffer (100
ml/mg protein) to prevent unwanted coupling of Tns buffer
(present in lyophilised plasminogen) to the Sepharose gel.
One gram of cyanogen bromide activated Sepharose 4B
(Pharmacia) was swollen for 15 min. in a solution of ImM HC1
(200ml/g) and washed in the same solution on a sintered glass
filter (porosity G3). The plasminogen solution was then
mixed end over end with the swollen Sepharose gel at room
temperature for two hours. Residual active groups remaining
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on the gel after coupling were blocked by transferring the
gel to 0.2M glycine (pH 8.0) for 2h at room temperature.
Excess adsorbed protein was then removed by further washing
of the gel on a sintered glass filter in 5 successive changes
of sodium bicarbonate buffer (0.1M, pH 8.3) containing 0.5M
NaCl, followed by 0.1M acetate buffer (pH 4.0) containing
0.5M NaCl. The plasminogen-Sepharose conjugate was poured
into a 10 cm glass column with an internal diameter of 6 mm
(Pharmacia) attached to a peristatic pump (Pharmacia). The
plasminogen antiserum (Dakopatts) was dissolved at a 1:5
dilution in 5 ml of phosphate buffered saline and loaded onto
the column. The sample was eluted in phosphate buffered
saline with a flow rate of 0.5ml/min. and 18 x 1 ml fractions
collected. The absorbance of these fractions was measured at
280nm in a spectrophotometer to determine the presence of
antibody depleted antiserum. Fractions 5-9 containing
depleted antiserum were pooled. The depleted antiserum was
used in place of primary antiserum in immunostaining as a
further control.
4.2.2 Results
Sections of gingiva stained with plasminogen antiserum,
without a trypsin digest stage, showed pale diffuse staining
in gingival epithelium, which was most intense with a 1:25
dilution of antiserum. Sections in which primary antiserum
was replaced with non-immune serum also showed background
staining in the epithelium particularly with lower dilutions
of non-immune serum (1:25). Sections stained only weakly
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with antiserum to IgG and IgA (Table 26).
Staining of gingival mucosa with all antibodies was
markedly enhanced by the inclusion of a trypsin digest stage
(Table 27). Tryps inisation of sections for 10 min. was
optimal. Further trypsin digestion failed to improve the
quality of staining and after 30 min. in trypsin solution,
sections more readily floated off the slides during
subsequent staining procedures. Strong specific staining of
sections was observed with IgG and IgA antiserum using
dilutions as low as 1 : 200 - 1: 400 (Table 27). Both antisera
showed a different distribution of staining which was typical
of the normal pattern of distribution of the antigen (Fig.
89). No background staining was observed in the absence of
primary antiserum or after staining with non-immune serum.
Staining with antiserum to plasminogen showed specific
staining of endothelial cells lining vessels with dilutions
of antibody as low as 1:200. Inflammatory cells present in
the gingival mucosa also stained positively with antiserum to
human plasminogen (Fig. 90). The positive cells appeared to
be plasma cells. No staining was ever observed in these
cells in the absence of primary antibody or after staining
with non-immune serum (Fig. 91). Staining of inflammatory
cells was always intracellular. The morphology of
endothelial cells made it difficult to determine whether
plasminogen was intracellular or simply adsorbed onto the
cell surface.
In gingival epithelium, intense uniform staining was
203
TABLE26




































































































Section of gingival mucosa stained with polyclonal antiserum
to IgA (x400 mag).
 
FIG. 90
Section of gingival mucosa stained with polyclonal antiserum
to human plasminogen (1:200). Staining is observed in
endothelial cells lining vessels and in inflammatory cells
(xlOO mag).
FIG. 91
Section of gingival mucosa stained with non-immune serum
(1:100) (xlOO mag).
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Section of gingival mucosa stained with polyclonal antiserum
to human plasminogen (1:200) showing uniform staining in
epithelium except for surface keratin layers (x400 mag).
FIG. 93
Section of gingival mucosa stained with non-immune serum
(1: 100) (x400 mag).
 
observed in all layers of the epithelium using a 1:25
dilution of antiserum to plasminogen. Lower titres of
antibody (1:100-1:200) resulted in a weaker but still uniform
pattern of staining in the epithelium (Fig. 92). Indeed,
weak background staining was observed in epithelium stained
with non-immune serum at dilutions of 1:100 (Fig. 93) and
also in occasional sections stained only with tertiary
antibody.
The specificity of immunostaining with antiserum to
plasminogen was further studied after depletion of antibody
to human plasminogen by passing the antiserum over a
plasminogen-Sepharose linked gel. Staining of endothelial
cells and white blood cells was completely absent after
staining with antibody depleted antiserum. Within the same
series of sections, however, occasional non-specific staining
was still apparent in all the epithelial layers in the
absence of primary antibody or in sections stained with non¬
immune or antibody depleted antiserum. Immunoperoxidase
staining of minor salivary glands, breast and kidney
epithelium showed specific staining for plasminogen
in salivary gland and mammary gland duct cells and in renal
tubule cells (Figs. 94 and 95). Staining did not occur if
primary antibody was omitted during the staining procedure or
if antibody depleted antiserum was used.
In Summary:
1. Immunoperoxidase staining of untryps inised sections was
weak after staining with IgG or IgA antisera and absent
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FIG. 94
Section of salivary gland stained with polyclonal antiserum
to human plasminogen (1:200), showing staining in duct
epithelium (x200 mag).
FIG. 95
Section of salivary gland stained with non-immune serum
(1:100) (x200 mag).
 
after staining with low dilutions of anti-plasminogen
antiserum.
Staining of trypsinised sections of oral mucosa with
anti-plasminogen antiserum resulted in uniform staining
in all layers of the gingival epithelium, however,
background staining was sometimes observed in sections if
primary antibody was omitted during staining procedures,
after staining with antibody depleted antiserum, or with
PAP complexes used alone in the staining procedure.
In trypsinised sections, staining with anti-plasminogen
serum was specific to endothelial cells and certain




Immunofluorescence studies were therefore carried out to
determine whether or not more specific staining for
plasminogen could be obtained.
4.3.1 Materials and Methods
Sections of gingival mucosa (11) and oral sqamous cell
carcinomas (13) were collected directly from surgery in serum
free medium and frozen in OKT mountant in a stream of carbon
dioxide vapour. Sections (4um) were cut in a cryostat and
mounted on pre-cleaned slides. Sections were fixed for up to
12 hours in one of three fixatives: ice cold acetone,
methanol or 70% methanol. Antiserum to human plasminogen,
raised in rabbits (Dakopatts), was applied to sections at
dilutions ranging from 1:10 - 1:50 in TBS for lh at room
temperature. The sections were gently washed in two changes
of TBS for 15 min. and fluorescein conjugated anti-rabbit
immunoglobulin (Dakopatts) applied at dilutions from 1:10 -
1:50. The sections were then washed in two changes of TBS
and counterstained with Mayer's haematoxylin. Sections were
mounted in buffered glycerol (BDH Chemicals). Fluorescence
in sections was photographed using XPI 400 ASA film in a
Leitz Dialux microscope with fluorescence filter 12 (450—
490nm). In control sections primary antiserum was replaced








Strongstainininbasalnd pricklecellayersofepith¬ eliumw theakbackground staininginotherepi el al layersandconn ctivetissue
♦♦ ♦♦
1:50




























Section of gingival mucosa
stained with polyclonal
antiserum to human plasmin¬
ogen (1:20). Fluorescence
is confined mainly to basal
eelIs (x200 mag).
FIG. 97




Section of gingival mucoa stained
with polyclonal antiserum to
human plasminogen (1:20), showing




Fig. 98 (x200 mag).
 
4.3.2 Results
No significant differences were observed in morphology
or preservation of antigenicity of the sections after
fixation with any of the fixatives as long as fixation times
were kept short, ie less than lh. Prolonged fixation, for
example overnight, markedly reduced tissue immunoreactivity.
Optimal staining was achieved using a 1:20 dilution of
plasminogen antiserum and a 1:20 dilution of FITC conjugated
antiserum. Lower dilutions, particularly of primary
antiserum (1:10), increased the level of background staining
(Table 28). All sections of gingival mucosa stained
positively for plasminogen in the basal layer of the
epithelium (Figs. 96 and 97). Staining, which was
intracellular, was most intense and consistent in the basal
layer of epithelium, although not all basal cells stained
positively in each section. Staining also occurred, although
less frequently in prickle cells (Figs. 98 and 99).
Endothelial cells and cells and plasma within vessels also
fluoresced when stained with antiserum to plasminogen.
Staining was never observed at these sites if primary
antiserum was omitted during the staining procedure or if
antibody depleted antiserum to plasminogen or non immune
serum was used in place of the primary antiserum.
Specific staining with plasminogen antiserum was
observed in eight of the thirteen oral squamous cell
carcinoma specimens stained. Staining occurred mainly in
tumour cells and vessel endothelium with occasional staining
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in connective tissue. Examples of these are shown in Figs.
100 to 104.
No staining was observed if primary antiserum was
replaced with TBS during the staining procedures or after
staining with non-immune serum or antibody depleted
antiserum.
Fewer of the carcinomas fluoresced after staining with
antiserum to plasminogen when compared to gingival mucosa,
and staining tended to be weaker.
In Summary:
1. Highly specific staining of basal and prickle cells was
observed in sections of normal oral mucosa after staining
with antiserum to human plasminogen.
2. Only eight of the thirteen specimens of oral squamous
cell carcinomas showed epithelial cells staining
positively for plasminogen and staining tended to be
weaker.
3. No staining was observed in any of these sections if
primary antiserum was omitted during the staining




Section of oral squamous cell carcinoma stained with
polyclonal antiserum to human plasminogen (1:20).
Fluorescence is observed in fragments of epithelium on the
surface of sections (xlOO mag).
FIG. 101
Light micrograph of,Fig. 100 (xlOO mag).
 
FIG. 102
Section of oral squamous cell carcinoma stained with
polyclonal antiserum to human plasminogen (1:20).
Fluorescence is observed in narrow cords of infiltrating
tumour cells (xlOO mag).
FIG. 103
Light micrograph of Fig. 102 (xlOO mag).
 
FIG. 104
Section of oral squamous cell carcinoma stained with
polyclonal antiserum to human plasminogen (1:20). Bright




Immunoperoxidase staining of sections of gingival
mucosa untreated with proteolytic enzymes was found, in
agreement with other authors, to be weak or absent. (Curran
and Jones, 1978; Mepham et a_l 1979; Preatorius-Clausen,
1988). In earlier studies, paraffin embedded tissues fixed
in unbuffered formalin, or in acetic acid containing
fixatives, which increased permeability of cell membranes
were shown to retain greater tissue reactivity (Curran and
Jones, 1977). These authors, therefore, postulated that many
antigens were not necessarily destroyed by cross linking
fixatives but were made inaccessible to the large molecules
used in immunoperoxidase staining. Digestion of sections,
particularly by trypsin, was found to be very useful in
unmasking antigens in tissues fixed in buffered formalin
(Mepham et a_l 1979; Curran and Gregory, 1980). The process
of trypsin digestion may act to increase tissue permeability
or act directly on the antigen to free cross linked molecules.
Trypsin digestion of sections of gingival mucosa
resulted in highly specific staining of tissues with
antiserum to IgG and IgA, with no background staining in the
absence of primary antiserum or after staining with non¬
immune serum. Similar specific staining with anti-
plasminogen serum was observed in endothelial cells lining
vessels and within inflammatory cells in the connective
tissue of gingival mucosa sections. It is unclear, iue to
the morphology of endothelial cells, whether staining for
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plasminogen was intracellular. Endothelial cells have been
shown to readily adsorb plasminogen onto their cell surface
(Hajjar et al_ 1986) and it seems unlikely that endothelial
cells would synthesize plasminogen as it is abundant in the
local environment. In contrast, plasminogen in inflammatory
cells was intracytoplasmic and is possibly synthesized in
these cells. The inflammatory cells were of an undetermined
lineage but, on the basis of their morphology, they may have
been plasma cells or of myeloid origin. Plasminogen may be
associated with a phagocytic function as activated
macrophages are known to secrete plasminogen activator
(Unkeless et aJL 1974) although the presence of plasminogen
within these cells has not been reported.
In the present study immunoperoxidase staining for
plasminogen in gingival epithelium was less clear. In
epithelium lining salivary gland ducts, breast duct and
kidney tubules, staining with anti-plasminogen serum was
specific. No background staining was apparent in
the epithelium in sections stained in the absence of primary
antibody, with non-immune serum or antibody depleted
antiserum. Strong staining also occurred in stratified
gingival epithelium, but staining was always uniform
throughout the epithelial layers except occasionally in the
surface keratin layers. These findings would suggest that
plasminogen is distributed evenly in cells in all epithelial
layers at any given time. In view of the complex nature of
protease cascades this seems unlikely and it may be that non¬
specific staining occurred with the plasminogen antibody.
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Indeed, weak diffuse staining was also seen in these sections
in the absence of primary antibody or in sections stained
with non-immune or antibody depleted antiserum. Background
staining was also occasionally observed in sections stained
only with the PAP complex. Cross reactivity of other
antibodies in the primary antiserum may account for the lack
of specificity of staining, however, it does not account for
the staining in sections in the absence of this antiserum.
Non specific binding of antibodies to cytokeratin
tonofilaments has been reported by other authors (Curran and
Gregory, 1980). It may be that this is the cause of non
specific staining in sections in the present study.
Antigenicity of plasminogen may also have been affected by
other stages in the paraffin embedding process. Matthews
(1981) demonstrated that reagents other than cross linking
fixatives have a markedly deleterious effect on tissue
reactivity. In view of the difficulties encountered using
this technique, no other stages in the process were
investigated in this study.
Immunofluorescence staining of frozen sections of
gingival mucosa, fixed very briefly in either methanol or
cold acetone, showed more limited staining with anti-
plasminogen serum. Fluorescing cells were confined mainly to
the basal layer of epithelium although not all cells in the
basal layer stained positively. Occasional cells in the
prickle cell layer also stained positively with antiserum to
plasminogen. Isseroff and Rifkin ( 1983) and Nakagawa et aj_
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(1984) similarly detected plasminogen in the basal layer of
epithelium in skin using indirect immunofluorescence,
however, unlike the findings in the present study, staining
was confined only to the basal layer of the epithelium.
Staining in gingival epithelium was intracytoplasmic
but it is uncertain whether or not plasminogen is synthesized
in these cells. Basement membranes do not exclude plasma
proteins (Squier and Rooney, 1976) and plasma proteins have
been demonstrated, by immunoperoxidase staining, in gingival
epithelium (Genco et a_l 1974; Brandtzaeg, 1974; Coruh and
Mason, 1980). In most of these studies IgG and IgA were
demonstrated in intercellular spaces in the epithelium. In a
later study, however, Reibel (1982) showed that larger
molecules such as IgM and fibrinogen (Mr 340,000) were
present both inter and intrace 1 1 u 1 ar ly. Intracellular
fibrinogen was, however, confined to damaged cells in
inflammed oral mucosa. Plasminogen (Mr 92,000) is a smaller
molecule than fibrinogen and may also diffuse across the
basement membrane. Plasminogen is already known to bind to
basement membrane components and to a number of cell types
including endothelial cells, and to a limited extent
fibroblasts and smooth muscle cells (Hajjar et al_ 1 9 8 6 ;
Knusden et al 1 9 8 6) although it is unclear whether
plasminogen actually enters cells.
The presence of plasminogen in gingival epithelium can
therefore be explained, either by diffusion into the
epithelium, or by its synthesis in these cells. If positive
staining for plasminogen results from diffusion of this
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plasma protein across the basement membrane, the presence of
both a diffusion gradient and intercellular staining may be
expected, but neither were observed in sections stained with
immunoperoxidase or immunofluorescence staining techniques.
Plasminogen may be synthesised by basal cells which
retain this plasminogen as they move into the prickle cell
layer. This may explain the less frequent staining for
plasminogen in these cells. The absence of staining for
plasminogen elsewhere requires further investigation.
A possible role for plasminogen in the differentiation
of epithelium has been suggested by in vitro studies. Green
(1977) collected squames from supernatants of cultured
foreskin epithelium and found after further incubation of the
sloughed cells, that they required the presence of
plasminogen containing serum for nuclear digestion to occur.
Since the nuclear envelope develops before nuclear digestion
is complete, the envelope must either remain permeable to
plasminogen or plasminogen must be present before the nuclear
envelope has formed.
No plasminogen was detected in the cornified layers of
epithelium in gingival mucosa. Plasminogen has similarly
been detected by others only in the basal layer of epidermis
(Isseroff and Rifkin, 1983; Nakagawa et a_l 1984). These
findings are inconsistent with a role for plasminogen in
terminal differentiation iri vivo, although it is possible
that sufficient plasminogen is present in cells for nuclear
digestion to occur but not in sufficient quantity to be
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detected by immunofluorescence staining.
A role for plasminogen in tumour epithelial cells is
less difficult to suggest. Malignant cells express the
common property of invasion and destruction of surrounding
tissues. The process of cell invasion has generally been
considered to involve the production of proteases (Laug et al^
1975; Jones and deClerk, 1980; Kramer, 1982) and plasmin
has been shown to initiate the breakdown of the extracellular
matrix components fibronectin and laminin (Liotta et a_l
1981). Whether plasminogen is bound to tumour cells or is
synthesized i.n situ, an enhanced generation of plasmin
possibly by tumour epithelial plasminogen activator, could be
an important event in invasion and early implantation of
micro-metastases in blood vessel walls or stroma.
In one study, plasminogen has been demonstrated by
immunofluorescence staining to bind to the surface of tumour
cells in colon carcinoma (Burtin et a_l 1985). Plasminogen
stained the contours of tumour glandular structures, foci of
tumour cells and isolated tumour cells but no
intracytoplasmic staining was observed. The authors
suggested that plasminogen exuding from blood capillaries
within the tumour diffuses into the stroma and binds to
tumour cells. Plasmin once formed there may then play a role
in invasion of tumour cells, dissociation of tumour cells
from the main mass and the production of necrosis within the
tumour mass.
In this study, plasminogen was detected in eight of the
thirteen specimens of oral squamous cell carcinoma stained by
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immunofluorescence. In five of the positive biopsy specimens
tissue had been excised from the junction between normal and
malignant tissue, so should be representative of the tumour
invasion zone. The precise location from which tumour tissue
was taken in other specimens was not known. Plasminogen
staining in oral squamous cell carcinomas was intracellular
and not simply bound to the cell surface. Again the
question of intracellular synthesis versus endocytosis of
plasminogen within these cells cannot be answered using these
techniques, although it is interesting to note that Burtin
et a 1 (1985) failed to detect intracytoplasmic staining in
similar cells.
Using in vitro studies, Bogenmann and Jones (1983) have
demonstrated that degradation of matrix proteins by the
tumour cell lines HT1080 (human fibrosarcoma), B161F (mouse
melanoma) and a human rhabdomyosarcoma was plasminogen
dependent particularly in low cell density cultures. The
dependency for plasminogen changed with cell density and time
in culture, degradation becoming largely plasminogen
independent. Further breakdown of matrix proteins, at high
cell densities, may be achieved by other serine proteases or
by cathepsins which are known to be synthesised by some
melanoma cell lines (Sloane et a_l 1982). Such modulation of
plasminogen dependent degradation of matrix proteins suggests
that the pattern of hydrolytic enzymes produced iji vivo may
be responsive to environmental influences such as tumour site
or tumour cell density. Biswas et al (1978) found that the
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implantation site of V-2 carcinoma in rabbits determined
whether or not extractable collagenase was produced. In
another study Cajot et a_l (1986) characterised and
quantitated plasminogen activator expressed by human primary
colon carcinomas and colon carcinoma cell lines Col 112 and
Col 115 inoculated into outbred mice. They found that
subcutaneous grafts of Col 112 and Col 115 behaved as non¬
invasive well circumscribed tumours, while those cells
injected into the gastro-intestina1 tract had a highly
invasive growth pattern. Their studies also demonstrated a
good correlation between the production of plasminogen
activator and the malignant phenotype. Gastro-intestina1
extracts contained higher PA-PAI complexes than subcutaneous
implants, therefore lower plasminogen activator production
was not simply under inhibitor control. Alterations in
plasminogen activator activity may well result from
modulatory effects of the host tissue environment. Such
effects may include the availability of plasminogen at tumour
sites.
Of particular importance to tumour invasion was the
finding that plasminogen, which is bound to a surface, is
activated with much greater efficiency than fluid phase
plasminogen (Hajjar et a_l 1986 : Knudsen et a_l^ 1 98 6). In
addition, plasminogen which binds to matrix proteins,
possibly via lysine binding sites, is protected from the fast
acting inhibitor alpha-2-antiplasmin. This inhibitor relies
for its action on binding to plasminogen and plasmin via
lysine binding sites (Harpel, 1981), however, when these are
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occupied by matrix proteins even a 100 fold excess of
inhibitor was not able to abolish plasmin activity in
experimental systems (Knudsen et a_l 1 9 8 6). Only small
amounts of plasminogen and plasminogen activator may
therefore be required for lytic activity to occur and
protection from inhibitors would also result in prolongation
of plasmin activity. The synthesis of plasminogen by oral
squamous cell carcinomas, which may also synthesise
plasminogen activators would, therefore, confer an obvious
advantage for tumour invasion.
4.5 SUMMARY
Plasminogen has been detected by indirect
immunofluorescence in the basal and prickle cells in gingival
epithelium. Its function in these cells remains unclear but
it may be involved in aspects of terminal differentiation and
cell movement in epithelium.
Plasminogen was also detected intracellularly in tumour
epithelial cells. Its presence in these cells, particularly
at the site of tumour invasion, may enhance local generation





The association between malignancy and increased
plasminogen activator activity was observed as early as 1925
by Fischer. This experimental approach involved assaying for
plasminogen activators in fragments of normal and neoplastic
tissue and has disadvantages. Such samples include not only
tumour elements but vascular endothelium, blood and
inflammatory cells all of which may produce plasminogen
activator.
Interest in the role of plasminogen activator in the
modulation of tumour behaviour was renewed in the 1970's when
increased synthesis of plasminogen activator was detected
after transformation of cells in vitro (Ossowski et aj_ 1973;
Unkeless et a_l 1974; Pollack et a_l 1974; Quigley e_t al_
1974) .
Since this time a large number of studies have sought
to correlate enhanced plasminogen activator synthesis with
various parameters; including morphological transformation
of cells (Balduzzi and Murphy, 1975 ; Decker e_t aj_ 1 977),
tumourigenicity (Pollack et a_l 1 9 75 ; Laug et a_l 1 9 7 5 ;
Adelman et a_l 1981; Ramshaw et aj_ 1986) and metastatic
capacity of transformed cells lines or neoplastic tissues
(Wang et a_l 1980; Eisenbach et a_l 1985). Whilst there
appeared, in many cases, to be an obvious correlation between
these events, apparently conflicting findings were reported
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(Mott et a_l 1974; Wolf and Goldberg, 1976; Nicholson et
al 1976; Montesano et al^ 1977; Whur et a 1^ 1980) in which
plasminogen activator was either not necessary or was
insufficient for tumour invasion.
The emergence of uPA as the key enzyme in malignant
tissues (Markus et a_l 1 9 8 3 ; Mira-y-Lopez et al^ 1 9 83 ;
Ossowski et al^ 1983; Burtin et a_l 1985; Khoga et a_l 1985;
Camiolo and Greco, 1986; Mignatti et a_l 1986; Busso et aj^
1987) and the discovery of pro-enzyme forms of plasminogen
activators (Kielberg et a_l 1985) and specific inhibitors of
both uPA and tPA (Sprengers and Kluft, 1987) have meant that
much of the work to date requires re-evaluation.
Further more, it was recognised that for plasminogen
activator to have a causal role in tumour invasion, the
overall activator content may not necessarily be higher than
that of normal tissues but that the activator must at least
be located in areas where tumour invasion occurs. Analysis,
therefore, of the occurrence of activators in tumour tissues
should be coupled with histochemical studies of plasminogen
activators.
Early histochemical studies were performed using the
fibrin overlay technique (Peterson and Zettergen, 1970;
Peterson et al. 1975) but those failed to distinguish between
uPA and tPA activity. Since fibrin potentiates the action of
tPA it is possible that mainly tissue activator was localised
in these studies. Many of these studies also failed to
localise plasminogen activators in cancer cells (Weiss and
Beller, 1969; Svanberg et al 1975; Newstead et a_l_ 1 9 7 6 ;
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Ljungner et a_l 1 984) which may be the result of PA-inhibitors
in these tissues.
The development of specific antibodies to uPA and tPA
and the use of non-fibrin based assays has allowed a clearer
picture of the role of plasminogen activator in neoplasia to
emerge. To date, however, few have been reported. In human
colon carcinomas, uPA has been identified by
immunocytochemistry in neoplastic cells and is particularly
intense in transitional areas between normal and neoplastic
tissue and in areas of tumour invasion (Markus et al_ 1983 ;
Burtin et a_l 1985; Khoga et al_ 1985).
In considering the role of plasminogen activators in
cancer several questions must now be addressed.
Investigations should elucidate whether transformed cells or
specific tumours contain plasminogen activators, how this
property influences the functional behaviour of neoplastic
cells and whether elimination of these plasminogen activators
inhibits tumour invasion and metastases.
In the present study it has been demonstrated 'hat
normal oral epithelium contains plasminogen activators,
although their precise functions in epithelium are still ill
understood. Epithelial cells in oral squamous cell
carcinomas also contain plasminogen activators of both uPA
and tPA types although staining for activators was weak and
may be due to the presence of inhibitors in the tissue.
However, plasminogen, which may protect plasmir. i^r.
activators from the action of inhibitors, was also identified
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in sections of oral squamous cell carcinomas at the junction
between normal and malignant tissues.
Whether sufficient enzyme is present in these tissues
to modulate tumour behaviour is unknown. Regulation of
plasmin activity occurs at many levels:
At a subcellular level, there may be increased transcription
of PA genes, repression of constitutive biosynthesis of PA-
inhibitors or increased synthesis of enzymes which activate
pro-PA. Indeed, it has recently been shown in HeLa cells in
vitro that increased transcription of PA genes occurs in
response to tumour promoters (Waller and Schleuning, 1985).
Activation of pro-enzymes of plasminogen activator represent
a further point at which the plasmin cascade may be
controlled. The assumption that pro-enzymes will be
activated by trace amounts of proteases in the extracellular
compartment is incorrect. Evidence has shown that a
proportion of plasminogen activator secreted from cells can
remain in the single chain form (Skriver et a_l 1 984). The
mechanisms which control pro-enzyme activation may involve
PA-inhibitors; however, as yet, little information
concerning these mechanisms has been reported. In addition,
inhibitors of proteases which are abundant in tissues, may
further modulate extracellular proteolytic activity.
Furthermore, plasminogen activator production in cells in
vitro is subject to hormonal control at physiological
concentrations of these hormones. These may exert
qualitatively similar effects on tumours ijn vivo.
In experimental studies, which seek to define a role
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for plasminogen activator in neoplasia, plasminogen
activators must be identified, appropriate methods of
assaying enzyme activity must be employed and the relative
contribution of pro-enzymes and their inhibitors assayed.
For many human diseases, tissue culture is often the
only method with which to study disease processes. In the
present study an iri vitro model was developed in which to
quantitate plasminogen activators in normal and neoplastic
epithelial cultures. Many early efforts to grow epithelium
in vitro have been hampered by the rapid differentiation of
epithelium and its overgrowth by fibroblasts. Advances in
tissue culture techniques particularly the emergence of new
media for keratinocyte growth (Tsao et a_l 1982; Boyce and
Ham, 1983) have altered the balance in favour of cellular
proliferation and have extended the lifespan of such
cultures.
In this study the size of biopsy material limited
methods available for culturing tissue and oral keratmocytes
were grown in explant culture in a minimally supplemented
medium. Oral epithelium in. vitro forms a multilayered
stratifying tissue similar to parent tissue i_n vivo. The
pattern of growth and differentiation of epithelium iri vitro
is remarkably alike in a number of tissue culture systems
(Holbrook and Hennings, 1983) and the reproducibility of this
model makes it useful in the study of normal physiology and
disease processes.
Cultures established from oral squamous cell
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carcinomas were shown, by EM and immunoperoxidase staining,
to contain nearly pure populations of epithelial cells.
These cells retained a morphology associated with the
malignant phenotype, a reduced capacity to differentiate,
altered cell-cell and cell-substrate adhesion, increased cell
migration and increased growth rate. Tumour heterogeneity
does, however, constitutes a major problem in the
investigation of cancer cells. Different areas of the tumour,
and particularly sub-populations selected .in vitro, may
differ with respect to the properties being investigated. By
using primary cultures, the genetic and phenoytpic properties
of the cultures were as close as possible to the parent
tissue (Fidler and Hart, 1978).
Using a fibrin based assay, plasminogen activator
activity in tumour cultures grown for four weeks in vitro was
shown to be significantly lower than that of gingival
keratinocyte cultures. The predominant activator synthesized
by both normal and malignant tissues was uPA and differences
in enzyme activity were not, therefore, the results of the
potentiating action of fibrin on tPA activity in the samples.
SDS-PAGE separates plasminogen activators from non-
complexed and complexed inhibitors in samples. In comparing
normal and tumour extracts expressing equivalent levels of
activity on fibrin plates, tumours were found to contain much
higher levels of plasminogen activator activity than gingival
keratinocyte cultures. Tumour cultures therefore contain
both higher levels of plasminogen activator and PA-inhibitors
than their equivalent normal counterpart. Tumour
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supernatants were also shown to contain more PA-PAI complexes
than gingival keratinocyte cultures. These observations,
therefore, support the hypothesis that malignant cells
synthesize and secrete more plasminogen activator than
normal tissues.
Findings in this work indicate that plasminogen
activators, particularly uPA, and its substrate, plasminogen,
are present in normal epithelium and neoplastic tissue both
in vivo and i_n vitro.
Whether these activators function in tumour invasion
and metastases is unknown. The hormonal milieu of the local
environment is obviously an important factor. In addition,
increased synthesis of PA-inhibitor by tumours may ablate
proteolytic activity at the site of invasion and
immunocytochemical localisation of these complexes _in vivo
may help clarify their role. Interestingly, plasminogen,
which was also detected in transitional areas between normal
and malignant tissue in oral squamous cell carcinomas,
protects plasminogen activator from the action of plasmin
inhibitors in i_n vitro systems (Knudsen et al_ 1986). No
evidence is available concerning the interactions between
plasminogen and PA-inhibitors.
Through the use of animal models of tumour invasion,
involving the injection of cultured cells, a causative role
for plasminogen activator in tissue degradation and
metastases can be further investigated.
Inhibition of tumour formation and metastases in animals by
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specific inhibitors of uPA and tPA, and hormonal modulation
of enzyme activity would provide sound evidence concerning
the role of plasminogen activators in tumour biology.
Few studies of this nature have been reported in the
literature. Recently, however, Mira-y-Lopez et a_l (1983)
found that hydrocortisone reversibly blocked the growth of
mammary tumours in mice and that growth rate of the tumours
resumed at control rates if exogenously supplied
hydrocortisone was withdrawn. They also found that pre-
treatment with hydrocortisone could delay the appearance of
primary tumours and reduced their numbers. Hydrocortisone
reduction of tumours in mice was correlated with a reduction
in plasminogen activator activity in tumour cells. Later
Busso et al_ (1987) showed that the reduction in plasminogen
activator activity of dexamethasone treated cells resulted
from a decrease in the concentration of uPA mRNA and a
decrease in the synthesis of single chain pro-enzyme but also
from increased synthesis of PA-inhibitor. The hormonal
milieu of the local environment is therefore of considerable
importance. Certain polypeptides for example are also known
to increase plasminogen activator activity (Lee and
Weinstein, 1978; Dayer et a_l 1981, Sudol et a_l 1 985).
Since many tumour cells are capable of synthesizing their own
growth hormones by autocrine secretion (DeLarco and Todaro,
1978) this mechanism may play an important role in the
aggressiveness of a particular tumour. Furthermore, Laiho et
al (1986) have shown that transforming growth factor-beta is
capable of inducing plasminogen activator synthesis, in
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fibroblasts. Enhancement of secretion of plasminogen
activator in adjacent normal tissues by tumour cell TGF-beta
may lead to an increase in plasminogen activator activity in
the vicinity of tumour cells. The site of injection of
tumour xenografts into nude mice has also been shown to
influence the production of plasminogen activator synthesis
by these tumours (Cajot et a_l 1986). Enzyme synthesis by
these tumours was correlated with tumour invasiveness. Such
differences in plasminogen activator production may well be
the result of differences in expression of hormones at these
sites.
Conclusive evidence of the involvement of plasminogen
activator synthesis and metastases has been shown in only one
study to date. Ossowski and Reich (1983) found that
antibodies which specifically inhibited the enzyme activity
of human uPA but not chicken uPA decreased metastases of
human tumour (Hep-3) to chicken lung after transplantation
onto the chorioallantoic membrane of chick embryos. Since
growth at the site of injection was not inhibited, then uPA
must play an important role at an early stage in the
metastatic process.
Further such studies as these are obviously required to
gain a better understanding of the role of plasminogen
activators in tumour invasion. The in vitro model described
in the present study in which plasminogen activators and
their inhibitors have been identified and characterised
should provide a useful tool to assist the further
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